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ABSTRACT  
 
In recent years, there has been a growing interest in natural and traditional medicines for the 
treatment of wounds.  Attempts to find agents that promote wound-healing and that are 
affordable, effective and non-toxic have a long history.  In South Africa, hundreds of different 
indigenous plants are used to treat wounds and burns.  The merits of relatively few of these 
have been scientifically evaluated.  Bulbine natalensis and Bulbine frutescens of the 
Asphodelaceae family are indigenous to southern Africa and are widely used as a skin remedy.  
This study aimed to investigate the in vitro and in vivo effect of Bulbine natalensis and Bulbine 
frutescens on cutaneous wound healing. 
 
In vitro cell culture study: In vitro studies were carried out on dermal fibroblasts and human 
keratinocytes cultured under standard conditions using Iscove’s Modified Eagles Medium 
(MEM) and Dulbecco’s MEM respectively. Confluent cultures of both cell lines were treated with 
varying concentrations of the leaf extracts of B. frutescens and B. natalensis.  These cultures were 
subjected to the MTT, WST-1 and BrdU assays to determine the cytotoxicity and proliferation 
effect of the extracts.  In addition, migration of cells across a score was analysed over a 48 hour 
period.  In vivo animal study:  Excisional and incisional wounds were created on the back of 12 
domestic pigs.  Mirror imaged wounds were created as control wounds. The excisional wounds 
were biopsied at days 2, 4, 7, 10 and 16 and the incisional wounds were biopsied at day 16.  The 
rate of closure of the wounds was also recorded. Each excisional wound was analyzed for its 
biochemical composition by estimating the total amount of protein, DNA, collagen and 
hexosamine that was present in the wound tissue.  The wound healing process was documented 
histologically (using haematoxylin and eosin and a Mallory’s trichrome stain) and 
immunohistochemically (using anti- α smooth muscle actin, vascular endothelial growth factor 
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and transforming growth factor β receptors I and II).  The incisional wounds were used to test 
tensile strength of the healed wounds using a tensiometer. 
 
In the in vitro studies, neither extract caused cytotoxicity to either the fibroblast or keratinocyte 
cells.  Cell proliferation was greater than 100% at 0.1-5 and 100-300 μg/ml for Bulbine 
natalensis and at 0.1μg/ml for Bulbine frutescens.   There was no significant difference in the 
effects of the two leaf extracts on cell proliferation.  The biochemical analysis of the wound 
tissue showed a significant increase in the collagen, protein and total DNA content of both B 
frutescens and natalensis treated wounds when compared to the untreated wounds.  There was 
no significant difference in the hexosamine content of both B. frutescens- and B. natalensis-
treated and untreated wounds. Analysis of the wound tissue displayed an increase rate of 
closure of the wound tissue treated with B. frutescens and B. natalensis when compared to the 
untreated wounds.  Full re-epithelialisation of both treated wounds occurred earlier than in the 
untreated wounds.   
 
  These findings have important implications for the use of these extracts to treat wound 
healing.  
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1. INTRODUCTION 
 
The use of traditional medicines is firmly entrenched in the cultural practices of 
developing countries (Makunga et al., 2008).   Globally however, and especially in 
developed countries, there has been a ‘cultural renaissance’ towards natural methods 
of healing (Makunga et al., 2008).  In the United States alone, 62% of the population 
use complementary and alternative medicines contributing annually to a US$20 
billion industry (Makunga et al., 2008).  The World Health Organisation (WHO) 
estimated that about 80% of the world’s population still rely on plant based 
medicines for their primary health care needs (WHO, 2002).  Medicines derived from 
such plants as Cinchona succirubra and Cinchona ledgeriana (for quinine; an anti-
malarial), Papaver somniferum (for codeine and morphine; both analgesics) and 
Digitalis purpurea or Digitalis lanata (for digoxin; a cardiac glycoside) are widely 
used (Rates, 2000). More recently, newer drugs such as taxol (from the yew tree, 
Taxus brevifolia) have been developed for use in cancer therapy (Murphy et al., 1993; 
Harvey, 2001; Teicher, 2008).   
 
There has been a growing interest in natural and traditional medicines for wound 
healing, driven largely by the extremely high financial burden of the treatment of 
wounds (Tonnesen et al., 2000).   Tonnesen et al. (2000) estimated that in the United 
States alone, there are at least a total of 2.5 million acute wounds per annum, arising 
from burns.   The ideal therapy for wound healing should be affordable, effective and 
non-toxic.  Prevention of infection and the associated discomfort of wound healing 
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are also of major importance in the search for agents that expedite healing (Shukla et 
al., 1999).    
 
Approximately one-third of all traditional medicines are used for the treatment of 
wounds or skin disorders, compared to only 1-3% of modern drugs (Mantle et al., 
2001).  The use of such medicinal plant extracts has arguably been based largely on 
historical or anecdotal evidence, since there is relatively little scientific data 
supporting these claims.  Similarly in South Africa, while hundreds of different plants 
are used by traditional healers to treat wounds and burns, the merits of relatively few 
of these have been scientifically evaluated.  One plant, indigenous to southern Africa 
and widely used as a skin remedy by people of both African and European decent is 
Bulbine of the Asphodelaceae family (Van Wyk and Gericke, 2000).   
 
1.1 Bulbine  
 
According to Hutchings et al. (1996) and Van Wyk et al. (2002), the Bulbine species 
used in South Africa for its (skin) wound healing properties are Bulbine asphodeloides 
(B. asphodeloides), Bulbine frutescens (B. frutescens) and Bulbine natalensis (B. 
natalensis) (Table 1.1).   
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Table 1.1 Bulbine species used in traditional medicine 
Genus Synonyms Common/Vernacular Names 
B. asphodeloides  ‘copaiva’, ‘geelkatstert’, ‘kopieva’, ‘wildekopieva’, 
‘ibhucu’, ‘intelezi’, ‘mmele’ 
B. frutescens B. caulescens 
B. rostrata 
burn jelly plant, cat’s tail,  ‘balsemkopiva’, 
‘rankkopieva’, yellow & orange garlic, 
‘ingelwane’, ‘ibhucu’, ‘ithethe elimpofu’ 
B. natalensis B. latifolia 
B. brunsvigiaefolia 
‘rooiwortel’, ‘ibhucu’ , ‘ibucu’ 
 
This study focuses on the effect of two of these Bulbine species on wound healing:  B. 
natalensis and B. frutescens (Fig. 1.1) as B. asphodeloides is less commonly used for 
wound healing in South Africa. 
 
Figure 1.1:  A. B. natalensis with broad, fleshy leaves; B. B. natalensis inflorescens;                                                    
C. B. frutescens with long fleshy leaves and D. B. frutescens inflorescens 
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B. natalensis is a perennial with broad pointed fleshy leaves (Fig. 1.1).   It has long, 
thin flowering stems with clusters of star-shaped yellow flowers.  This plant is 
indigenous to southern Africa particularly South Africa, Malawi, Zimababwe and 
Mozambique.  In South Africa, it favours the provinces of Kwa-Zulu Natal and Eastern 
Cape. B. frutescens is a geophytic shrublet with numerous long, bright green leaves.  It 
grows in dense short masses with yellow or orange flowers (Fig. 1.1).  It is found 
throughout South Africa, preferring dry areas like the Northern, Western and Eastern 
Cape (Joffe, 1993; Dyson, 1998).   The leaves of both the plants are filled with a clear 
gel similar in appearance and consistency to the gel from the leaves of Aloe vera.   
 
The gel of both these Bulbine species is commonly used by traditional healers and the 
local population for the treatment of wounds, burns, rashes, itches, ringworm, 
cracked lips and herpes, and is applied directly to the skin or used in the form of a 
warm poultice (Hutchings et al., 1996).   
 
Although the stem and root of Bulbine are known to contain anthraquinones such as 
chrysophanol (which has anti-bacterial properties) and knipholone (Van Staden and 
Drewes,  1994; Van Wyk et al., 1995), these are thought to be of minor importance in 
wound healing.  Rabe and Van Staden (1997) tested the antimicrobial activity of 
water and methanol extracts of the leaf sap of B. frutescens on cultures of 
Staphylococcus aureus, Staphylococcus epidermis, Bascillus subtilis, Escherichia coli  
and Klebsiella pneumoniae.  They concluded that there was no antimicrobial activity 
attributed to the extracts of B. frutescens.  Abegaz et al. (2002) however found that 
several phenylanthraquinones isolated from B. frutescens displayed antiparasitic 
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activity when tested against Plasmodium falciparum, Trypanosoma cruzi and 
Trypanosoma brucei rhodesiense. 
 
It is not known which component of the Bulbine plant is effective in wound healing.  
Van Wyk et al. (2002) speculated that since Bulbine belongs to the same family as 
Aloe vera, its  healing effect is more likely to be due to glycoproteins (such as  aloctin 
A and aloctin B) which have been found in the leaf gel of Aloe vera, a plant 
internationally recognised for its healing properties. These glycoproteins have not 
yet been identified in Bulbine, nor have their effects been scientifically evaluated.  
 
1.2  Cutaneous (skin) wound-healing 
 
Skin is composed of three layers: an epidermis, dermis and variable hypodermis.  The 
epidermis is the surface layer in contact with the environment (Fig. 1.2).  It consists 
of stratified squamous keratinised epithelium. The predominant cell type in the 
epidermis is the keratinocyte.  Other cells found in the epidermis include 
melanocytes, Langerhans cells and Merkel’s cells.  The epidermis consists of several 
layers that reflect the stages in the process of keratinocyte maturation or 
keratinisation.  In thick skin, these layers are, from the basement membrane to the 
exterior, the stratum basale, the stratum spinosum, the stratum granulosum, the 
stratum lucidum and the stratum corneum (Fig. 1.2).  In thin skin, the stratum 
lucidum is absent (Junquiera and Carneiro, 2005; Ross and Pawlina, 2005).   
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Figure 1.2: Histological structure of thin skin from scalp.                                                                                              
A. epidermis and dermis(x5); B. epidermis (x100) 
E- epidermis; HF- hair follicle; D- dermis; SC- stratum corneum; SG- stratum granulosum; SS- stratum 
spinosum; SB-stratum basale.   
(Histology Collection of the School of Anatomical Sciences, University of the Witwatersrand) 
 
 
The stratum basale is the deepest layer of the epidermis (Fig. 1.2).  The 
keratinocytes in this layer are small, cuboidal in shape and are attached to the 
basement membrane.  A variable amount of melanin is present in the cytoplasm of 
these cells which are transferred from the neighbouring melanocytes interspersed in 
this layer.  These keratinocytes in the basal layer are regarded as stem cells of the 
skin and can undergo mitosis (Marks and Miller, 2006).  The formation of new 
keratinocytes in this layer gradually pushes previously formed cells into the next 
layer, the stratum spinosum.    The keratinocytes in this layer are polygonal in shape 
and, following fixation, remain in contact with each other by a system of intercellular 
bridges formed from small cytoplasmic projections on the cell surface.  The 
cytoplasm of the cells in this layer contain many tonofilaments (intermediate 
filaments) which are particularly concentrated in the cytoplasmic projections leading 
into the desmosomes and are more numerous in the layers closer to the stratum 
A B 
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granulosum, the next layer of the epidermis (Junquiera and Carneiro, 2005; Ross and 
Pawlina, 2005).  As keratinocytes approach the surface of the epidermis, they 
accumulate intermediate filaments and secrete a waxy material into the intercellular 
space; these changes are visible in the stratum granulosum.   In thick skin, the 
stratum granulosum consists of a few layers of flattened cells while in thin skin, a 
single layer may be visible. The cytoplasm of the keratinocytes in the stratum 
granulosum contains numerous, keratohyalin granules. The keratohyalin granules 
form "free" accumulations in the cytoplasm of the cells.  Together, the intermediate 
filaments and the contents of the keratohyalin granules form the fibrous protein, 
keratin.  In addition, the cells of the stratum granulosum contain membrane-bound 
granules which contain a mixture of lipids. The keratinocytes of this layer release the 
contents of these granules into the intracellular spaces. The lipids fill the entire 
interstitial space, which is important for the epidermis to function as a barrier to the 
external environment (Junquiera and Carneiro, 2005; Ross and Pawlina, 2005).  The 
next layer of the epidermis is the stratum lucidum, which consists of several layers 
of flattened dead cells. The nuclei of the keratinocytes begin to degenerate in the 
more superficial layers of the stratum granulosum. In the stratum lucidum, faint 
nuclear outlines are visible in only a few of the cells.  In human thin skin, the stratum 
lucidum is absent.  As maturing keratinocytes seal off the intercellular spaces through 
which they receive nutrients, they eventually die and form the stratum corneum, a 
tough and relatively impermeable layer of hardened, dead cells.  In the stratum 
corneum, cells are completely filled with keratin filaments.  Individual cells are 
difficult to observe because nuclei can no longer be identified, the cells are very flat 
and the space between the cells has been filled with lipids, which cement the cells 
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together into a continuous membrane. Closest to the surface of the epidermis, the 
stratum corneum has a somewhat looser appearance. Eventually, as cells reach the 
surface, they are sloughed off (Junquiera and Carneiro, 2005; Ross and Pawlina, 
2005).  In human skin, the entire epidermis above the basal layer is replenished 
within about two to four weeks.  Replacement is accelerated by injury.   
 
The epidermis forms an uneven boundary with the dermis characterized by 
fingerlike connective tissue protrusions of the dermis, called dermal papillae, into the 
epidermis.  This is complimented by similar epidermal protrusions called epidermal 
ridges or rete ridges (Fig. 1.2A).   The dermis is generally described as having two 
distinct layers: the papillary layer and the reticular layer (Junquiera and Carneiro, 
2005; Ross and Pawlina, 2005).  The papillary layer consists of loose connective 
tissue immediately below the epidermis.  This layer is relatively thin and includes the 
area of the dermal papillae.  The collagen fibers (predominantly type I and III) in this 
layer are not as thick as in the reticular layer.   There is an irregular network of elastic 
fibers present.  The reticular layer lies immediately below the papillary layer and is 
the thicker and less cellular layer of the two.  It contains thick irregular bundles of 
collagen (mostly type I) and coarser elastic fibres.  The dermis contains many 
specialized cells and structures.  These include the hair follicles (normally associated 
with the arrector pili muscle), associated sebaceous and apocrine glands, eccrine 
(sweat) glands, blood vessels, nerves and specialized nerve cells.  The major cell 
types found in the dermis include fibroblasts (which normally replenish the 
extracellular matrix (ECM)), endothelial cells (found lining vessels and capillaries), 
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macrophages (normally present, but increase in number during inflammation) and 
platelets (which release growth factors and adherence proteins during 
inflammation) (Junquiera and Carneiro, 2005; Ross and Pawlina, 2005).   
 
Skin, while structurally adapted to serve as a protective barrier is also vulnerable to 
injury.   Wound healing is a well ordered response to injury characterised by diverse 
cellular activities that include inflammation, cell migration, angiogenesis (formation 
of new blood vessels) and matrix deposition (Brown et al., 1992).  The repair of a 
wound is a complex process, generally independent of the form or site of injury 
(Rosenberg and de la Torre, 2003).  Skin healing is predominantly a process of re-
epithelialisation and contraction through a process of connective tissue repair (Leitch 
et al., 1993).  Re-epithelialisation is the process of restoring an intact epidermis after 
cutaneous injury (Li et al., 2007) and is keratinocyte-dependant (Fig. 1.3).  The 
process of contraction, which is defined as the closure of an open wound by the 
inward movement of the surrounding integument (Leitch et al., 1993), is fibroblast-
dependant (Cho-Lee and Moon, 2003).  The end product is a predominantly collagen, 
fibrous scar.   
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Figure 1.3: The process of re-epithelialisation (modified from Parks, 1999) 
 
Re-epithelialisation involves several processes viz. keratinocyte migration from areas 
adjacent to the wound, keratinocyte proliferation, differentiation of the neo-
epithelium into a stratified epidermis and the formation of an intact basement 
membrane (Li et al., 2007).    
 
 Collagen and other components of the ground substance are synthesized in the 
highly vascular granulation tissue that is formed within the wound space.  Since 
collagen provides strength and integrity to the dermis and other supporting tissues, 
its synthesis, secretion and subsequent organization plays an integral role in wound 
healing (Chithra et al., 1998a; 1998b).   
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The three overlapping stages of wound-healing are (Fig. 1.4): 
a.  inflammation (haemostasis and inflammation)  
b.  proliferation and  
c.  tissue remodelling or maturation. 
 
Figure 1.4: Stages of wound healing (Kloth and McCulloch, 2002) 
A- inflammatory phase; B- proliferative phase and C- maturation phase 
 
 
In each of these stages, specific components play a part through several mediators 
(Kloth and McCulloch, 2002).  The following is a brief summary of the phases of 
wound healing: 
A 
B 
C 
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a. The inflammatory phase 
The inflammatory phase (also called the exudative phase) is characterized by 
haemostasis and inflammation.  It is initiated immediately after injury by the release 
of several growth factors, cytokines and low-molecular-weight compounds from the 
serum of the injured blood vessels and granulating platelets (Werner and Grose, 
2003).  Collagen activates the clotting cascade, initiating the inflammatory phase. The 
damaged cell membranes release thromboxane A2 and prostaglandin 2-α, potent 
vasoconstrictors. This initial response helps to limit haemorrhage (Werner and 
Grose, 2003).   
 
Multiple chemokines (Table 1.2), including epidermal growth factor (EGF), 
fibronectin, fibrinogen, histamine, platelet-derived growth factor (PDGF), serotonin, 
and von Willebrand factor are released in the first few hours following wounding 
(Singer and Clark, 1999). These factors help stabilize the wound through clot 
formation which is composed of cross-linked fibrin and extracellular matrix (ECM) 
proteins such as fibronectin, vitronectin and thrombospondin (Clark, 1993; Werner 
and Grose, 2003). The blood clot provides a matrix for invading cells and acts as a 
reservoir for growth factors required in the proceeding stages of wound healing 
(Werner and Grose, 2003). 
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Table 1.2: Cytokines in wound healing (adapted from Singer and Clark, 1999) 
Cytokines Major Source Target Cells and Major Effects 
Epidermal growth factor (EGF) 
family 
Epidermal and mesenchymal 
regeneration 
EGF platelets Pleiotropic cell motility and proliferation 
Transforming 
growth factor (TGF)α 
macrophages, 
epidermal 
cells 
Pleiotropic cell motility and proliferation 
Heparin binding EGF macrophages Pleiotropic cell motility and proliferation 
Fibroblast Growth Factor (FGF) 
family 
Wound vascularisation 
Basic FGF macrophages, 
endothelial 
cells 
Angiogenesis and fibroblast proliferation 
Acidic FGF macrophages, 
endothelial 
cells 
Angiogenesis and fibroblast proliferation 
Keratinocyte GF fibroblasts Epidermal cell motility and fibroblast 
proliferation 
Transforming Growth Factor (TGF) 
β family 
Fibrosis and increased tensile strength 
TGFβ1 and  TGFβ2 platelets, 
macrophages 
Epidermal cell motility, chemotaxis of 
macrophages and fibroblasts, ECM 
synthesis and remodelling 
TGFβ3 macrophages Anti-scarring effects 
Other  
Platelet derived GF 
(PDGF) 
platelets, 
macrophages, 
epidermal 
cells 
Fibroblast proliferation and 
chemoattraction, macrophage 
chemoattraction and activation 
Vascular endothelial 
GF (VEGF) 
epidermal 
cells, 
macrophages 
Angiogenesis, increase vascular 
permeability 
Tumor necrosis 
factorα (TNFα) 
neutrophils Pleiotropic expression of growth factors 
Interleukin-1 (IL-1) neutrophils Pleiotropic expression of growth factors 
Insulin like GF 1 fibroblasts, 
epidermal 
cells 
Re-epithelialisation and granulation tissue 
formation 
Colony-stimulating 
GF 1 
multiple cells Macrophage activation and granulation 
tissue formation 
 
The chemokines recruit inflammatory leucocytes to the wound site. The infiltrating 
neutrophils kill bacteria and decontaminate the wound of foreign debris (Singer and 
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Clark, 1999) (Fig. 1.5). In response to specific chemo-attractants, monocytes also 
infiltrate the wound and become activated macrophages which initiate the formation 
of granulation tissue.  These invading cells also produce a variety of proteinases and 
reactive oxygen species as a defence against microorganisms and are involved in 
phagocytosis of debris (Werner and Grose, 2003). These cells are also essential for 
wound healing and secrete numerous enzymes and cytokines (Table 1.2), e.g. 
collagenases, which debride the wound, degrading collagen around the damaged 
cells; interleukins and tumor necrosis factor (TNF) which stimulate fibroblasts and 
 
Figure 1.5: Inflammatory phase - A cutaneous wound three days after injury- the wound is filled 
with a fibrin clot and inflammatory cells have invaded the wound area. TGF-β1, TGF-β2  and TGF-β3 - 
transforming growth factor β1,  β2 and  β3, respectively; TGF-α- transfroming growth factor α; FGF- 
fibroblast growth factor; VEGF- vascular endothelial growth factor; PDGF- platelet derived growth factor; 
IGF- insulin like growth factor and KGF- keratinocyte growth factor [Singer and Clark (1999).] 
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promote angiogenesis; and transforming growth factor (TGF) which stimulates 
keratinocytes (Rosenberg and de la Torre, 2003).  This step marks the transition to 
the process of tissue reconstruction, ie, the proliferative phase.  
 
b. The proliferative phase 
The second stage of wound-healing is the proliferative phase (Fig. 1.6). 
Epithelialisation, angiogenesis, granulation tissue formation, and collagen deposition 
are the principal steps in this anabolic portion of wound-healing (Singer and Clark, 
1999). If the basement membrane remains intact, the epithelial cells migrate towards 
the surface in the normal pattern. This is equivalent to a first-degree skin burn and 
the normal layers of epidermis are restored in 2-3 days. If the basement membrane 
has been destroyed which is similar to a second- or third-degree burn, then the 
wound is re-epithelialised from the normal epidermal cells at the periphery of  the 
wound and from the skin appendages, if intact (e.g., hair follicles, sweat glands) 
(Rosenberg and de la Torre, 2003).    
 
Granulation tissue begins to form approximately 4 days after injury (Tonnesen et al., 
2000). Numerous new capillaries are found in the granular substance.  Macrophages 
and blood vessels move into the wound space (Moulin et al., 2000).  Macrophages 
provide a continuing source of cytokines which are needed to stimulate fibroplasia 
and angiogenesis.  Fibroblasts in the neighbourhood of the wound begin to 
proliferate and migrate into the wound matrix where they produce large amounts of 
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ground substance and then collagen (Fig. 1.6).  Glycosaminoglycans and 
proteoglycans are synthesized by fibroblasts in the wound area.  These substances 
form a highly hydrated gel-like ground substance, a provisional matrix in which the 
collagen fibers are embedded.  As the collagen accumulates, hexosamine levels 
decrease (Dunphy and Udupa, 1955).  In addition, fibroblasts in the wound area 
acquire a contractile phenotype and transform into myofibroblasts (Werner and 
Grose, 2003).  Myofibroblasts play a major role in wound contraction.  
 
Figure 1.6: A cutaneous wound five days after injury- blood vessels are sprouting into the fibrin clot 
as epidermal cells resurface the wound.  Proteinases thought to be necessary for migration are shown. U-
PA- urokinase-type plasminogen activator; MMP-1,2,3 and 13- matrix metalloproteinases 1, 2, 3, and 13; 
t-PA- tissue plasminogen activator   (Singer and Clark, 1999) 
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The ultimate part of the proliferative phase is granulation tissue formation. This 
commences approximately four days after injury.  Initially, granulation tissue is 
composed of fibroblasts and macrophages, and then blood vessels move into the 
wound space (Fig. 1.6).  As the granulation tissue matures, the ECM components 
appear.  The fibroblasts are responsible for the synthesis, deposition and remodelling 
of the ECM (Singer and Clark, 1999).   
 
Angiogenesis plays an important role in wound healing and newly formed blood 
vessels constitute 60% of repair tissue (Shukla et al., 1999). The formation of new 
blood vessels is necessary to sustain the newly formed granulation tissue.  
Angiogenesis is a complex process that relies on the ECM in the wound bed as well as 
the migration and mitogenic stimulation of the endothelial cells (Madri et al., 1996).  
The resulting connective tissue in the wound area is known as granulation tissue 
because of the granular appearance of the numerous capillaries within it.   
 
The factors which stimulate angiogensis in wound healing are gradually being 
elucidated.  Initially, it was thought that FGF-1 (acidic FGF) and FGF-2 (basic FGF) 
were responsible for angiogenesis (Folkman and Klagsbrun, 1987).  More recently, 
other factors have been shown to have angiogenic properties e.g. VEGF, TGFβ, 
angiogenin, angiopoietin and human mast cell tryptase.    It is thus now well accepted 
that several growth factors assist wound healing. 
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The ground substance is deposited into the wound bed, followed by collagen 
deposition as the wound undergoes the final phase of repair. Many different 
cytokines are involved in the proliferative phase of wound repair (Rosenberg and de 
la Torre, 2003).  The exact mechanisms of how these cytokines effect proliferation is 
not yet fully understood.  Some of the cytokines include PDGF, insulin-like growth 
factor (IGF), and EGF. All are necessary for collagen formation. Once an abundant 
collagen matrix has been deposited in the wound, the fibroblasts stop producing 
collagen and the fibroblast-rich granulation tissue is replaced by a relatively acellular 
scar (Singer and Clark, 1999).  The scar tissue is mechanically insufficient and lacks 
appendages, including hair follicles, sebaceous glands and sweat glands (Werner and 
Grose, 2003). 
 
c.  The maturation phase  
 
The final phase of wound healing is the maturation (re-modelling) phase. The 
wound undergoes contraction, ultimately resulting in a smaller amount of apparent 
scar tissue. The entire process is a dynamic continuum with an overlap of each of the 
preceding phases and continued remodelling which takes more than a year to 
complete.   One of the crucial processes in wound healing is the progressive increase 
in biomechanical strength of the healing tissue.  Stabilization of the new matrix and 
increase in mechanical strength results from the formation and maturation of 
intermolecular collagen cross-links.  These links are initially bivalent and then 
convert into the multivalent mature cross-links as scar tissue matures (Paul et al., 
1997).  The strength of a wound therefore relates to the size, number and 
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architectural arrangement of the collagen fibrils (Berthod et al., 2001). Tensile 
strength is a quantitative parameter that can be correlated with the degree of cell 
proliferation of fibroblasts and the alignment and density of the collagen fibre 
networks in the dermis (Cho-Lee and Moon, 2003).  The wound reaches maximal 
strength at one year, with a tensile strength that is 30% of normal skin (Singer and 
Clark, 1999). Collagen deposition continues for a prolonged period, but the net 
increase in collagen deposition plateaus after 21 days (Rosenberg and de la Torre, 
2003).   
 
The synthesized collagen molecules are laid down at the wound site and become 
cross linked to form fibers.  Wound strength is acquired from both the remodelling of 
the collagen and the formation of stable intra- and inter-molecular cross links.  If the 
tensile strength of the wound which was treated with an exogenous agent is greater 
than the untreated wound, then it may be inferred that the agent not only increases 
collagen synthesis, but also aids in the cross linking of the protein (Chithra et al., 
1998b). 
 
The process of wound healing appears to be controlled by multiple growth factors 
and chemokines.  The roles of many of the endogenous growth factors have only been 
partly elucidated based on expression studies or cell culture studies.  The in vivo 
function of many of these growth factors still remains to be confirmed (Werner and 
Grose, 2003).   
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1.3 Vascular endothelial growth factor (VEGF) in wound healing 
 
VEGF (initially named vascular permeability factor, VPF) currently includes VEGF-A, 
VEGF-B, VEGF-C, VEGF-D, VEGF-E and placenta growth factor (PLGF) (Werner and 
Grose, 2003, Kapoor et al., 2006).  VEGFs are structurally closely related to the  
platelet derived growth factors (PDGF) (Kapoor et al., 2006).  VEGFs exert their 
function by binding to three different trans-membrane tyrosine kinase receptors viz. 
VEGFR-1, VEGFR-2 and VEGFR-3 (Fig. 1.8).  VEGF-A and its associated receptors 
VEGFR-1 and VEGFR-2 has been recognized as the major regulator of vasculogenesis 
and angiogenesis during development (Gale and Yancopoulos, 1999) and its role in 
the regulation of angiogenesis in wound healing has recently been noted (Werner and 
Grose, 2003).  Studies have shown that VEGF-A is strongly expressed after cutaneous 
injury by keratinocytes and macrophages (Brown et al., 1992,  Frank et al., 1996).  
The associated receptors have been detected in the blood vessels found in 
granulation tissue (Lauer et al., 2000). 
 
VEGF-A is an endothelial cell specific mitogen that exists as four variants based on 
molecular weight, in humans i.e. 121, 165, 189 and 206 amino acids.  VEGF121 and 
VEGF165 are exported from the cell while VEGF189 and VEGF206 are cell-associated 
(Elçin et al., 2001).  It has been previously reported that VEGF121 and VEGF165 are 
both readily available forms that are predominantly expressed in most human cells 
and tissues (Corral et al., 1999). VEGF165 appears to biologically active in 
physiological and pathological angiogenesis, being the most potent angiogenic 
protein known (Kapoor et al., 2006).   
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VEGF has a number of functions. It has potent angiogenic activity. It increases 
microvascular permeability, exerts mitogenic effects on endothelial cells stimulating 
their proliferation and migration.  It also induces the expression of interstitial 
collagenase and promotes macrophage migration (Elçin et al., 2001).  Reactive 
oxygen species which are thought to aid in killing bacteria also up-regulate VEGF 
expression (Bates and Pritchard-Jones, 2003).  VEGF is produced in large quantities 
by the epidermis (Tonnesen et al., 2000) especially in the basal layer (Kapoor et al., 
2006) during wound healing and is induced by hypoxia.  VEGF released by epidermal 
keratinocytes (Frank et al., 1995) is critical for angiogenesis during the proliferative 
phase of granulation tissue formation from day 4 to day 7 (Nissen et al., 1998; 
Tonnesen et al., 2000), peaking on day 7 following injury (Kapoor et al., 2006).  VEGF 
expression can be regulated by certain enzyme systems like nitric oxide syntase 
(NOS) and cyclooxygenase (COX) (Kapoor et al., 2006).   
 
 
1.4 Myofibroblasts in wound healing 
 
Myofibroblasts were first described by Gabiani in 1979 (Bates and Pritchard-Jones, 
2003) and are largely responsible for the contraction of the wound edges (Bates and 
Pritchard-Jones, 2003).   In the early stages of wound healing, fibroblasts invade the 
wound space where they proliferate and differentiate into myofibroblasts.  
Myofibroblasts are a unique group of ‘smooth-muscle-like fibroblasts’ containing α-
smooth muscle actin (αSMA) and a lesser amount of vimentin in their cytoplasm.  
These myofibroblasts are functionally different from fibroblasts in that they are 
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essential to neodermal formation and wound contraction (Moulin et al., 2001).  
Wound contraction occurs biphasically.  In the first phase immediately following 
wounding, contraction is myofibroblast independant.  In the second phase, 
myofibroblasts increase the rate of contraction by using an actin-myosin complex.  
Intracellular actin microfilaments terminate in adhesion complexes at the cell surface 
which connect them with the surrounding ECM and result in matrix reorganisation 
and wound contraction (Mirastschijski et al., 2004). 
 
Another important event in wound healing is the migration and growth of 
keratinocytes in the neo-epidermis followed by the formation of a complete 
basement membrane that ensures the structural and mechanical stability of the 
dermo-epithelial junction.  Keratinocyte interactions with fibroblasts differ from that 
of keratinocytes with myofibroblasts.  Moulin et al. (2000) suggest that 
myofibroblasts are involved in neo-epidermis formation and contraction whereas 
fibroblasts stimulate keratinocyte growth and neo-dermis formation.  Myofibroblasts 
have been shown to express VEGF mRNA (Bates and Pritchard-Jones, 2003). 
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1.5 Transforming growth factor β (TGF β) in wound healing 
 
The TGF-β superfamily comprises TGF-β (1-5, with only 1-3 in humans), inhibins, 
activins and bone morphogenic proteins (Kapoor et al., 2006).  TGF-β stimulates or 
inhibits the growth of many cell types, depending upon the presence of other growth 
factors and is a potent chemo-attractant for macrophages (Lynch et al., 1998). 
 
The effects of TGF-β are mediated by heteromeric receptor complexes consisting of 
receptor type I (TGFβRI) and receptor type II (TGFβRII) which activate intracellular 
signalling cascades (Werner and Grose, 2003).  Three isoforms of TGF-β exist in 
mammalian tissue viz., TGF-β1, TGF-β2 and TGF-β3. They are usually secreted in a 
complex with latent TGF-β-binding protein which is removed extracellularly to 
release the active TGF-β (Werner and Grose, 2003) (Fig. 1.7). Active TGF-βs then 
mediate their function by binding to the receptor complex.  In addition, they bind 
with high affinity to a non-signalling type III receptor (TGFβRIII) (Fig. 1.7).  The three 
TGF- βs have distinct but overlapping functions.  They are mitogenic for fibroblasts , 
but inhibit proliferation of most other cells, including keratinocytes. They are also 
stimulators of the expression of ECM proteins and integrins (Massagué, 1990). 
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Figure 1.7: Transforming growth factor β receptors (TGF-βR): TGF-β is secreted as an inactivated 
precursor which binds to latency associated protein (LAP).  When activated, TGF-β is either sequestered 
by extracellular binding proteins or it binds to receptor type III which then presents it to receptor type II 
or I. (Werner and Grose, 2003) 
 
 
There is a continuous supply of TGF-βs during wound healing (Massagué, 1990). 
Following injury, TGF-β1 is released by platelets.  This acts as a chemoattractant for 
neutrophils, macrophages and fibroblasts.  The presence of these cells further 
increases TGF-βs secretions.  All three isoforms of TGF-β have been detected in 
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wound healing with the distribution of each isoform being characteristic.  Rapid 
induction of TGF-β1 and TGF-β2 occurs early in wound healing while TGF-β3 
expression is seen in later stages of wound healing.  TGF-β1 and TGF-β2 are 
stimulators of ECM production.  The TGFβRI and TGFβRII are widely distributed and 
found on essentially all cell types (Gold et al., 1997 and Schmid et al., 1998).  TGF-β 
stimulates fibroblast division at low concentrations, but stimulates differentiation at 
high concentrations (Slavin, 1996). The differentiated phenotype is associated with 
increased ECM production.   It is thought that TGF-βs stimulate re-epithelialisation 
and granulation tissue formation.  TGF-β1 plays a central role in cutaneous scar 
formation and is a potential target for anti-scarring agents.  TGF-β3 is an antagonist 
of TGF-β1 (Kapoor et al., 2006).   
 
 
 
1.6 Animal models in wound healing experiments 
 
The medical literature describes a number of in vitro and in vivo wound healing 
models (Sullivan et al., 2001).  In vivo testing of potential intervention therapies is 
important as in vitro assays are limited in their ability to replicate all of the factors 
which interact in complex biological processes such as wound healing (Vardaxis et al., 
1997).  While human studies may be the most ideal, they are often complicated and 
impractical, especially in identifying sufficient numbers of patients with identical and 
similar wounds (Sullivan et al., 2001).  In addition, objective measurements of human 
wound healing are difficult in that these experiments require numerous biopsies for 
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histological assessment during the healing period.  It is for this reason that animal 
studies provide a suitable alternative to assess the efficacy of potential therapies 
(Sullivan et al., 2001). 
 
It is important to choose an animal model carefully for wound healing studies.  
Wound healing research has been carried out on numerous animal models viz. rat, 
mouse, rabbit, guinea pig and more recently, the pig.  Smaller animal models are often 
preferred due to the cost and ease of handling (Sullivan et al., 2001).   This however is 
not ideal as these smaller animals differ considerably both anatomically and 
physiologically, from human subjects.  Smaller animals typically have dense body hair 
and a thin epidermis and dermis.  Healing is also primarily through contraction 
rather than re-epithelialisation (Sullivan et al., 2001).   
 
The pig has proven to be a superior model to assess wound healing interventions 
(Vardaxis et al., 1997) as its skin is both anatomically and physiologically similar to 
human skin (Sullivan et al., 2001) (Fig. 1.8).  Pig skin consists of two layers: the 
epidermis and dermis, with a relatively thick hypodermis consisting of fat.  The 
epidermis is a stratified sqaumous keratinised epithelium.  Both stratum granulosum 
and stratum basale are filled with basophilic granules (Mowafy and Cassens, 1975).  
The porcine epidermis is thrown into a great number of folds resulting in the 
formation with well developed rete-ridges (Winter, 1972; Vardaxis et al., 1997; 
Sullivan et al., 2001).   Studies on pig and human skin have shown a similar epidermal 
thickness and dermal-epidermal ratio (Vardaxis et al., 1997; Sullivan et al., 2001).  In 
addition, both skin types have comparable hair and blood vessel size, orientation and 
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distribution.  Biochemically, porcine collagen is like human collagen and is therefore 
used in a number of wound healing products (Heinrich et al., 1971).   
 
Both pig and human have apocrine sweat glands in their skin (Montagna and Yun, 
1964).  In addition, the panniculus carnosus which is found in smaller loose skinned 
animal models is absent in pigs and humans (Sullivan et al., 2001). 
 
 
 
 
 
 
 
 
 
 
Figure 1.8: Histological features of pig skin and human skin. 
 A-pig skin; B-human skin x10, H&E (Sullivan, 2001) 
 
 
Functionally, pig and human skin both have a similar epidermal total turnover time - 
porcine skin is ~30 days and human skin is ~27-28 days (Vardaxis et al., 1997).  The 
type of keratinous proteins and the lipid composition of the stratum corneum are 
comparable in both skin types.   Immunohistochemical studies have also shown 
similar expression patterns and responses to growth factors such as EGF, IL-1α, bFGF 
and PDGF (Wollina, 1991). 
Hair follicle 
A B 
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  While there are many similarities between porcine and human skin, differences do 
exist.  In porcine skin, the stratum lucidum is absent in the epidermal layer. This skin 
is thus similar to thin skin of humans rather than the thick skin. The pig contains no 
eccrine glands.  Unlike human skin, porcine skin has lower elastic fibre content 
(Montagna and Yun, 1964) but this is higher than in other mammals. Mast cells are 
abundant in the papillary layer of porcine skin.  Hence, the pig has a rapid and 
marked mast cell sensitivity to stress.  The sub-epidermal plexus is less developed in 
the pig (Sullivan et al., 2001).  Yet in spite of these differences, Sullivan et al. (2001) 
concluded in a review of the pig as a wound healing model, that healing in porcine 
skin was comparable to human skin and that pig skin is an excellent tool for the 
evaluation of potential therapeutic agents for wound healing.  The use of pigs in 
wound healing studies however is infrequent due to the cost of using pigs over that of 
other smaller animals (Sullivan et al., 2001).  In addition, pigs are difficult to handle 
and grow quickly.   
 
In this study, the pig was chosen as the in vivo animal model, as porcine skin has 
many similarities to human skin in anatomical structure and in the process of wound 
healing. 
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1.7 Wound creation models 
 
In vivo animal studies usually utilise two methods of creating the wound area that is 
to be studied viz. incisional and excisional wounding.  The choice of these wound 
types depend on the parameters of wound healing to be analysed.  
 
Incisional wounds 
 
Incisional wounds are formed by cutting the skin with a surgical blade.  This results 
in rapid disruption of the tissue integrity with minimal collateral damage.  There is 
rapid release of blood cells into the wound space, haemostasis and the formation of a 
fibrin clot.  Pig skin, like human skin is firmly attached to the underlying structures 
and gapes little in this type of incision (Sullivan et al., 2001).  These wounds may be 
closed with sutures, staples or clips.  This results in rapid and efficient bridging of the 
wound edges by granulation tissue and the new epithelium.  This type of wound is 
excellent for biomechanical analysis of wound strength. It is less adequate for 
histological assessment of healing because of the limited volume:area ratio of wound 
healing activity (Davidson, 2001). 
 
Excisional wounds 
Excisional wounds involve the removal of an area of the tissue.  The area which 
begins to heal provides an adequate sample for determining biochemical and 
histological analysis (Davidson, 2001). In full thickness wounds, there is complete 
removal of the epidermis and dermis to the depth of the fascial plane or 
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subcutaneous fat (Davidson, 2001). The wound that is formed then heals by cell 
migration from the wound margin and the formation of a fibrin clot (eschar) that is 
invaded by granulation tissue. Various devices are used to generate this type of lesion 
in a standardized fashion, including biopsy punch, scalpel, and dermatome (Davidson, 
2001). This model offers the advantages of significant wound volume, involvement of 
all dermal components, and epithelialisation only from the wound margins.  The 
ability to analyze chemistry, histology, and cell populations in the wound site  
(Davidson, 2001) is afforded by the larger volume:area of tissue. The rate of healing is 
monitored as a percentage of the total excisional volume (or cross-sectional area) 
filled with granulation tissue (neo-epidermis), extent of re-epithelialisation, 
histological organization of connective tissue, angiogenesis, and biochemical content 
of collagen or proteoglycans (Davidson, 2001).  
 
Study Rationale  
 
As seen from this brief review, wound-healing is a complex process in which many 
different cell types, processes and factors are involved.  The main goal of wound 
management is rapid wound closure and a functional aesthetic scar.  Plant extracts 
may influence one or more of the pathways involved in wound-healing.  If an 
indigenous plant, traditionally used for healing, can be scientifically proven to 
enhance the healing process, this would be of major beneficial value to the people of 
South Africa in particular. 
 
In order to investigate the effect of a plant extract, the process of wound-healing 
needs to be uncoupled in the first instance, and certain processes e.g. 
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epithelialization, fibroblast proliferation and collagen deposition, would initially need 
to be examined.  This will be followed by studies of wound healing in an in vivo 
situation in both an animal and human model. 
 
 
AIM OF STUDY 
The aim of this study was to compare the in vitro and in vivo effect of B. frutescens and 
B. natalensis on cutaneous wound healing.  The investigation involved three parts; the 
aims of each are detailed below: 
 
Part 1 - An in vitro study of the effects of B. natalensis and B. 
frutescens on human epidermal keratinocytes and dermal 
fibroblasts: 
A. To investigate and compare the effect of the leaf gel of B. frutescens and B. 
natalensis on human dermal fibroblast and human keratinocyte cell cultures.  The 
following aspects were examined on each of the cell lines: 
a. the cytotoxic effect of the extracts 
b. the proliferative effect of the extracts 
c. the migratory effect of the extracts 
d. the antimicrobial effect of the extracts 
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Part 2 - An in vivo animal study of the effects of B. natalensis- and B. 
frutescens-treated wounds compared to untreated wounds in pig 
skin: 
To investigate the effect of the B. frutescens and B. natalensis leaf extracts on 
incisional and excisional full thickness skin wounds using an animal model.  The 
following aspects were studied: 
a. Rate of contracture and period of epithelialisation 
b. Mechanical strength of the re-epithelialised wound 
c. Biochemical analysis:  
i. estimation of collagen content 
ii. estimation of hexosamine content 
iii. estimation of total protein content 
iv. estimation of total DNA content  
d. Histological structure of wound closure 
e. Immunohistochemistry – to investigate the expression of α-smooth muscle 
actin (αSMA), VEGF and TGF-βRI and TGF-βRII 
 
Part 3 - An in vivo study human study of the effects of B. natalensis- 
and B. frutescens-treated wounds compared to untreated wounds in 
skin: 
To investigate the effect of the B. frutescens and B. natalensis leaf extracts on 
superficial lesions on human skin. 
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2. MATERIALS & METHODS 
2.1 Preparation of the Bulbine gels 
Plant material (i.e. B. frutescens and B. natalensis) for this study was sourced from the 
Walter Sisulu Botanical Gardens in Roodepoort, Johannesburg.  The taxonomic 
identity of the plants was confirmed by the principal horticulturalist.  The plant 
voucher numbers were:  B. frutescens, GSIS323 and B. natalensis, GSIS324.  
 
In an initial pilot study, the gel from the leaves of B. frutescens and B. natalensis was 
prepared individually according to the method used by Chithra et al. (1998a; 1998b) 
for the preparation of the leaf gel extract from the Aloe vera plant.  Briefly, the full 
size mature leaves from each plant were cut.  The rind was removed and the 
colourless parenchyma was ground in a blender and centrifuged at 10 000 rpm for 30 
minute at 4:C to remove the fibres.  The supernatant was lyophilized and frozen until 
needed.  The lyophilized gel was reconstituted with phosphate buffered saline (PBS) 
and then filtered using a sterile filter with a pore size of 0.2μm. This lyophilised leaf 
gel was initially used in the cell culture studies but did not have any effect on the cell 
cultures.  The use of the reconstituted gel without filter sterilisation was difficult 
because of the presence of a large number of fibrous strands which made viewing the 
cells difficult. 
 
Therefore, for all experiments reported in this thesis, an alternative method for the 
preparation of leaf extract was used.  The mature leaves of B. frutescens and B. 
natalensis plants were harvested and washed in running water.  The leaves were 
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wiped with 70% alcohol.  The exposed ends of each leaf were cut using a sterile 
surgical blade.  A sterile pizza machine was then used to squeeze the gel out of the 
leaves.  The gel was collected in a sterile petri dish.  Fresh gel was squeezed for each 
experiment.  The pH of the fresh leaf gel of B. frutescens and B. natalensis, tested using 
litmus paper, was 4 and 5, respectively.  This method of using the fresh gel was 
chosen because it is the fresh gel from the leaves that is used by the indigenous 
peoples of South Africa for treating skin ailments and wounds.   
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2.2 An in vitro study of the effects of B. natalensis and B. frutescens 
on human epidermal keratinocytes and dermal fibroblasts 
 
Human ethics clearance for this study was obtained from the University of the 
Witwatersrand Human Ethics Committee (M050108). 
 
The following two cell lines were used for all the experiments: 
1. The CCD-1140Sk normal adult dermal fibroblast cell line was purchased from 
the American Type Culture Collection® (ATCC®) (catalogue no. CRL-2714) and 
cultured in Iscove’s modified Eagles Medium (IMEM) supplemented with 10% 
fetal calf serum. 
2. The HaCaT cell line, an immortalized, but non-tumourgenic keratinocyte cell 
line which retains its differentiation potential (Boukamp et al., 1988) was 
generously provided by the German Cancer Research Center (DKFZ) and 
cultured in Dulbecco’s modified Eagles Medium (DMEM) supplemented with 
10% fetal calf serum and 0.1% penicillin/streptomycin . 
 
Monolayer cultures of both cell lines were maintained under standard culture 
techniques at 37°C in 5% CO2 in air.  IMEM, DMEM, fetal calf serum and all other 
reagents were obtained from Whitehead Scientific (Pty) Ltd, South Africa. 
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Figure 2.1: Flow diagram of tissue culture experiments 
 
 
The following assays were carried out on monolayer cultures of both the cell lines 
using B. frutescens and B. natalensis (Fig. 2.1): 
 
The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] cell 
viability assay (Mosmann, 1983) which is a standard colorimetric assay, was used to 
determine the cytotoxicity of the potential medicinal plants.  In this assay, the yellow 
MTT enters the cell mitochondria and is reduced to an insoluble purple formazan salt 
that can be quantified using spectrophotometry (Mosmann, 1983).   This assay was 
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done at the laboratory facilities of the School of Therapeutic Sciences (Faculty of 
Health Sciences, University of the Witwatersrand). Briefly, for all of the MTT assays, 
keratinocyte and fibroblast cells were seeded into Nunc® 96 well microplates at a 
concentration of 1.6 x105 cells per ml of medium.  The cell cultures were then treated 
with varying concentrations of the fresh leaf gel extracts prepared in medium (DMEM 
for keratinocytes and IMEM for fibroblasts) at the time of seeding. Wells with cells 
which were not treated with the extracts were used as the untreated control cultures, 
while wells which contained medium only (no cells) were used as a blank for 
spectrophotometry.  The cells were incubated at 37:C in 5% CO2 for 48 hours.  Four 
hours before the end of incubation, 20μl of the MTT solution (50mg/ml MTT made up 
in PBS (pH 7.4) (Appendix A1) was added to each well in the microplate. After four 
hours of incubation, the medium was removed from each well and replaced with 
150μl of dimethyl sulfoxide (DMSO) to dissolve the blue/purple crystals formed in 
the cells. The microplate was then read in a spectrophotometer at a test wavelength 
of 540nm and a reference wavelength of 690nm.  The viability of the cells was 
determined as a percentage of the untreated controls.  
 
The WST-1 assay which measures the metabolic activity of viable cells was used to 
measure in vitro cell proliferation. This assay is based on the cleavage of the 
tetrazolium salt WST-1 to a formazan dye by mitochondrial succinate-tetrazolium 
reductase in viable cells. As the cells proliferate, the quantity of the formazan dye 
increases (Brodie et al. 1999).  WST-1 has been reported to have increased sensitivity 
when compared to other cytotoxicity assays (Tan and Berridge, 2000).  Briefly, for all 
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of the WST-1 assays, cells were seeded into Nunc® 96 well microplates at a 
concentration of 1.6 x105 cells per ml of medium and incubated at 37°C in 5% CO2 in 
air for 24 hours.  Cells were treated with varying concentrations of the fresh leaf gel 
made up in the respective cell culture media. Wells with untreated cultures were 
used as controls, while wells which contained medium only and no cells were used as 
a blank for spectrophotometry.  The cells were then incubated for 24 hours after 
which 10μl of WST-1 was added to each well. Cells were then incubated for a further 
4 hours.  During this 4 hour period, the absorbance at 600nm was measured using a 
spectrophotometer at 0.5, 1, 2 and 4 hours.  The absorbance values obtained from the 
WST-1 assay are a direct correlation of cell number (Brodie et al. 1999). 
 
The Bromodeoxyuridine (BrdU) Cell Proliferation Assay in which BrdU (a 
synthetic analogue of thymidine) is incorporated into the newly synthesized DNA of 
replicating cells, was used to measure DNA synthesis of the cells. For all of the BrdU 
assays, cells were seeded into Nunc® 96 well microplates at a concentration of 1.6 
x105 cells per ml of medium and incubated at 37:C in 5% CO2 in air.  After two days, 
the cells were confluent and the medium was replaced with medium containing 
various concentrations (0.1-900μl/ml) of the fresh gel extracted from the leaves of B. 
frutescens and B. natalensis made up in the respective cell culture medium.  Following 
incubation for 24 hours, the cells were then washed in a PBS solution (Appendix A1). 
The BrdU kit (Calbiochem®; catalogue number QIA58) was used according to the 
manufacturer’s instructions. Briefly, the cells were treated with the BrdU antibody 
and incubated for 2 hours, then washed to remove any unbound antibody before 
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being treated with horseradish peroxidise-conjugated goat anti-mouse IgG HRP. 
Tetra-methyl benzidine was then added.  This results in a blue solution which 
changes to yellow with the addition of a stopping reagent. The plate was then read on 
a spectrophotometer at a wavelength of 540nm.  The intensity of the colour in each 
well is directly proportional to the amount of proliferation occurring.  
The Score Assay was used to measure the time in which a score made in the 
monolayer cultures ‘closed’ and to visualize the migration of the cells (Liang et al., 
2007).  For this assay, cells were seeded into Nunc® four well microplates at a 
concentration of 1.6 x105 cells per ml of medium (DMEM and IMEM for the 
keratinocyte and fibroblast cultures, respectively) and incubated at 37:C in 5% CO2 in 
air for 24 hours.  The cultures were then incubated for 24 hours with a 50% 
concentration of fresh gel extracted from the leaves of B. frutescens and B. natalensis 
made up in the respective media.  Thereafter, the medium was aspirated and 
replaced with fresh medium without any extract.  Untreated cultures were used as 
controls.  All cultures were then scored with a P200 pipette tip (Liang et al., 2007).  
The scores were photographed on a Carl Zeiss inverted phase control microscope at 
regular intervals over a period of 48 hours.  The time to ‘closure’ (i.e. full population 
of the score by the migrated cells) was recorded. 
All experiments were repeated six times. 
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Antimicrobial activity  
The leaf extracts were also analysed for their efficiency in preventing wound 
infection, decreasing the bacterial adherence or decreasing the bacterial proliferation 
of already colonized wounds. The minimal inhibitory concentration of the plant 
extracts against Staphylococcus aureas, Staphylococcus epidermidis and Pseudomonas 
aeruginosa was determined using the method of Eloff (1998) and the laboratory 
facilities of the School of Therapeutic Sciences (Faculty of Health Sciences, University 
of the Witwatersrand). These are the most common pathogens causing human wound 
infection. The leaf gel from B. natalensis and B. frutescens with a starting 
concentration of 64mg/ml was made up in sterile water .  This was then serially 
diluted in a 96 well microtiter plate.  Cultures (100μl of a 1% solution) of 
Staphylococcus aureus (ATCC® No. 6538), Staphylococcus epidermidis (ATCC® No. 
2223) and Pseudomonas aeruginosa (ATCC® No. 27858) made up in sterile Müller-
Hinton broth (Merck, Germany) were added to three rows each of the microtiter plate 
and incubated for 24 hours.  Thereafter, 40μl of 0.2mg/ml p-iodonitrotetrazolium 
violet (INT) (Sigma Aldrich) was added to each well. Six hours later the microtiter 
plate was visually assessed.  Spectrophotometer analysis was not performed as the 
microbial growth was distinctly evident in all wells. 
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2.3 An in vivo animal study of the effects of B. natalensis- and B. 
frutescens-treated wounds compared to untreated wounds in 
pig skin 
 
2.3.1 Experimental animals 
Animal ethics clearance for this part of the study was granted by the Animal Ethics 
Committee of the University of the Witwatersrand, Johannesburg (AESC #2006 
2804).   
 
Post-weaning female pigs (Sus scrofa domestica) were chosen for this study due to the 
similarities between porcine and human skin.  This component of the study utilised a 
total of 12 pigs which weighed between 20-30kgs immediately post-weaning.  The 
animals were allowed to acclimate themselves to the animal facilities at the Central 
Animal Unit of the University of Witwatersrand Medical School for five days prior to 
surgery. 
 
Wound creation 
When using pigs as an animal model, it is important to standardise the biopsy sites as 
contraction varies depending on the site of the wound (Sullivan et al., 2001).  The 
wounds in this study were created using the methods described by Chithra et al. 
(1998a; 1998b).  Since skin thickness, wound contraction and healing can depend on 
the site of injury, each animal served as its own control by using mirror-image 
wounds.  Mirror-image wounds have the advantage of providing a control site at an 
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anatomically similar position to the ‘experimental’ site with regard to location and 
orientation (Gonçalves et al., 2007).   
 
The animals were premedicated with intramuscular ketamine (15mg/kg) and 
phenobarbitone (0.4mg/kg).  General anaesthesia was induced by the administration 
of 1-2% halothane by a mask.  The skin on the dorsal aspect of all the animals was 
then shaved.  The animals were divided into two groups viz. a B. frutescens and a B. 
natalensis group.   
 
Each of the animals had two sets of mirror-imaged wounds created on either side of 
the dorsal midline as follows (Fig. 2.2): 
 
a. 2 x 2cm full-thickness (i.e. down to the subcutaneous fascial sheath) 
incisional wound.   These wounds were closed using interrupted sutures with 
silk thread to secure the edges of the incisional wounds. These wounds were 
used for testing the tensile strength of the repaired skin. 
 
b. 5 x 0.4mm full-thickness (completely transdermal) excisional wounds made 
with a biopsy puncture.  These wounds were used for biochemical and 
histological analysis. 
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Figure 2.2: Flow diagram of animal experiments 
 
 
The day on which the wounds were created is referred to as day 0.  The wounds were 
treated with 1ml of the corresponding leaf extract applied topically to the wound 
twice a day (treated, n=6 for each harvest day).  At this time 1ml of sterile water was 
applied to the respective untreated wounds (untreated, n=6 for each harvest day). All 
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wounds were covered with Opsite® and secured with Elastoplast® and a veterinary 
sock.  This was to prevent the wounds becoming soiled and being infected as the pigs 
were prone to rolling on the sty floor.  The leaf gels were applied and dressings were 
changed daily.   Each of the pigs was housed individually and received food and water 
ad libitum.   
 
 
Figure 2.3: Representative photographs of  
a: wounds created on dorsal surface of a pig; b-d: tissue being harvested 
 
 
The excisional wound together with a uniform perimeter of surrounding tissue was 
harvested on the 2nd, 4th, 7th, 10th and 16th day after wounding (Fig. 2.3) following 
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anaesthetising (as above for wound creation) of the pig.    The outer margin of the 
excisional wounds was traced on transparent film immediately before harvesting.  
The excised tissue was then bisected; one half was stored at -70:C for biochemical 
analysis and the other half was fixed in 10% buffered formalin (Appendix C1) for 
histological analysis.  At the time of harvesting, a calibration tag was placed adjacent 
to the wound and all wounds were photographed with a Sony Photoshot® camera. 
 
 
2.3.2 Analysis of the wound biopsies 
 
2.3.2.1 Rate of contracture and period of re- epithelialisation 
 
The time taken for full re-epithelialisation of the wound biopsies was noted.  The time 
for the excisional wounds to ‘close’ was calculated from the digital photographs and 
the wound tracings.   The wound tracings on the transparent film were scanned 
together with a mm-ruler for calibration of the image using Hewlett Packard PSC 
1500 All-in-One Scanner®.  Digitized images were captured and converted into TIFF 
format.  The image was imported into the ImageJ® program (a free image processing 
and analysis software programme developed by NIH) and the area of the wound 
(mm2) was calculated by tracing the wound edge manually.  This was repeated three 
times for each wound tracing and the repeatability of the measurements tested for 
accuracy and repeatability using the Lin’s Concordance Correlation Co -efficient Test 
(Lin, 1989). If the Lin’s Concordance Correlation (Pc) value was less than 0.9, all the 
measurements were re-taken and re-analysed using Lin Concordance Correlation Co-
WitsETD
The in vitro and in vivo effect of B. frutescens and B. natalensis on wound healing 
 
46 
 
efficient Test until a value between 0.9 and 1 was obtained.  The mean of the three 
measurements was then used for statistical analysis. 
 
The change in wound size over a period of 16 days was then calculated as the 
percentage of the original wound area that was created: 
 
Area of wound created with the 4mm biopsy punch   = Wound area at Day 0 
= πr2 
        = 3.1415 x 22 
        = 12.57mm2 
 
Therefore,  
% change in wound re-epithelialised =   
𝑊𝑜𝑢𝑛𝑑  𝑎𝑟𝑒𝑎  𝑎𝑡  𝑑𝑎𝑦  0 − 𝑊𝑜𝑢𝑛𝑑  𝑎𝑟𝑒𝑎  𝑎𝑡  𝐷𝑎𝑦  𝑋
𝑊𝑜𝑢𝑛𝑑  𝑎𝑟𝑒𝑎  𝑎𝑡  𝑑𝑎𝑦  0
 𝑥 100   
                  =  
12.57𝑚𝑚 2−𝑤𝑜𝑢𝑛𝑑  𝑎𝑟𝑒𝑎  𝑎𝑡  𝑑𝑎𝑦  𝑋
12.57𝑚𝑚 2
 𝑥 100 
 
 
2.3.2.2 Measurement of tensile strength  
 
The tensile strength of the treated and untreated incisional wounds harvested on day 
16 was examined using a method adapted from Shukla et al.  (1999) and Cho-Lee and 
Moon (2003).  The TA. XT. Plus Texture Analyser® system housed in the School of 
Therapeutic Sciences at the University of the Witwatersrand, was used to measure 
the maximum force and time taken for the skin samples harvested on day 16 to snap 
or break.  This system provides a mechanical test frame fitted with pneumatic 
clamps.  
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The harvested 16 day incisional wounds were trimmed into strips that were 20mm 
long and 2mm wide with the area of the original wound lying lengthwise in the 
middle of the sample.  The TA. XT. plus Texture Analyser® system was calibrated with 
a 5kg load and a 10mm distance between the upper and lower clamp surfaces at the 
start of testing.  The skin strips were then mounted securely into the upper and lower 
clamps (Fig. 2.4).  The skin sample was then stretched for 0.19 seconds (this time 
period was determined from calibrating the system at a 10mm distance between the 
clamps).  The stretch distance and maximum force tolerated by each skin sample was 
recorded. 
 
 
Figure 2.4: Photograph of a day 16 incisional wound skin sample mounted on the TA. XT. plus 
Texture Analyser® system 
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2.3.2.3. Biochemical analyses of the excisional wounds  
 
The excised tissue was biochemically analysed to estimate the total amount of 
collagen (hydroxyproline), hexosamine, protein and DNA present in the treated and 
untreated wound tissue as detailed below and each of these tests were repeated six 
times, except for the estimation of collagen which was repeated five times.   
 
 
a. Estimation of collagen (hydroxyproline) 
Hydroxyproline is a basic constituent of collagen (Shukla et al., 1999). The collagen 
content of the granulation tissue was determined by estimating hydroxyproline 
content, as described by Woessner (1961) and modified by Switzer (1991) and  
Reddy and Enwemeka (1996). 
 
The wet tissue samples were weighed and 0.02g of each sample was homogenised in 
50μl of 0.9% saline (Appendix B1) which was then vortexed with 50μl of 10M NaOH.  
The resulting solution was autoclaved at 120:C for 20 minutes.  The hydrolysis 
solution (100μl) was then transferred into eppendorf tubes and mixed with 
chloramine-T reagent (Appendix B2).  This was then incubated for 25 minutes at 
room temperature. Thereafter, 500μl freshly prepared p-dimethylamino-
benzaldehyde (Ehrlich's reagent) solution (Appendix B3) was added and incubated 
for 20 minutes at 60°C. Following incubation, 150μl of each solution was transferred 
to a 96-well microplate and read at an absorbance of 550nm using a 
spectrophotometer.   
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Hydroxyproline content was determined by comparing the amount obtained from the 
skin samples with a standard curve.  The standard curve was obtained by using serial 
dilutions of 1mg hyroxyproline in 1ml of assay buffer solution. An example of the 
standard curve obtained from the absorbance values of the hydroxyproline is shown 
in figure 2.5.  This was repeated six times for each wound tissue sample.  The change 
in the collagen content of the treated and untreated groups was expressed as a ratio.  
 
 
Figure 2.5: Representative graph of the standard curve obtained for estimation of collagen 
concentration from the hydroxyproline standard (1mg/100ml) 
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b. Estimation of hexosamine  
Hexosamine levels will decrease as collagen accumulates (Dunphy and Udupa, 1955) 
and is therefore used to deduce the increase in collagen concentrations in the tissue.  
  
The hexosamine content of the granulation tissue was estimated by a modified Elson-
Morgan reaction developed by Rondle and Morgan (1955) and modified by Levvy and 
McAllan (1959).   
 
The B. natalensis- and B. frutescens-treated and untreated wound tissue for each of 
the biopsy days was dissected and 0.02g was weighed, homogenised in 50μl saline 
and then vortexed with 50μl NaOH.  This solution was then autoclaved at 120:C for 
20 minutes.  Thereafter, 100μl of the solution was transferred into eppendorf tubes 
and 20μl of potassium tetraborate (Appendix C1) was added.  This solution was then 
vortexed and heated in boiling water for 3 minutes before cooling in tap water.  
Following cooling, 600μl of p-dimethylamino-benzaldehyde solution (Ehrlich's 
reagent) (Appendix C2) was added to each solution, thoroughly mixed and then 
placed in a 37:C water bath for 20 minutes. The solution was then cooled in running 
tap water and the absorbance was measured at 530nm using a spectrophotometer. 
The amount of hexosamine of each sample was extrapolated using a standard curve 
for hexosamine. The standard curve was obtained by using serial dilutions of 0.1% N-
acetylglucosamine  (Appendix C3) made in assay buffer solution. 
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The technique was repeated six times for each wound tissue sample.  The change in 
the hexosamine content of the treated and untreated (control) groups was expressed 
as a ratio. 
 
 
c. Estimation of protein (Lowry protein assay) 
B. natalensis- and B. frutescens-treated and untreated wound tissue for each of the 
biopsy days was dissected and weighed to 0.2g. The tissue was then homogenised 
with 5ml of homogenising buffer (Appendix D1) with DTT and protease inhibitor 
cocktail stock (Sigma-Aldrich Co., USA). This was done slowly to prevent foaming by 
limiting the amount of air entering.  The homogenised solution was centrifuged at 12 
000 rpm for 20 minutes at 4:C.  The supernatant was gently aliquoted into 200μl 
aliquots that were stored at -70:C until used. 
 
The total protein content of each sample was then determined by using the Lowry 
protein assay.  The assay is based on the addition of the folin phenol reagent which 
forms a complex with protein and copper thus resulting in a colour change (from 
yellow to blue) (Hartree, 1972). 
 
Bovine serum albumin (BSA) was used as the standard for the protein assays.  A 
working stock solution was made of 2000μg BSA in 1000μl of PBS (pH 7.4). A serial 
dilution of the stock solution was then carried out in the respective wells of an ELISA 
96 well-microtiter plate.  The protein samples of the treated and untreated tissue 
were diluted in PBS (1:20) prior to testing.  In the respective wells of the plate, 50μl 
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of the diluted protein sample and 200μl of reagent A (sodium carbonate with copper 
sulphate and sodium potassium tartrate) (Appendix D2) was added.  This was 
incubated for 10 minutes at room temperature on a shaker.  Thereafter, 50μl of Folin 
reagent (Appendix D2) was added and incubated for 30 minutes on a shaker.  The 
absorbance of the solutions in the microtiter plate was read at an absorbance of 
690nm using as Labsystems Multiskan Ascent® (Amersham Pharmacia Biotech, 
Burkinghamshire, UK).  A standard curve was created by plotting the absorbance 
values of the BSA standards against their concentrations.  The protein concentration 
of the samples was then extrapolated from the graph and multiplied by the dilution 
factor. 
 
This was repeated six times for each wound tissue sample.  The change in the protein 
content of the treated and untreated (control) groups was expressed as a ratio.  
 
 
d. Estimation of total DNA content 
The protein and DNA content of granulation tissue indicates the levels of protein 
synthesis and cellular proliferation.  Higher protein and DNA content will indicate 
cellular proliferation and suggest an increase in the synthesis of collagen.  According 
to Chithra et al. (1998b), the collagen/DNA ratio in granulation tissue may be taken 
as the index of the synthesis of collagen per cell in the wound area.  
 
DNA content was extracted from the B. natalensis- and B. frutescens-treated and 
untreated wound tissue for each of the biopsy days using the phenol-chloroform 
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method.  Tissue (0.02g) from the treated and untreated (control) wounds was placed 
in sterile eppendorf tubes together with 200μl lysis buffer (Appendix E1) and 20μl of 
Proteinase K (Appendix E2).  This was then incubated overnight on a heat block at 
55:C.  The solutions were then heated on the heat block at 85:C for 10 minutes.  
Thereafter, 400μl of a phenol-chloroform mixture (Appendix E3) was added and 
vortexed.  This solution was centrifuged for 3 minutes and 12 000rpm.  The upper 
phase in each eppendorf was then carefully removed with a sterile pipette and 
transferred to a new sterile labeled eppendorf.  In this step, it was important not to 
remove the protein layer at the interface.  The phenol-chloroform mixture (400μl) 
was then added and the mixture centrifuged for 3 minutes at 12000rpm.  Again, the 
aqueous upper phase was carefully pipetted into a sterile labeled eppendorf 
containing 40μl of 3M sodium acetate and 280μl isopropanol.  The eppendorf tubes 
were then centrifuged at 14 000rpm for 30 minutes.  A small pellet was visible at the 
bottom of each eppendorf tube. The supernatant was then carefully pipetted off and 
discarded.  Thereafter, 500μl of 70% ethanol was added and the tube was centrifuged 
for 2 minutes.  The ethanol was removed from the tube and the pellet allowed to dry 
for 2 minutes at 65:C.  The pellet was then resuspended in 100μl MilliQTM water and 
incubated on a heat block at 65:C for 10 minutes. 
 
The total amount of DNA in each of the samples was then measured in triplicate using 
a Thermo Scientific NanoDropTM 1000 Spectrophotometer.   
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2.3.2.4. Histological analyses of the excisional wounds 
Serial sections (4μm thick) of paraffin-embedded treated and untreated porcine 
tissue mounted on silane coated slides (Appendix F1) were prepared for histology 
and immunohistochemistry.   
 
a. Haemotoxylin and eosin stain 
In order to compare the histology of the treated and untreated wound tissue, every 
sixth section was deparaffinised in xylene and rehydrated in a series of graded 
alcohols.  These sections were then stained with haemotoxylin and eosin (Appendix 
F2).  Haemotoxylin and eosin are widely used as stains for general morphology.  The 
haemotoxylin stain is a basophilic stain which stains cell nuclei blue-black while the 
eosin stain is an eosinophilic stain which stains the cytoplasm and connective tissue 
fibres in shades of pink, orange and red (Bancroft and Gamble, 2002). The layers of 
the epidermis and dermis were studied to describe the regeneration of the epidermis.   
 
b. Mallory’s trichrome stain  
In order to compare the deposition of collagen in the treated and untreated wound 
tissue, sections were deparaffinised in xylene and rehydrated in a series of graded 
alcohols.  These sections were then processed with three stains: 1% acid fuschin, 5% 
phosphotungstic acid water and the Mallory’s mixture.  This trichromatic stain 
colours collagen and reticular fibres deep blue, nuclei and smooth muscle red, elastic 
fibres pink, red blood cells and myelin orange. 
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For collagen deposition studies in the wound area, the faintest traces of staining 
reaction, hyalinization, and irregular arrangement of collagen bundles were 
considered as +, while the most intense reaction and compactly arranged collagen 
bundles were considered as +++. Two areas in each section (of the six treated and six 
untreated sections per treatment day) were assessed for neo-vascularization and 
fibroblast proliferation.  
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2.3.2.5. Immunohistochemical analyses of the excisional wounds 
  
a. Immunolocalisation of smooth muscle actin 
 
Formalin fixed, paraffin embedded tissue was sectioned at 4μm and mounted on to 
silane coated slides (Appendix G1) for immunohistochemistry.  The sections were 
then dewaxed in xylene and passed through a series of graded alcohols before 
washing in running tap water for 5 minutes.  The sections were then incubated with 
3% hydrogen peroxide in H2O for 30 minutes to block endogenous peroxidase 
activity. After triple washing of the sections in PBS (pH7.6) (Appendix G2) for 5 
minutes each, the sections were incubated in a humid chamber with 20% normal 
rabbit serum in PBS to block non-specific binding.  Monoclonal anti-smooth muscle 
actin (SMA) antibody was obtained from Santa Cruz Biotechnology.  A series of 
dilutions was carried out to determine the optimal concentration of the antibody 
using mouse heart as the control tissue.  Animal ethics approval for the use of the 
mouse heart tissue was granted by the Animal Ethics Committee of the University of 
the Witwatersrand, Johannesburg (AEC# 2007232A). The sections were then 
incubated in a humid chamber at room temperature with the primary antibody (anti-
smooth muscle actin) at a dilution of 1:200 made up in 3% BSA-PBS for 60 minutes.   
 
After washing the section three times in PBS, the sections were incubated in a 
secondary antibody (mouse immunoglobulins from Dako, Denmark) at a 
concentration of 1:50 for 30 minutes in a humid chamber.  The sections were washed 
three times in PBS and then incubated with a strepavidin horseradish peroxidase 
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complex (Dako, Denmark) at a dilution of 1:500 in BSA-PBS (Appendix G3) for 30 
minutes.  The sections were then washed three times in PBS and stained with the 
chromagen, diaminobenzidine (DAB) (Dako, Denmark) (Appendix G4) for 5 minutes, 
followed by washing in running tap water for 5 minutes.  Sections were 
counterstained with Mayer’s haematoxylin for 20 seconds and washed for a further 5 
minutes.  The sections were then passed through a series of graded alcohols and 
xylene before coverslipping with entellan. 
 
 
b. Immunolocalisation of VEGF 
 
Formalin fixed, paraffin embedded tissue was sectioned at 4μm and mounted on to 
silane coated slides for immunohistochemistry.  The sections were then dewaxed in 
xylene and passed through a series of graded alcohol before washing in running tap 
water for 5 minutes. Antigen retrieval was carried out by microwaving the sections in 
citrate buffer (pH 6) (Appendix G5) twice for 5 minutes and then cooling at room 
temperature for 20 minutes. The sections were then incubated with 3% hydrogen 
peroxide in H2O for 30 minutes to block endogenous peroxidase activity. After triple 
washing of the sections in PBS (pH7.6) for 5 minutes each, they were incubated in a 
humid chamber at room temperature with 10% normal rabbit serum in PBS to block 
non-specific binding.  Primary mouse monoclonal VEGF antibody (sc-7269) was 
obtained from Santa Cruz Biotechnology.  A series of dilutions was carried out to 
determine the optimal concentration of the antibody using human breast cancer as 
the control tissue. Human ethics approval (M050521) for the use of the breast 
carcinoma tissue was granted by the Human Ethics Research Committee of the 
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University of the Witwatersrand, Johannesburg.  The sections were then incubated in 
the primary antibody at a dilution of 1:50 made up in PBS overnight at 4:C.  After 
washing the sections three times in PBS, they were incubated in a secondary antibody 
(rabbit anti-mouse antibody, Dako, Denmark) at a dilution of 1:300 made up in PBS 
for 30 minutes in a humid chamber at room temperature.  The sections were washed 
three times in PBS and then incubated with a strepavidin horseradish peroxidase 
complex (Dako, Denmark) at a dilution of 1:300 in BSA-PBS for 30 minutes.  These 
were then washed three times in PBS and stained with the chromagen, DAB (Dako, 
Denmark) for 5 minutes, followed by washing in running tap water for 5 minutes.  
Sections were counterstained with Mayer’s haematoxylin for 20 seconds and washed 
for a further 5 minutes.  The sections were then dehydrated through a graded series 
of alcohols and cleared in xylene before coverslipping with entellan.  
 
c. Anti- TGFβRI and Anti- TGFβRII 
Formalin fixed, paraffin embedded tissue was sectioned at 4μm and mounted on to 
silane coated slides for immunohistochemistry.  The sections were then dewaxed in 
xylene and passed through a series of graded alcohol before washing in running tap 
water for 5 minutes. Antigen retrieval was carried out by microwaving the sections in 
citrate buffer (pH 6) (Appendix G5) twice for 5 minutes and then cooling at room 
temperature for 20 minutes. The sections were then incubated with 0.3% hydrogen 
peroxide in H2O for 20 minutes to block endogenous peroxidase activity. After triple 
washing of the sections in Tris Buffered Saline (TBS) (pH7.6) (Appendix G6) for 5 
minutes each, they were incubated in a humid chamber at room temperature with 
10% normal goat serum in TBS to block non-specific binding.  TGBβR I and TGBβRII 
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antibodies (sc-398 and sc-220) were obtained from Santa Cruz Biotechnology.  A 
series of dilutions was carried out to determine the optimal concentration of the 
antibody using 4μm paraffin embedded sections of mouse ovary as the control tissue.  
Animal ethics approval (2004/100/4) for the use of the mouse ovary tissue was 
granted by the Animal Ethics Research Committee of the University of the 
Witwatersrand, Johannesburg.  The sections were then incubated in either the 
TGBβRI or the TGBβRII primary antibody at a dilution of 1:25 made up in TBS 
overnight at 4:C.  After washing the sections three times in TBS, they were incubated 
in a secondary antibody (goat anti-rabbit antibody, Dako, Denmark) at a dilution of 
1:300 made up in TBS for 30 minutes in a humid chamber at room temperature.  The 
sections were washed three times in TBS and then incubated with a strepavidin 
horseradish peroxidase complex (Dako, Denmark) at a dilution of 1:300 in BSA-PBS 
for 30 minutes.  These were then washed three times in TBS and stained with the 
chromagen, DAB (Dako, Denmark) for 5 minutes, followed by washing in running tap 
water for 5 minutes.  Sections were counterstained with Mayer’s haematoxylin for 20 
seconds and washed for a further 5 minutes.  The sections were then dehydrated 
through a graded series of alcohols and cleared in xylene before coverslipping with 
entellan. 
 
d.  Controls for immunohistochemistry 
Negative controls for all the immunohistochemistry were prepared using adjacent 
wound tissue sections which were treated identically as above except that the 
primary and secondary antibodies were respectively replaced with the buffer (PBS 
for αSMA and VEGF, and TBS for TGFβRI and TGFβRII).  
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Formalin fixed paraffin embedded mouse heart (Animal ethics clearance # 2007 
232A), human breast carcinoma tissue (Human ethics clearance # M05052) and  
mouse ovary (Animal ethics clearance # 2004/100/4)were prepared as described 
above and were used as the positive control for α-smooth muscle actin, VEGF and 
TGFβRI and TGFβRII immunolocalisation, respectively. 
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2.4 An in vivo human study of the effects of B. natalensis- and B. 
frutescens-treated wounds compared to untreated wounds  
 
Ethical clearance for this part of the study was obtained from the Human Ethics 
committee of the University of the Witwatersrand (Human ethics clearance # 
M050108).  Female adult patients presenting with bilateral superficial skin lesions at 
the Stoma Clinic at Helen Joseph Hospital and at the Dermatology Clinic at the 
Charlotte Maxeke Johannesburg Academic Hospital (at the time of the study, known 
as the Johannesburg General Hospital) were invited to participate in this study.  
Patients with chronic skin lesions, cancerous lesions and with associated medical 
conditions known to affect wound healing such as diabetes mellitus and vascular 
diseases, were excluded from this study.  Each potential participant was given an 
overview of the study using the Subject Information Sheet (Appendix H1).  Six 
patients from the Dermatology Clinic at the Johannesburg General Hospital initially 
agreed to participate in this part of the study by signing as informed consent form 
(Appendix H2).  Of these, two were from the “Coloured” and four from indigenous 
African population groups.  Most patients at both clinics from indigenous African 
population groups refused to participate in this study preferring to use 
conventionally accepted ‘Western’ medication for their lesions. 
 
A digital photograph of both skin lesions of each patient was taken at the time of the 
first meeting.  The leaf gel extract was then given to the patient in a colour-coded-
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bottle with directions on how to apply the gel.  No information of the plant source 
appeared on the bottle.  The patient was instructed to treat one lesion with the 
extract and to leave the second lesion untreated for seven days.  At the end of the 
seven days, the patient was instructed to return to the clinic to obtain a second bottle 
of the leaf gel extract and for a follow-up digital photograph of the skin lesion.  The 
digital photographs were then used to compare the re-epithelialisation of the treated 
and untreated lesions. 
 
STATISTICAL ANALYSIS 
In this study, the Student’s t-test and a one way analysis of variance (ANOVA) tests 
(p≥ 0.05) were used for the comparison between two means and to thus establish 
statistically significant differences between the treated and untreated groups and 
between the B. natalensis and B. frutescens treated groups.  SPSS® for Windows 
Version 16.0 and Microsoft Excel® were used to perform all statistical tests. 
 
All cell culture and biochemical tests were repeated six times.  The results are 
expressed as a mean ± standard deviation (SD) of the mean of the absorbance values.  
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3. RESULTS 
3.1 An in vitro study of the effects of B. natalensis and B. frutescens 
on human epidermal keratinocytes and dermal fibroblasts 
 
The result of each of the assays used in the cell culture studies is detailed below.  For 
ease of reading and reporting, cultures that were treated with either B. frutescens or 
B. natalensis are referred to as treated cultures.  The control cultures that were not 
treated with the plant leaf gel extracts are referred to as untreated cultures.   The 
average pH of the leaf gels of B. frutescens and B. natalensis used in all experiments 
was 4 and 5, respectively. 
 
a. MTT assay 
In general, the results of the MTT assay revealed that the leaf gel extract of B. 
frutescens and B. natalensis was not cytotoxic to either the keratinocyte or the 
fibroblast cultures (Figs. 3.1 and 3.2).   
 
For the HaCaT keratinocyte cell cultures, there was no significant difference between 
B. natalensis-treated and the untreated cultures (p=0.96).  In contrast, at higher 
concentrations, the B. frutescens-treated keratinocytes showed significantly more 
non-viable cells when compared to the corresponding untreated cultures (p=0.01).  
This was particularly noted at concentrations greater than 100μl/ml (Fig. 3.1).  In the 
keratinocyte cultures, an effect greater than 100% of the untreated cultures was seen 
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at a concentration of 0.1μl/ml for B. frutescens and, 0.1, 5 and 100-300μl/ml for B. 
natalensis (Fig. 3.1). 
 
In the dermal fibroblast cultures, the effect of the treatment with B. natalensis and B. 
frutescens was not significantly different from that of the untreated cultures (p=0.94 
and p=0.24, respectively).   An effect greater than 100% of the untreated fibroblast 
cultures was seen at concentrations of 0.1μl/ml of B. frutescens and 200 and 
300μl/ml of B. natalensis (Fig. 3.2) in the treated cultures. 
 
When comparing the cytotoxic effect of the leaf gel extracts between the cell lines (i.e. 
B. frutescens on keratinocyte and fibroblast cultures and similarly, B. natalensis on 
keratinocyte and fibroblast cultures), there was no significant difference in the effect 
of B. frutescens (p=0.11) and B. natalensis (p=0.29) on each of the cell lines tested. 
 
However, when comparing the effect of the two gel extracts on a particular cell line 
(i.e. B. frutescens and B. natalensis on keratinocytes, and B. frutescens and B. natalensis 
on fibroblasts), the difference in the effect of the two extracts was statistically 
significant in the keratinocyte cell cultures (p=0.02) but not in the fibroblast cell 
cultures (p=0.94).  The effect of B. frutescens on the keratinocyte cell line was dose 
dependant, increasing as the concentration increased while the effect of B. natalensis 
was more constant with a peak 0.1 and 100-200μl/ml. 
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Figure 3.1: MTT assay – the effect of B. frutescens and B. natalensis on HaCaT keratinocytes               
(n=6 for each plant leaf gel) 
 
 
Figure 3.2: MTT assay – the effect of B. frutescens and B. natalensis on human dermal fibroblasts 
(n=6 for each plant leaf gel) 
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b. WST-1 Assay 
 The cell numbers for both the keratinocyte and fibroblast cell lines was significantly 
greater at all concentrations of B. frutescens and B. natalensis than for the untreated 
cultures (Figs. 3.3 and 3.4).   
 
In the dermal fibroblast cultures, the greatest effect of treatment with B. frutescens on 
cell number was seen at a concentration of 50μl/ml (Fig. 3.3).  This was followed by a 
gradual decrease as the concentration of the extract increased.   In contrast, B. 
natalensis had the greatest effect on cell number at concentrations between 300 and 
400μl/ml (Fig. 3.3).  Thereafter, there was a slow decrease in cell number.  On 
average, the cell number for the B. frutescens and B. natalensis-treated fibroblast 
cultures was 4.6 and 5.2 times that of the untreated (control) cultures.  There was no 
significant difference between the effect of the two leaf gels on the dermal fibroblast 
cultures (p=0.51). 
 
In contrast, in the keratinocyte cultures, the proliferative effect of B. frutescens 
mirrored that of B. natalensis in that there was a gradual increase in cell number, 
reaching a maximum at the 400μl/ml concentration (Fig. 3.4).  This was followed by a 
gradual decrease in cell number.  On average, the cell number for the B. frutescens 
and B. natalensis-treated keratinocyte cultures was 5.1 and 4.9 times greater than 
that of the untreated cultures.  There was no significant difference between the effect 
of the two leaf gels on the keratinocyte cultures (p=0.83). 
 
There was also no significant difference in the effect of B. frutescens and B. natalensis 
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between the two cell lines (p=0.55 and p=0.76, respectively).  
 
Figure 3.3: WST-1 assay –the effect of B. frutescens and B. natalensis on human dermal fibroblasts 
 
 
Figure 3.4: WST-1 assay – the effect of B. frutescens and B. natalensis on HaCaT 
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c. BrdU Assay 
The BrdU assay also demonstrated a statistically significant increase in cell 
proliferation at all concentrations for both the B. frutescens and B. natalensis extracts 
respectively, compared to the untreated cultures of both cell types (Figs. 3.5 and 3.6).   
 
In the keratinocyte cell cultures, B. natalensis had the greatest effect on cell 
proliferation at a concentration of 400μl/ml (Fig. 3.5).  In contrast, the effect of B. 
frutescens was greatest at 700μl/ml.  At all of the other concentrations tested, the 
effect of B. frutescens was fairly constant.  There was no significant difference 
between the effects of the two leaf gel extracts on the keratinocyte cell cultures 
(p=0.41).  
 
The effect of the leaf gels on proliferation as shown by the BrdU assay was less 
pronounced in the fibroblast cell cultures.  Both B. natalensis and B. frutescens exerted 
a maximum effect at 400μl/ml (Fig. 3.6).  Again, there was no significant difference on 
proliferation of the fibroblast cell line between the two leaf gels on the fibroblast cell 
cultures (p=0.77). 
 
There was also no significant difference between the effect of B. natalensis and B. 
frutescens on the keratinocyte and fibroblast cultures (p=0.57 and p=0.67, 
respectively). 
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Figure 3.5: BrdU assay – the effect of B. frutescens and B. natalensis on HaCaT keratinocytes 
 
 
Figure 3.6: BrdU assay – the effect of B. frutescens and B. natalensis on human dermal fibroblasts 
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d. Score assay 
 
The score assay measures the time to ‘closure of the wound’.  HaCaT cultures were 
confluent at the time of scoring.  In general, the cells were of uniform size and 
polygonal in shape with close cell-to-cell contacts (Fig. 3.7a).  Immediately after 
scoring, the ‘wound’ area was clear of cells and had a uniform edge (Fig. 3.7b).  The 
fibroblast cell cultures were also confluent at the time of ‘wounding’ (Fig. 3.8a). These 
cells were spindle shaped with a number of extended processes.  The score edge that 
was created in these cultures was uniform with no cells in the scored area (Fig. 3.8b).  
 
The keratinocyte cultures treated with B. frutescens (n=6) and B natalensis (n=6) 
closed within 32 hours, while the untreated scores (n=6) did not close at all in this 
time frame.  In the keratinocyte cell cultures, the cells were not scattered in the score 
area (Fig. 3.7c and e).  The scores appeared to close by the displacement of the score 
edges closer to each other due to cell proliferation on either side of the score.    
 
In general, the scores created in the fibroblast cultures took longer (mean: 4 hours) 
than the keratinocyte cultures to ‘close’. The fibroblast cultures treated with B. 
frutescens (n=6) ‘closed’ within 40 hours, while those cultures treated with B 
natalensis (n=6) ‘closed’ within 36 hours.  The scores of the untreated cultures (n=6) 
were ‘closed’ by 48 hours. In the fibroblast cell cultures, the cells were found 
scattered in the score with the migrating cells lying in random directions (Fig. 3.8c 
and e).  The migrating cells displayed long processes.   
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Figure 3.7: Representative photomicrograph of a HaCaT keratinocyte score assay – 
a, standard culture prior to scoring and treatment (x40); b, untreated score at 4 hours (x10); c, untreated 
score at 32 hours (x10); d, B. natalensis- treated score at 4 hours(x10); e, B. natalensis-treated score at 32 
hours (x10). Arrows indicating cells entering the score area. 
 
 
Figure 3.8: Representative photomicrograph of a human dermal fibroblast score assay – 
 a, standard culture prior to scoring and treatment(x40); b, untreated score at 4 hours (x10); c, untreated 
score at 36 hours (x10); d, B. natalensis- treated score at 4 hours(x10); e, B. natalensis-treated score at 36 
hours (x10). Arrows indicating cells entering the score area. 
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3.2 An in vivo animal study of the effects of B. natalensis- and B. 
frutescens-treated wounds compared to untreated wounds in pig 
skin 
 
3.2.1  Rate of contracture and period of re-epithelialisation 
Daily inspection of the wounds was conducted and no local adverse effects were 
noted on the surrounding skin of the pig or on hair growth, from the treatment with 
both leaf gel extracts or with the sterile saline. By day 16 hairs had sprouted from all 
wound sites. Scabs (eschar) formed on all wounds by day 2.  Both treated and 
untreated wounds of all the pigs were fully re-epithelialised by day 7 (i.e. B. 
natalensis, n=6 and B. frutescens, n=3 pigs; untreated wounds, n=12).  However, in 3 
pigs treated with B. frutescens, complete re-epithelialisation occurred by day 4.     
 
The area of the wounds treated with the leaf extracts was indistinguishable from the 
surrounding normal skin by day 10.  This only occurred on day 16 in the case of the 
untreated wounds. 
 
The percent of wound contraction for untreated wounds and B. natalensis- and B. 
frutescens-treated wounds are shown in figure 3.9.  There was a significant increase 
in wound contraction in the B. natalensis-treated wounds when compared to the 
untreated wounds on days 2, 4 and 10 (p=0.004, p=0.007 and p=0.03, respectively).  
In the B. frutescens-treated wounds, a significant increase in wound contraction when 
WitsETD
The in vitro and in vivo effect of B. frutescens and B. natalensis on wound healing 
 
73 
 
compared to that of the untreated wounds was evident only on day 4 (p=0.004) (Fig. 
3.9).  There was no significant difference in the rate of contraction of the wound on 
any of the treatment days between the B. natalensis- and B. frutescens-treated 
wounds. 
 
 
Figure 3.9: Percent of contraction for B. natalensis-treated, B. frutescens-treated and untreated 
wounds over the experimental period.                                                                                                                              
Note the  indicates significant differences between the treated and untreated wounds. 
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3.2.2.2 Measurement of tensile strength 
 
The tensile strength of the incisional wounds harvested on day 16 is shown in figure 
3.10.  The tensile strength of the wounds treated with B. frutescens and B. natalensis 
were significantly stronger than that of the untreated wounds (p=0.002 and p=0.019, 
respectively), with the B. natalensis-treated wounds being stronger than the B. 
frutescens-treated wounds (p=0.02).  The stretch distance (mm) for the wounds over 
a period of 19 seconds was: untreated wounds, 10.82; B. frutescens-treated, 12.98 and 
B. natalensis-treated, 11.64, respectively.  The stretch distance is an indication of the 
elasticity of the tissue. This implies that while the B. natalensis-treated wounds were 
stronger, the B. frutescens-treated wounds were more elastic than the B. natalensis-
treated wounds because B. frutescens-treated wounds were able to stretch for a 
greater distance. 
 
 
Figure 3.10: Tensile strength of incisional wounds at day 16 
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3.2.2.3. Biochemical analyses of the excisional wounds treated with 
B. natalensis and B. frutescens compared to the untreated wounds 
 
a. Estimation of collagen (hydroxyproline) 
 
The collagen content in the granulation tissue of the treated and untreated wounds 
for B. natalensis and B. frutescens is shown in figures 3.11 and 3.12, respectively.   
 
The mirror imaged untreated wounds for both treatment groups showed no 
significant difference (p=0.398) to each other. The collagen content of the untreated 
tissue gradually increased from day 2 and reached a peak at day 7.  At day 10 there 
was a decrease in collagen content with an increase again at day 16.   
 
In the group treated with B. natalensis leaf gel, treatment caused a significant 
difference in the collagen content of the wound tissue between the untreated and 
treated wounds (p=0.007).  The collagen content in the treated group increased, to 
peak at day 10, where it was 2.76 times more than in the untreated wounds (Table 
3.1).  Although this was followed by a decrease on day 16, the collagen content was 
still greater (1.75 times) than that of the untreated wounds on the same day.  Over 
the duration of the 16 days of treatment, the average collagen content of the treated 
wounds was 1.70 Times greater than that of the untreated wounds (Table 3.1). 
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Figure 3.11: Collagen content of B. natalensis-treated and untreated wounds.                                             
Data is given as mean ± S.D. for six wounds in each group per day of treatment 
 
 
 
 
 
Table 3.1: Summary of collagen concentration (mg/100ml) per day of treatment  
COLLAGEN CONCENTRATION (mg/100ml)  AVERAGE PER DAY 
DAY 
B. natalensis- 
treated wounds 
Untreated wounds 
Ratio 
Treated:Untreated 
2 20.09±2.07 13.33±2.56 1.51 
4 16.65±0.97 14.75±5.75 1.13 
7 21.28±4.86 15.97±0.65 1.33 
10 26.39±5.44 9.55±1.41 2.76 
16 17.62±2.32 10.06±2.04 1.75 
Mean for the 16 day period  1.70 
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Figure 3.12: Collagen content of B. frutescens-treated and untreated wounds.                                         
Data is given as mean ± S.D. for six wounds in each group per day of treatment 
 
 
 
Table 3.2: Summary of collagen concentration (mg/100ml) per day of treatment 
COLLAGEN CONCENTRATION (mg/100ml) AVERAGE PER DAY 
DAY 
B. frutescens-treated 
wounds 
Untreated wounds 
Ratio 
Treated:Untreated 
2 15.89±3.91 12.45±1.40 1.28 
4 15.93±0.96 13.01±2.01 1.22 
7 19.47±6.63 13.47±3.12 1.45 
10 16.22±0.49 8.01±3.82 2.02 
16 12.76±1.75 9.04±5.31 1.41 
Mean for the 16 day period  1.48 
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Similarly, treatment with B. frutescens resulted in a significant difference between the 
collagen content in the treated and untreated wounds (p=0.013).  In this treatment 
group however, the collagen content of the treated wounds peaked at day 7 (Fig. 
3.12) being 1.45 times that of the untreated wounds (Table 3.2).  Although the 
collagen content was lower on day 10 than on day 7 in the treated group, the 
difference in the concentration between the treated and untreated wounds was at the 
greatest (treated wounds were 2.02 times the collagen content compared to the 
untreated wounds).  Over the duration of the 16 day treatment period, the collagen 
content of the B. frutescens-treated wounds was 1.48 times that of the untreated 
wounds (Table 3.2). 
 
There was no significant difference between the B. natalensis and B. frutescens-
treated groups (p=0.063), although collagen content of the treated wounds peaked on 
different days (Day 10 and 7, respectively).  In both groups, the highest ratio of the 
collagen concentration of the treated:untreated wounds occurred on day 10. 
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b. Estimation of hexosamine  
 
There was no significant difference in the hexosamine content of the untreated 
wounds between both treatment groups (p=0.55).  In the untreated wounds of both 
groups, the maximum content of hexosamine was present on day 4 followed by a 
gradual decrease to day 16.   
 
There was also no significant difference between the B. natalensis and B. frutescens-
treated groups (p=0.64).  Treatment with both leaf gels followed the same pattern in 
hexosamine content (Figs. 3.13 and 3.14) as the untreated wounds with a maximum 
hexosamine content on day 4 followed by a steady decrease to day 16.  In both the 
treated and untreated wounds, there was an overall decrease in hexosamine content 
between day 2 and day 16. 
 
 
Over the duration of the 16 day treatment period, the hexosamine content (mean) of 
the B. natalensis and B. frutescens-treated groups was 1.08 and 1.07 times greater 
than that of the untreated groups, respectively (Tables 3.3 and 3.4).  Statistically, this 
was not significantly different from the untreated wounds.  In both treatment groups 
the highest ratio of treated:untreated wounds occurred on day 7 with a gradual 
decrease to day 16.  The lowest ratio was prevalent in wounds on day 16. 
 
WitsETD
The in vitro and in vivo effect of B. frutescens and B. natalensis on wound healing 
 
80 
 
 
Figure 3.13: Hexosamine content of B. natalensis-treated and untreated wounds.                                      
Data is given as mean ± S.D. for six wounds in each group day of treatment 
 
 
Table 3.3: Hexosamine concentration (mg/100ml) per day of treatment 
HEXOSAMINE CONCENTRATION (mg/100ml) 
AVERAGE PER DAY 
DAY 
B. natalensis-treated 
wounds 
Untreated wounds 
Ratio 
Treated:Untreated 
2 54.96±0.66 57.70±4.21 1.05 
4 73.66±13.38 83.93±8.14 1.14 
7 57.72±12.10 71.63±2.05 1.24 
10 49.16±4.19 48.65±15.80 0.99 
16 46.41±1.80 41.41±3.36 0.89 
Mean 56.38±6.43 60.66±6.71 1.08 
 
0
20
40
60
80
100
2 4 7 10 16
H
e
x
o
sa
m
in
e
 c
o
n
ce
n
tr
a
ti
o
n
 (
m
g
/
1
0
0
m
g
)
TREATMENT DAY
Hexosamine content B. natalensis  treated wounds
B. natalensis treated UntreatedWitsETD
The in vitro and in vivo effect of B. frutescens and B. natalensis on wound healing 
 
81 
 
 
Figure 3.14: Hexosamine content of B. natalensis-treated and untreated wounds.                                       
Data is given as mean ± S.D. for six wounds in each group per day of treatment 
 
 
Table 3.4: Hexosamine concentration (mg/100ml) per day of treatment 
HEXOSAMINE CONCENTRATION (mg/100ml) AVERAGE PER DAY 
DAY 
B. frutescens-treated 
wounds 
Untreated wounds 
Ratio 
Treated:Untreated 
2 51.51±1.44 52.53±11.61 1.02 
4 69.38±13.62 79.32±20.51 1.14 
7 53.43±11.54 61.72±14.58 1.16 
10 43.02±2.18 45.56±13.09 1.06 
16 43.13±1.41 39.11±2.44 0.91 
Mean 52.10±6.04 55.65±12.45 1.07 
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c. Estimation of protein  
 
Over the 16 day treatment period, the untreated wounds in both treatment groups 
displayed no significant difference from each other (p=0.79) (Figs. 3.15 and 3.16).  In 
both groups of untreated wounds, there was a rapid increase in the protein content 
from day 4 to day 7 preceded a sharp decrease to day 16.   
 
Both groups of treated wounds followed a similar pattern in protein content to the 
untreated wounds in that the highest protein content was prevalent on day 7 and 
then gradually decreased to day 16 (Figs. 3.15 and 3.16).   
 
Treatment with B. natalensis appeared to significantly increase the protein content of 
the wounds over that of the untreated wounds (p=0.03).  Over the duration of the 16 
day treatment period, there was an increase in the protein content in all of the 
treated wounds (Table 3.5).  This increase followed the same pattern as the untreated 
wounds until day 7.  On day 10, a major decrease in the amount of protein was noted 
in the untreated wounds compared to the treated wounds (Fig. 3.15). 
 
 
B. frutescens treatment, similarly to B. natalensis treatment, increased the protein 
content of the wounds significantly over that of the untreated wounds (p=0.04) over 
the 16 day treatment period.  This increase followed the same pattern as the 
untreated wounds until day 7.  On day 10, the decrease in the amount of protein in 
the untreated wounds was slightly greater than in the treated wounds. 
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There was no significant difference in the protein content between the two treated 
groups (p=0.30).  The mean ratio of the treated to untreated wounds in the B. 
natalensis and B. frutescens groups was 2.38 and 2.02, respectively (Table 3.5 and 
3.6). 
 
Figure 3.15: Protein content of B. natalensis-treated and untreated wounds.  
 
Table 3.5: Summary of protein concentration (mg/100ml) per day of treatment 
PROTEIN CONCENTRATION (mg/100ml)AVERAGE PER DAY 
DAY Untreated B. natalensis-treated 
Ratio 
Treated:Untreated 
2 4670.20±154.76 6623.60±1312.79 1.42 
4 3617.58±13.34 5211.72±50.70 1.44 
7 6475.13±1406.18 9318.41±5.34 1.44 
10 1527.00±389.87 7899.22±72.04 5.17 
16 2067.85±138.75 4999.22±1134.02 2.42 
Mean 3671.55±960.58 6810.42±514.98 2.38 
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Figure 3.16: Protein content of B. natalensis-treated and untreated wounds.  
 
 
Table 3.6: Summary of protein concentration (mg/100ml) per day of treatment 
PROTEIN CONCENTRATION (mg/100ml) AVERAGE PER DAY 
DAY Untreated B. frutescens-treated 
Ratio 
Treated:Untreated 
2 4408.71±3495.44 6199.31±1739.72 1.41 
4 3797.14±261.49 6296.47±298.85 1.66 
7 5410.64±82.72 7261.55±266.83 1.34 
10 1446.57±53.37 4700.35±5.34 3.25 
16 1673.92±152.09 4060.69±357.60 2.43 
Mean 3347.39±809.02 5703.67±533.66 2.02 
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d. Estimation of total DNA content 
 
The total DNA content of the untreated wounds of both groups displayed a similar 
pattern (Figs. 3.17 and 3.18).  There was an increase in DNA content to day 7, 
followed by a sharp decrease to day 10.  There was no significant differences between 
the untreated groups (p=0.87). 
 
Treatment with both leaf gels significantly increased the DNA content of the wounds 
compared to the untreated wound (B. natalensis, p=0.04 and B. frutescens, p=0.04).  
However, the effect of B. natalensis and B. frutescens was not significantly different 
from each other (p=0.80).   Over the 16 day treatment period, there was a noticeable 
increase in DNA content in both sets of treated groups compared to the untreated 
wounds (B. natalensis, 1.78 and B. frutescens, 1.77 times that of the control).  
However, in the group treated with B. natalensis there was a more gradual increase in 
the DNA content from day 4 to day 7 than in the B. frutescens group. 
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Figure 3.17: DNA content of B. natalensis-treated and untreated wounds.  
 
 
Figure 3.18: DNA content of B. frutescens-treated and untreated wounds.  
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e. Collagen: DNA ratio 
 
The ratio of collagen content to DNA content is said to be an indication of the 
synthesis of collagen (Chithra, 2003).  The ratio of collagen:DNA content for both 
treatment groups and the untreated control wounds is given in Table 3.7.  There was 
no significant difference between treatment with either B. natalensis or B. frutescens 
compared to the untreated wounds (p=0.57 and p=0.37, respectively).  There was no 
statistically significant difference between both untreated groups. 
 
Table 3.7: Summary of collagen:DNA content 
RATIO OF COLLAGEN:DNA CONTENT 
DAY 
B. frutescens group B. natalensis group 
Treated Untreated Treated Untreated 
2 0.096 0.163 0.133 0.186 
4 0.059 0.077 0.052 0.093 
7 0.050 0.050 0.053 0.056 
10 0.051 0.054 0.080 0.052 
16 0.049 0.069 0.061 0.078 
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3.2.2.4. Histological analyses of the B. natalensis- and B. frutescens-
treated wounds compared to untreated wounds in pig skin 
 
The histology of the biopsied excisional untreated and the B. natalensis- and B. 
frutescens- treated wounds were examined in order to describe the wound at 
different points in time during the healing process using haematoxylin and eosin and 
the Mallory trichrome stains.  The results of the analysis of the three groups per day 
is summarised in Table 3.8.  The results for each are also described below.  
 
Montages of representative wounds for the three groups are presented with each 
description of wound healing for each day over the 16 day period.  Note: the 
differences in the distribution of light across these figures are due to the 
compilation of these montages. 
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Table 3.8 : Summary of wound healing features from histological sections 
Day and Treatment  
 
N 
Granulation 
tissue 
Migrating 
keratinocytes 
Blood 
vessels 
Wound 
contraction 
Collagen 
D
A
Y
 2
 
Untreated 12 + + + + - 
B. natalensis-treated 6 +++ ++ ++ ++ - 
B. frutescens-treated 6 ++ + ++ + - 
D
a
y
 4
 
Untreated 12 ++ + + + - 
B. natalensis-treated 6 +++ ++ ++ ++ + 
B. frutescens-treated 6 +++ +++ 
+++ 
(++)* 
+++ ++ 
D
a
y
 7
 
 
Untreated 12 +++ +++ ++ ++ + 
B. natalensis-treated 6 +++ +++ +++ +++ ++ 
B. frutescens-treated 6 +++ +++ +++ +++ ++ 
D
a
y
 1
0
 Untreated 12 +++ - ++ +++ ++ 
B. natalensis-treated 6 ++ - +++ +++ +++ 
B. frutescens-treated 6 + - +++ +++ +++ 
D
a
y
 1
6
 Untreated 12 ++ - ++ +++ ++ 
B. natalensis-treated 6 + - + +++ +++ 
B. frutescens-treated 6 + - + +++ +++ 
Key: *In the B. frutescens-treated wounds at day 4, two groups of wounds were discernable viz.                        
fully re-epithelialised and partly re-epithelialised treated wounds. 
 
Table 3.9: Mean maximal distance between wound edges (mm) and percent closed from day 0  
Day Untreated B. natalensis B. frutescens 
 
Mean distance % Closed Mean distance % Closed Mean distance % Closed 
2 3.71 ±0.38 7.00 3.18 ±0.40 20.50 3.44 ±0.41 14.00 
4 3.14 ±0.33 21.50 2.69 ±0.24 32.75 2.58 ±0.36 35.50 
7 1.68 ±0.24 58.00 1.39 ±0.32 62.25 1.43 ±0.45 64.25 
10 1.18 ±0.35 70.50 0.79 ±0.22 80.25 0.82 ±0.19 79.50 
16 Wound Contraction Complete 
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The mean maximal distances between the wound edges is shown in Table 3.9.  This 
indicates the time taken for the wound space to contract or ‘close’ and is independent 
of re-epithelialisation.  Wound contraction was more rapid in both treated groups 
than in the untreated wounds.  In the untreated wounds, wound contraction was 
initially slow from day 2 to day 4; followed by a sudden increase in contraction 
between day 4 and day 7.  The wound contraction in the untreated wounds differed 
from both treated groups.  Treatment with B. natalensis and B. frutescens resulted in a 
similar pattern of wound contraction.  Treatment with both B. natalensis and B. 
frutescens resulted in a gradual rate of contraction from day 2 to day 16. The overall 
contraction of both groups of treated wounds was greater than the untreated 
wounds. 
 
 
a. Wound healing on day 2 post-wound creation 
 
The mean maximal distance between the wound edges for the untreated (n=12), the 
B. natalensis-treated (n=6) and the B. frutescens-treated wounds (n=6) on day 2 
following wound creation is shown in Table 3.9.   There was no statistically 
significant difference between the three groups. 
 
 
The granulation tissue of the untreated wound on day 2 was sparse and displayed  
scattered fibroblasts and large numbers of red blood cells (Fig. 3.19 and 3.20).  
Numerous blood vessels were noted.  No collagen fibres were present in the 
granulation tissue.  There was a distinctly visible neo-epidermis over the edges of the 
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wound area (Figs. 3.19).  The migrating edge (‘tongue’) of epidermis was several cell 
layers thick.  The basement membrane and stratum basale were distinct throughout 
the neo-epidermis but became indistinct in the region of the migrating ‘tongue’ (Fig. 
3.21).   
 
On day 2, both treated groups also displayed normal granulation tissue formation.  In 
the B. natalensis-treated group, the granulation tissue was dense with a greater 
number of fibroblasts present in the granulation tissue than in the corresponding 
untreated tissue (Fig. 3.20 and 3.23).  Red blood cells were scattered in the 
granulation tissue.  Numerous blood vessels were also present.   Neo-epidermis 
formation was present in all of the B. natalensis treated wounds on day 2 (Figs. 3.22 
and 3.24).  The extent of migration of the keratinocytes to re-epithelialise the wound 
area was greater than that in the untreated tissue (Figs. 3.19 and 3.24).  The stratum 
basale was distinguishable throughout the neo-epidermis but not in the migrating 
‘tongue’.  
 
In the B. frutescens-treated group on day 2, the granulation tissue was more dense 
than that of the untreated tissue, but not as dense as the B. natalensis-treated group 
on the same day (Figs. 3.23 and 3.25).  The extent of migration of the keratinocytes in 
this group was comparable with the untreated group but not as advanced as the B. 
natalensis treated group (Fig. 3.25). There appeared to be more blood vessels present 
in the granulation tissue of the B. frutescens-treated group (Fig. 3.26) when compared 
to the untreated tissue, but this was not quantified.  Neo-epidermis formation was 
present in all day 2 wounds of the B. frutescens treated groups.   
WitsETD
The in vitro and in vivo effect of B. frutescens and B. natalensis on wound healing 
 
92 
 
In all three groups, there was no evidence of collagen formation in the granulation 
tissue (Figs. 3.27, 3.28 and 3.29).  There was a fibrin clot present in all wound spaces 
(as seen in this representative section of a B. frutescens-treated wound, Fig. 3.29).  
This comprised of a dense network of fibrin and red blood cells. 
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Figure 3.19: Wound healing in untreated tissue on day 2 post-wound creation.  
A. Illustration of the stage of wound healing 
 B. Representative histological section of untreated tissue on day 2 post-wound creation. 
Note the formation of the neo-epidermis (NE) and the sparse granulation tissue( GT).  In the area 
adjacent to the wound, hair follicles (HF)- hair follicle, sebaceous glands (SG) are present.  Only part of 
the eschar (Es) which normally fills the wound can be seen, due to removal of the tissue during sectioning. 
(H and E, x5) 
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Figure 3.20 Representative histological section of day 2 untreated wound showing granulation 
tissue. 
Note the fibroblasts (F) and red blood cells (RC) scattered in the sparse granulation tissue (H and E, x40) 
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Figure 3.21: Representative histological section of an untreated wound on day 2 post-wounding.   
Note the keratinocytes forming the migrating tongue (MK).  The neo-epidermis is several layers thick 
(NE).  MK is relatively thin with and indistinguishable stratum basale (SB).  The underlying granulation 
tissue (GT) is well formed. (H and E;  x40) 
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Figure 3.22: Wound healing of B. natalensis- treated tissue on day 2 post-wound creation.  
A. Illustration of the stage of wound healing  
 B. Representative histological section of day 2 B. natalensis-treated wound tissue 
                                  Note the extensive migration of the neo-epidermis and the granulation tissue formation 
HF- hair follicle; SG- sebaceous gland; GT- granulation tissue; NE- neo-epidermis; Es- eschar. (H and E, x5) 
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Figure 3.23:  Granulation tissue of a B. natalensis- treated wound on day 2 post-wounding. 
Note the presence of numerous fibroblasts (F) and red blood cells (RC).  A number of small vessels 
indicated by red arrows are visible. (H and E, x40) 
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Figure 3.24: Representative histological section of a  B. natalensis-treated wound showing the 
migrating tongue on day 2 post- wounding. 
Note the formation of the neo-epidermis (NE) with a distinct stratum basale (SB).    (H and E, X40) 
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Figure 3.25: Wound healing of B. frutescens-treated tissue on day 2 post-wound creation. 
A. Illustration of the stage of wound healing  
 B. Representative histological section of B. frutescens-treated wound. 
Note the formation of the neo-epidermis (NE) and the granulation tissue (GT).  The dermis (D), 
hypodermis (HD) and granulation tissue (GT) are visible.  The eschar (Es) fills the wound space.                                
 (H and E, x5) 
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Figure 3.26:  Granulation tissue of a B. frutescens- treated wound on day 2 post-wound creation. 
Note the presence of numerous fibroblasts (F) and blood vessels (black arrows).  (H and E, x40) 
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Figure 3.27: Representative histological section of untreated wound on day 2 post-wounding. 
Note the fibrin clot (FC) is well formed with numerous red blood cells and fibrin in the wound space.  
There is no collagen deposition visible in the wound space. The adjacent unwounded tissue (UW) has 
dense collagen bundles with intersperse blood vessels (bv).  
 (Mallory trichrome stain, x40) 
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Figure 3.28: Representative histological section of a B. natalensis-treated wound on day 2 post-
wounding. 
 Note that the granulation tissue (GT) has abundant fibroblasts and no collagen and the eschar (Es) in the 
wound space is distinct (Mallory trichrome stain x40) 
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Figure 3.29: Representative histological section of day 2 B. frutescens-treated wound. 
Note the fibrin clot is dense with a large number of red blood cells and fibrin.  There is no collagen 
deposition visible in the wound space (Mallory trichrome stain, X40) 
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Wound healing on day 4 post-wound creation 
 
 
The mean maximal distance between the wound edges for the untreated (n=12), the 
B. natalensis-treated (n=6) and the B. frutescens-treated (n=6) wounds is shown in 
Table 3.9.  Wound contraction was significantly different in both treated groups when 
compared to the untreated group (B. natalensis-treated, p=0.007 and B. frutescens-
treated p=0.004) with the greatest contraction prevalent in the B. frutescens-treated 
group.  There was no statistically significant difference between the two treatment 
groups. 
 
The area of the wound space was clearly visible in the untreated wounds and the B. 
natalensis-treated group (Figs. 3.30 and 3.31).  Neo-epidermis formation was present 
in all the wounds i.e. untreated and the B. natalensis- and B. frutescens- treated groups 
(Figs. 3.30, 3.31 and 3.32).  The extent of the migration of keratinocytes was visibly 
different in both treatment groups when compared to the untreated group.  The 
extent of keratinocyte migration was greatest in the B. frutescens-treated group (Fig. 
3.30), followed by the B. natalensis-treated group.  In the B. frutescens group, there 
was evidence of full re-epithelialisation (Fig. 3.32) in 50% of the treated wounds.  The 
remaining 50% of the B. frutescens-treated wounds (Fig. 3.33) showed similar re-
epithelialisation to the B. natalensis-treated wounds.  Hair follicles were present in 
the wound area of all three groups but were more numerous in the B. frutescens-
treated group.   Keratinocytes from the hair follicles also appeared to contribute to 
the re-epithelialisation. 
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Figure 3.30: Wound healing of untreated tissue on day 4 post-wound creation       
A. Illustration of the stage of wound healing  
 B. Representative histological section of day 4 untreated untreated wound. 
                                 Note the formation of the neo-epidermis (NE) and the limited area of granulation tissue 
(GT) formation.  Prominent well developed hair follicles (HF) and sebaceous glands (SG) are present in 
the wound area. This may be due these structures being partly intact following the biopsy and therefore 
regenerating more quickly.(H and E, x10) 
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Figure 3.31: Wound healing of B. natalensis-treated tissue on day 4 post-wound creation      
A. Illustration of the stage of wound healing  
 B. Representative histological section of day 4 B. natalensis-treated wound. 
Note the re-epithelisation that is almost complete and the limited area of granulation tissue (GT) present 
below in the dermis  (D) below the neo-epidermis (NE).  The wound area is still clearly distinguishable. (H 
and E, x10) 
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Figure 3.32: Wound healing of B. frutescens-treated tissue on day 4 post-wound creation      
A. Illustration of the stage of wound healing  
 B. Representative histological section of day 4 B. frutescens-treated wound. 
HF- hair follicle; GT- granulation tissue; NE- neoepidermis.                                   
 Note the full re-epithelialisation of the wound area and the collagen interspersed in the granulation 
tissue (GT).  The area of the wound is not distinguishable from the surface.  The neo-epidermis (NE)has 
well developed rete ridges.  Hair follicles (HF)are visible in the dermis. (H and E, x10) 
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Figure 3.33: Wound healing of B. frutescens-treated tissue on day 4 post-wound creation      
A. Illustration of the stage of wound healing  
 B. Representative histological section of day 4 B. frutescens-treated wound. 
                             Note the extent of the migration of the neo-epidermis (NE) and the dense granulation 
tissue (GT) in the dermis below the wound area. The eschar (Es) is visible in the wound space. (H and E, 
x10) 
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The granulation tissue of the untreated wound on day 4 showed the presence of 
infiltrating cells, but was less dense than both treatment groups (Fig. 3.34).  A large 
number of fibroblasts were present in the granulation tissue at this stage. The 
number of blood vessels present in the granulation tissue appeared to be greater 
than that of the untreated wounds on day 2.  The granulation tissue of the B. 
natalensis- and B. frutescens-treated groups appeared more dense with fibroblasts 
and numerous blood vessels when compared to that of the untreated wounds on day 
4 (Fig. 3.35 and 3.36).  In the B. frutescens- treated group, the wounds with full re-
epithelialisation and the wounds that had not completely re-epithelialised showed no 
difference in the granulation tissue. 
 
There was evidence of collagen formation (evident as blue staining in the Mallory 
trichrome stained sections) in the granulation tissue of all wounds (Fig. 3.37).  The 
collagen deposition although not quantified histologically, appeared to be greater in 
the B. frutescens-treated group than in the B. natalensis-treated group.  There was 
little collagen deposition in the untreated groups. 
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Figure 3.34: Representative histological section of granulation tissue of untreated tissue on day 4 
post-wound creation.      
Note the granulation tissue has a number of scattered fibroblasts (F) and red blood cells (RC).  Numerous 
blood vessels (BV) are also present 
(H and E, x40) 
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Figure 3.35: Representative histological section of granulation tissue of B. natalensis-treated 
tissue on day 4 post-wound creation      
BV- blood vessels; C- collagen is adjacent tissue                                    
Note the granulation tissue is dense with a large number fibroblasts (F) and numerous blood vessels (BV)  
(H and E, x40) 
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Figure 3.36: Representative histological section of granulation tissue of B. frutescens-treated 
tissue on day 4 post-wound creation      
Note the granulation tissue is dense with a large number o f fibroblast s and blood vessels (BV).(H and E, 
x40) 
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Figure 3.37: Representative histological sections of day 4 to day 16 post-wound creation  
Note: the collagen fibres are stained blue. There appears to be a gradual increase in the deposition of 
collagen in all groups from day 4 to day 16.  There also appears to be an increase in collagen in both 
treatment groups compared to the untreated wounds.(Mallory trichrome, x40) 
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In one of the B. natalensis-treated wounds on day 4, there was complete re-
epithelialisation of the wound area (Fig. 3.38).  In this specimen, the granulation 
tissue was very dense with many fibroblasts and numerous blood vessels.  There was 
also growth of the epithelial layer into the granulation tissue.  No hair follicles were 
present in this wound.  
 
 
Figure 3.38: Wound healing of B. natalensis-treated tissue on day 4 post-wound creation      
 Note the extensive growth of the epithelium into the granulation tissue (GT).  The thick neo-epidermis 
has completely re-epithelialised the wound area (WS).  There are a number of blood vessels present in the 
granulation tissue.  The wound area has no hair follicles present although both hair follicles and glands 
can be seen at the periphery of the wound . (H and E, x5) 
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Wound healing on day 7 post-wound creation 
 
 
 
The mean maximal distance between the wound edges for the untreated, the B. 
natalensis-treated and the B. frutescens-treated wounds is shown in Table 3.9.  The 
wound contraction of the untreated group was not statistically different from that of 
the treated groups on day 7 post wounding.  There was also no statistically significant 
difference between the two treatment groups.   
 
 
Migration of keratinocytes to cover the wound area was complete in all three groups 
(Figs. 3.39, 3.40 and 4.41).  However, the wound ‘space’ was clearly visible in the 
untreated group (Fig. 3.39) as a depression on the skin surface.  This depression was 
not visible in either of the treatment groups (Figs. 3.40 and 3.41).  In the B. frutescens-
treated group, the area of the wound on the surface of the skin was indistinguishable 
from the surrounding area.  The neo-epidermis was thicker in the B. natalensis-
treated wounds than the untreated and the B. frutescens-treated wounds.   The 
basement membrane was clearly visible throughout the neo-epidermis of all three 
groups.  In the untreated wounds, rete ridges were not present while in both the 
treated groups these ridges were beginning to be evident. 
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Figure 3.39: Wound healing of untreated tissue on day 7 post-wound creation      
A. Illustration of the stage of wound healing  
 B. Representative histological section of day 7 untreated wound. 
WS- wound space; E- epidermis; D- dermis; HD- hypodermis; HF- hair follicle; GT- granulation tissue; NE- 
neo-epidermis. Note the complete re-epithelialisation of the wound (ne) and the dense granulation tissue 
(GT).  The wound space (WS) is still distinguishable from the surrounding tissue. The adjacent dermis (D) 
has hair follicles (HF) and an underlying hypodermis is visible (H and E, x5) 
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Figure 3.40: Wound healing of B. natalensis-treated tissue on day 7 post creation. 
A. Illustration of the stage of wound healing  
 B. Representative histological section of day 7 B. natalensis-treated wound. 
                             Note complete re-epithelisation of the wound area and the neo-epidermis (NE) and the 
dense granulation tissue (GT) in the dermis  (D)below the wound area.  The neo-epidermis is several 
layers thick. (H and E, x10) 
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Figure 3.41: Wound healing of B. frutescens-treated tissue on day 7 post-wound creation. 
A. Illustration of the stage of wound healing  
 B. Representative histological section of day 7 B. frutescens-treated wound. 
Note the complete re-epithelisation of the wound area and the neo-epidermis (NE).  The granulation 
tissue (GT) spans a wide area in the dermis (D).  Superficially, the wound area is indistinguishable from 
the surrounding tissue on the surface.  Fat cells are visible in the hypodermis (HD)  (H and E, x10) 
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By day 7 post-wounding, the granulation tissue of all the groups of wounds was well 
formed with a dense population of fibroblasts   (Fig. 3.42).  The granulation tissue of 
the B. natalensis treated group was more extensive (i.e. spanned a wider area) than 
that of the untreated group (Fig. 3.40).  There was evidence of collagen formation in 
the granulation tissue of all wounds (Figs. 3.42 and 3.37).  The collagen appeared to 
be more dense in both treatment groups than the untreated group and appeared 
much more dense in the B. frutescens group in the B. natalensis group (Fig. 3.37).  In 
all groups, the collagen fibres appeared to be arranged in parallel. 
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Figure 3.42: Representative histological section of granulation tissue on day 7 post-wounding. 
A. Untreated wound tissue; B. B. natalensis- treated tissue and C- B. frutescens-treated wound. 
                           Note the scattered fibroblasts (F) of the granulation tissue which is denser in both 
treatment groups than in the untreated wound.  The B. frutescens tissue has a large number of blood 
vessels (BV) present. There is some glandular tissue (G) formation evident in the B. natalensis treated 
tissue.  (H and E, x40) 
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Wound healing on day 10 post-wound creation 
 
The mean maximal distance between the wound edges for the untreated, the B. 
natalensis-treated and the B. frutescens-treated wounds is shown in Table 3.9.  The 
wound contraction of the untreated group was significantly less than that of B. 
natalensis treated group (p=0.03).   
 
 
Migration of keratinocytes to cover the wound area was complete and the wound 
space was not visible superficially in all three groups.  In the untreated wounds, this 
neo-epidermis was well developed and growth of the epidermis into the granulation 
tissue was apparent (Fig. 3.43).  This was especially evident in areas in which hair 
follicles were present.   The stratum basale was clearly visible throughout the neo-
epidermis of all three treatment groups (Fig. 3.43, 3.44 and 3.45). Rete ridges in the 
epidermis were not well developed in the untreated wounds.  In the B. natalensis 
treated group, the rete ridges appeared to be more developed but not as distinct as 
the surrounding unwounded tissue (Fig. 3.44).  In 66% of the B. frutescens-treated 
wounds on day 10, the rete ridges were not well developed (Fig. 3.45) but in the 
remaining 33% of the wounds, the rete ridges were very well developed and 
appeared exaggerated (Fig. 3.46).  The more developed rete ridges were 
accompanied by a greater distribution of hair follicles in the wound area.  The 
thickness of the epidermis was similar in both treatment groups and was thicker than 
that of the untreated wounds.  Several hair follicles were present in the granulation 
tissue of the wounds of all treatment groups. The vascularity of the tissue was also 
similar for all groups. 
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Figure 3.43: Wound healing of untreated tissue on day 10 post-wound creation      
 A. Illustration of the stage of wound healing  
 B Representative histological section of day 10 untreated wound. 
Note the complete re-epithelisation of the wound area and the thick neo-epidermis (NE) that has 
infiltrated into the granulation tissue (GT).  There are several hair follicles (HF) visible in the wound 
space and adjacent dermis (D). (H and E, x10) 
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Figure 3.44: Wound healing of B. natalensis-treated tissue on day 10 post-wound creation      
 A. Illustration of the stage of wound healing  
 B Representative histological section of day 10 B. natalensis-treated wound. 
Note the complete re-epithelisation of the wound area and the thick neo-epidermis (NE) with rete ridges 
below the wound space (WS).  There are several hair follicles (HF) visible in the granulation tissue (GT) 
and adjacent dermis (D). (H and E, x10) 
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Figure 3.45: Wound healing of B. frutescens-treated tissue on day 10 post-wound creation      
A. Illustration of the stage of wound healing  
 B Representative histological section of day 10 B. frutescens-treated wound. 
Note the complete re-epithelisation of the wound area and the neo-epidermis  (NE) that has no rete 
ridges.  The granulation tissue (GT) is sparse and the dermis has few hair follicles (HF). (H and E, x10) 
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Figure 3.46: Wound healing of B. frutescens-treated tissue on day 10 post-wound creation 
                                  Note the complete re-epithelisation of the wound area and the thick neo-epidermis 
(NE) with exaggerated rete ridges.  There is a prominent hair follicle (HF) visible in the wound area. (H 
and E, x10) 
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On day 10 post-wounding, the granulation tissue of all groups of wounds was well 
formed (Fig. 3.47 B-D). There appeared to be more fibroblasts present in the 
untreated tissue than in both treatment groups.  All three groups had blood vessels 
present in the granulation tissue.  The treated groups, however, displayed a greater 
density of vessels and a number of larger vessels.     Collagen fibres were present in 
all wounds. The collagen was more loosely arranged in the untreated wounds (Fig. 
3.37) than in the treated groups.  In the treated groups, the collagen appeared to be 
irregular while in the untreated group the fibres where parallel and regular. 
 
  WitsETD
The in vitro and in vivo effect of B. frutescens and B. natalensis on wound healing 
 
127 
 
 
 
Figure 3.47: Representative histological sections of : 
A-normal unwounded dermis; 
 B- Granulation tissue of untreated wound on day 10 post-wound creation;  
C- Granulation tissue of B. natalensis- treated wound on day 10 post-wound creation tissue; D- 
Granulation tissue of B. frutescens-treated wound on day 10 post-wound creation  
Note the scattered fibroblasts (F) in the granulation tissue with several blood vessels (BV) 
(H and E, x40) 
 
  
WitsETD
The in vitro and in vivo effect of B. frutescens and B. natalensis on wound healing 
 
128 
 
Wound healing on day 16 post-wound creation 
 
 
By day 16, the wounds in all three groups had completed contraction and re-
epithelialisation (Figs. 3.48, 3.49 and 3.50).  When viewed from the exterior, the 
wounds of both treatment groups were indistinguishable from the surrounding  
tissue.  The wound area of the untreated group was faintly visible. 
 
 
Migration of keratinocytes to cover the wound area was complete in all three groups 
by day 16 (Figs. 3.48, 3.49 and 3.50).  The neo-epidermis of the untreated group 
showed some growth of the epidermis into the granulation tissue (Fig. 3.48).   The 
basement membrane was clearly visible throughout the neo-epidermis of all three 
groups. Once again, the epidermal rete ridges were not well formed in the untreated 
wounds (Fig. 3.48).  In the B. natalensis treated group, the rete ridges appeared to be 
more developed and were very similar to the adjacent unwounded tissue.  The 
thickness of the epidermis was similar in both treatment groups and thicker than that 
of the untreated wounds.   
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Figure 3.48: Wound healing in untreated tissue on day 16 post-wound creation      
A. Illustration of the stage of wound healing  
 B. Representative histological section of day 16 untreated wound. 
Note the complete re-epithelisation of the wound area and the neo-epidermis (NE) that shows some 
formation of rete ridges.  There are several hair follicles visible in the granulation tissue (GT) of the 
wound area and in the adjacent dermis (D). The wound space (WS) is distinguishable from the adjacent 
epidermis (E) on the surface of the skin. (H and E, x10) 
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Figure 3.49: Wound healing of a B. natalensis-treated tissue day 16 post-wound creation  
A. Illustration of the stage of wound healing  
 B Representative histological section of day 16 B. natalensis-treated wound. 
Note the complete re-epithelisation of the wound area and the neo-epidermis (NE) that is 
indistinguishable from the surrounding tissue.  There are several well formed rete ridges.  There is a 
prominent hair follicle and glands visible in the wound area. (H and E, x10) 
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Figure 3.50: Wound healing of B. frutescens-treated tissue on day 16 post-wound creation      
A. Illustration of the stage of wound healing  
 B Representative histological section on day 16 B. frutescens-treated wound. 
Note the complete re-epithelisation of the wound area and the neo-epidermis (NE) lacking rete ridges.  
There are few hair follicles (HF) visible adjacent to the the granulation tissue (GT) of the wound area.    
(H and E, x10) 
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By day 16, the granulation tissue of all groups of wounds appeared to be less dense 
than in the preceding days (Fig. 3.51 A-C).  There appeared to be a greater number of 
fibroblasts present in the untreated wounds than in either of the treated groups.  
Several hair follicles were present in the granulation tissue area of the wounds of 
both the treatment groups. The vascularity of the untreated wounds appeared to be 
greater than in both treatment groups.  There was evidence of collagen fibres in the 
granulation tissue of all wounds – there appeared to be more collagen present in both 
treatment groups than the untreated group (Fig. 3.37).   The collagen fibres of the 
untreated wound appeared more loosely woven than that of the B. natalensis-treated 
wounds with more fibroblasts interspersed in the tissue.  The collagen fibres in the B. 
frutescens group appeared to be fairly dense with some overlapping. 
 
In both treatment groups there was a greater density of hair follicles and what 
appeared to be the formation of some glandular tissue (Figs. 3.48, 3.49 and 3.50). 
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Figure 3.51: Granulation tissue on day 16 post-wound creation      
A. Representative histological section of an untreated wound;  B Representative histological section of B. 
natalensis-treated wound; C.  Representative histological section of a B. frutescens treated wound. 
Note the scattered fibroblasts and blood vessels (BV).  Collagen (C) deposition is evident. (H and E, x40) 
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3.3.2.4. Immunohistochemical analyses of the excisional wounds 
a. α smooth muscle actin (α SMA) localisation 
Controls 
Mouse heart was used as a positive control for αSMA since myocytes are known to 
express αSMA (Vanderkerckhove et al., 1986; Schildmeyer et al., 2000).  Cytoplasmic 
localisation of the actin (Fig.3.52A) was evident within the cardiac tissue.   
 
In the wound tissue of pig skin, localisation of αSMA in the epidermis and dermis was 
evident (Fig. 3.52 D and G).   The specificity of the immunolocalisation of αSMA in pig 
skin was confirmed with negative controls using adjacent wound sections.  No 
immunolocalisation of αSMA was present in the sections in which the primary (Fig. 
3.52 E and H) and secondary (Fig. 3.52F and I) antibodies were replaced with PBS.  
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Figure 3.52: Representative histological sections of αSMA control tissue   
A- mouse heart tissue positive control,  B- mouse heart tissue negative control omitting the primary 
antibody; C- mouse heart tissue negative control omitting the secondary antibody; D- positive localisation 
of a day 2 pig skin wound, E- negative control of a day 2 pig skin wound omitting the primary antibody, F- 
negative control of a day 2 pig skin wound omitting the secondary antibody; G- positive localisation of a 
day 4 pig skin wound, H- negative control of a day 4 pig skin wound omitting the primary antibody, I- 
negative control of a day 4 pig skin wound omitting the secondary antibody.  (Stained with DAB and 
counterstained with haematoxylin; x5)  
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Immunolocalisation of αSMA in wounds treated with B. natalensis 
and B. frutescens compared to untreated wounds. 
Immunolocalisation of αSMA was present in several regions of the untreated and the 
B. natalensis- and B. frutescens-treated wounds on day 2.  In the epidermis, 
keratinocytes in all of the layers expressed localisation of αSMA.  In both the 
untreated and the B. frutescens-treated wounds on day 2, this expression of αSMA by 
the keratinocytes was similar to that of the adjacent unwounded epidermis and to 
each other (Fig.3.53 A and C).  In the B. natalensis-treated group, the expression of 
αSMA by the keratinocytes was less intense than that of the adjacent unwounded 
epidermis and the untreated and B. frutescens-treated wounds (Fig.3.53B).   
 
αSMA was also localised in the epithelium of the sebaceous glands and the root 
sheaths of the hair follicles.  There was no visible difference in this localisation in 
both the treated groups and in the untreated wounds.  The hair follicle root sheaths in 
all three groups showed strong expression of αSMA.  In the underlying granulation 
tissue, αSMA was localised in the walls of the blood vessels in all wounds (Fig. 3.53; 
indicated by red arrows) and in the dermis adjacent to the granulation tissue, there 
were several areas of localisation that indicated the presence of myofibroblasts (Figs. 
3.53 and 3.54).   Although not quantified, there appeared to be a greater number of 
myofibroblasts in both the untreated and the B. frutescens-treated wounds than in the 
B. natalensis-treated group. 
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Figure 3.53: Representative 
sections of αSMA localisation in 
wounds on day 2. 
 A- untreated wound;                           
B- B. natalensis-treated wound;                
C- B. frutescens-treated wound.  
Note the expression of αSMA in the 
epidermis, hair follicles and sweat 
glands.  Localisation of αSMA was 
also noted in capillaries (red 
arrows) and in condensations of 
myofibroblasts (black arrows). 
(anti- αSMA, x10) 
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Figure 3.54: Representative sections of αSMA localisation in untreated wounds and B. natalensis- 
and B. frutescens-treated wounds from day 2 to day 16 post-wound creation.   
Note the localisation of αSMA in the walls of the blood vessels and scattered in the dermis .  There is a 
progressive increase in the myofibroblasts population in both treated groups compared to the untreated 
wounds.  (anti- αSMA; x40 )  
B. frutescens-treated B. natalensis-treated Untreated 
WitsETD
The in vitro and in vivo effect of B. frutescens and B. natalensis on wound healing 
 
139 
 
There was also strong expression of αSMA in all wounds on day 4.  Both the control 
and B. natalensis- and B. frutescens- treated wounds showed immunolocalisation of 
αSMA in all layers of the neo-epidermis, the root sheaths of the hair follicles and the 
walls of the blood vessels (Figs. 3.54 and 3.55).  There was also expression of αSMA in 
the fibroblasts (indicating myofibroblasts) scattered in the dermis adjacent to the 
granulation tissue.   
 
The expression of αSMA in the keratinocytes of the epidermis was strongest in the 
untreated wounds and weakest in the B. natalensis- treated wounds (Figs. 3.54 and 
3.55 A and B). The granulation tissue of the untreated wounds and B. natalensis- 
treated wounds had few myofibroblasts.  The B. frutescens-treated wounds however 
showed several areas of αSMA localisation in the myofibroblasts located in the 
wound area accompanied by complete re-epithelialisation (Fig. 3.55 C) of the 
wounds.   
 
In the B. natalensis-treated wound showing growth of the epidermis into the dermal 
regions, there was localisation of αSMA in the keratinocytes (Fig. 3.55D).  This was 
also accompanied by several aggregations of myofibroblasts in the dermis below the 
wound and complete re-epithelialisation of the wound.   
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Figure 3.55: Representative sections of αSMA localisation in day 4 wounds. A- untreated wound; B- 
B. natalensis treated wound; C- B. frutescens treated wounds; D- B. natalensis treated wound with growth 
of the epidermis into the dermis. This down growth of the epidermis may indicate the presence of a hair 
follicle or a gland.  Note the expression of αSMA in the keratinocytes of the epidermis, hair follicles and 
sweat glands.  Localisation of αSMA was also noted in condensations of myofibroblasts (black arrows). 
There is also localisation of αSMA muscle bundles that appeared to be erector pilli muscles. (X10) 
 
A B 
C D 
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In the wounds on day 7, the expression of αSMA was weaker in the epidermal layers 
and in the dermis than in the preceding days.  Both the untreated and treated wounds 
showed immunolocalisation of αSMA in the epidermis (most strongly in the stratum 
spinosum), root sheaths of the hair follicles and walls of the capillaries (Fig. 3.56 A, B 
and C).  The localisation of αSMA was much weaker in the epidermis than on days 2 
and 4. 
 
Figure 3.56: Representative sections of αSMA localisation in day 7 wounds with insets 
demonstrating the area adjacent to the granulation tissue. A- Untreated wound; B- B. natalensis-
treated wound; C- B. frutescens-treated wounds. Note the weaker expression of αSMA in the layers of the 
epidermis, hair follicles and sweat glands. Intense localisation is present in the arrector pilli muscle. Black 
arrows in the insets indicate the location of myofibroblasts. (x10; insets, x40) 
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Myofibroblasts were present in the areas adjacent to the granulation tissue of the 
wounds in all three groups (Figs. 3.54 and 3.56 insets). In the untreated tissue, there 
appeared to be fewer myofibroblasts (although this was not quantified) than in both 
treated groups.  These myofibroblasts were more scattered in the underlying dermis.  
The wounds treated with B. natalensis gel displayed a greater number of 
myofibroblasts with stronger expression of αSMA.  These myofibroblasts were 
aggregated in the area adjacent to the wound granulation tissue (Fig. 3.56).  Few 
myofibroblasts invaded the area of the granulation tissue.  In the wounds treated 
with B. frutescens, myofibroblasts were evident as aggregations underlying the neo-
epidermis. 
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Re-epithelisation was complete in all wounds by day 10.  The expression of αSMA in 
the layers of the epidermis, root sheaths of the hair follicles and myofibroblasts in the 
area adjacent to the granulation tissue was weaker in the untreated wound tissue 
than in the B. natalensis- and B. frutescens-treated wounds (Fig. 3.57).  Myofibroblasts 
localisation appeared to be greatest in the B. natalensis-treated wounds.   
 
Figure 3.57: Representative sections of αSMA 
localisation in day 10 wounds with insets 
demonstrating the area adjacent to the 
granulation tissue.   A- Untreated wound; B- B. 
natalensis treated wound; C- B. frutescens-treated 
wound with well developed rete ridges. Note the 
weaker expression of αSMA in the epidermis, hair 
follicles and sweat glands of the untreated wound 
compared to both treatment groups. 
Myofibroblasts were more numerous in the 
B.natalensis-treated wounds. Black arrows in the 
insets indicate the location of myofibroblasts. (X10; 
insets, x40)  WitsETD
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By day 16, the untreated wounds showed weak expression of αSMA in the epidermis, 
sebaceous glands and hair follicles.  Stronger localisation was prevalent in both the B. 
natalensis- and B. frutescens- treated groups.  There was no observable difference in 
the strength of the expression of both the treated groups (Fig. 3.54). Aggregations of 
myofibroblasts in the area adjacent to the wound area were present in all groups.  
These aggregations were more numerous in the B. frutescens-treated group.  There 
were also more numerous blood vessels present in the dermis underlying the wound 
tissue of the B. frutescens group. 
Figure 3.58: Representative sections of αSMA 
localisation in day 16 wounds with insets 
demonstrating the area adjacent to the 
granulation tissue. 
 A- Untreated wound; B- B. natalensis treated 
wound; C- B. frutescens-treated wound with well 
developed rete ridges.. Note the weaker 
expression of αSMA in the untreated wound 
compared to both treatment groups. Black 
arrows in the insets indicate the location of 
myofibroblasts.  (X10; insets, x40))   WitsETD
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b. VEGF localisation 
Controls 
Human breast carcinoma was used as a positive control for VEGF since tumour 
genesis is known to be accompanied by angiogenesis.  Human breast carcinoma 
tissue is also recommended as a positive control tissue by Santa Cruz Biotechnology, 
Inc, the supplier of the antibody used in these experiments.    The breast carcinoma 
tissue displayed cytoplasmic localisation of VEGF as expected (Fig. 5.39).   
 
The specificity of the immunolocalisation of the VEGF antibody was confirmed with 
negative controls using adjacent sections of wound tissue.  No immunolocalisation of 
VEGF was present in the sections in which the primary and secondary antibodies 
were replaced with PBS (Fig3.59). 
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Figure 3.59: Representative sections of VEGF controls:   
A- VEGF localisation in human breast carcinoma section, B- Human breast carcinoma – negative control 
omitting the primary antibody; C- Human breast carcinoma omitting the secondary antibody.                   
D- VEGF localisation in pig wound tissue, E- Pig wound tissue – negative control omitting the primary 
antibody;   F- Pig wound tissue – negative control omitting the secondary antibody. (x40)   
  WitsETD
The in vitro and in vivo effect of B. frutescens and B. natalensis on wound healing 
 
147 
 
Immunolocalisation of VEGF in B. natalensis- and B. frutescens-
treated wounds compared with untreated wounds 
 
On day 2 post-wounding, there was evidence of VEGF localisation in the untreated 
wounds and in the wounds of both treated groups. In the epidermis, there was 
cytoplasmic localisation of VEGF in all the layers.  The localisation was relatively less 
intense in the stratum basale than in the stratum spinosum.  When comparing the 
three groups, VEGF localisation was weaker in the untreated and the B. natalensis-
treated wounds (Fig. 3.60) than in the B. frutescens-treated wounds. 
 
In the granulation tissue, there was scattered localisation of VEGF in all the groups. 
There were no observable differences in the localisation of the VEGF in the cells of the 
granulation tissue.   
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Figure 3.60: Representative sections of VEGF localisation in day 2 wounds. A& B- Untreated wounds 
neo-epidermis and wound granulation tissue; C & D- B. natalensis- treated wound neo-epidermis and 
granulation tissue; E&F- B. frutescens-treated wound neo-epidermis and granulation tissue. Note the 
localisation of VEGF in all layers of the epidermis.  This localisation is relatively less intense in the stratum 
basale.  In the granulation tissue, there is scattered localisation of VEGF. (x40) 
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On day 4, the expression of VEGF was less intense in the untreated wounds and in the 
B. natalensis-treated wounds than in the B. frutescens-treated wounds (Fig. 3.61).  
This localisation was also less intense than that of the day 2 post-wounding tissue.  
The VEGF expression was present in the cytoplasm of the epidermal cells, and was 
weakly expressed in cells of the stratum basale.  VEGF localisation was weaker in the 
neo-epidermis than in the surrounding unwounded tissue. 
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Figure 3.61: Representative sections of VEGF localisation in day 4 wounds. A & B- Untreated wounds 
neo-epidermis and wound granulation tissue; C & D- B. natalensis-treated wound neo-epidermis and 
granulation tissue; E & F- B. frutescens-treated wound neo-epidermis and granulation tissue. Note the 
less intense localisation of VEGF in the epidermis of the untreated wound and the B. natalensis-treated 
wound. (x40) 
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On day 7, there was evidence of VEGF localisation in all three groups (Fig. 3.62).  The 
strongest VEGF expression was in the epidermis of the B. frutescens-treated wounds.  
This expression was visible in all layers of the epidermis (including the stratum 
basale).  There was stronger expression of VEGF in the epidermal layers of the 
untreated wounds than that of the B. natalensis-treated wounds.  This expression in 
the untreated wounds however, was less intense in the stratum basale.  In the B. 
natalensis-treated wounds, the expression of VEGF was weak in all the layers of the 
epidermis.  In the granulation tissue on day 7, the cytoplasmic expression of VEGF 
was more intense in the B. frutescens-treated wounds. 
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Figure 3.62: Representative sections of VEGF localisation on day 7 wounds. A& B- Untreated wounds 
neo-epidermis and wound granulation tissue; C & D- B. natalensis-treated wound neo-epidermis and 
granulation tissue; E & F- B. frutescens-treated wound neo-epidermis and granulation tissue. Note the 
strong expression of VEGF in the epidermis of the B. frutescens-treated wound and in the untreated 
wound.  (x40) 
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VEGF was localised in all wounds on day 16 (Fig. 3.63).  In the epidermis, the 
strongest expression of VEGF was in the B. frutescens-treated wounds in all the layers 
(including the stratum basale) while in the untreated wounds, expression of VEGF in 
the epidermal layers was weak.  The expression was progressively less intense 
towards the stratum basale.  In the B. natalensis-treated wounds, the expression of 
VEGF was less intense in all the layers of the epidermis and almost absent in the 
stratum basale when compared to that of the B. frutescens-treated wounds.  There 
was cytoplasmic expression of VEGF in cells scattered in the granulation tissue.  This 
was strongest in the B. frutescens-treated wounds and the weakest in the untreated 
wounds. 
 
 
 
 
 
Figure 3.63: Representative sections of VEGF 
localisation in the neo-epidermis on day 16 
post-wound creation. A - Untreated wounds 
neo-epidermis; B- B. natalensis-treated wound 
neo-epidermis; C- B. frutescens-treated wound 
neo-epidermis (x40) 
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c. TGFβRI and TGFβRII localisation 
 
Controls 
Mouse ovary was used as a positive control for TGFβRI and TGFβRII since it is known 
to express TGF-β (Ghiglieri et al., 1995).  Localisation of TGFβRI and TGFβRII 
(Fig.3.64) was seen in the granulosa and theca cells of the mouse ovarian tissue. The 
specificity of the immunolocalisation of TGFβRI and TGFβRII was confirmed with 
negative controls using adjacent sections of wound tissue.  No immunolocalisation of 
TGFβRI and TGFβRII was present in the sections in which the primary (Fig. 3.64) and 
secondary (Fig. 3.53B) antibodies were replaced with PBS. 
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Figure 3.64: Representative sections of TGFβRI localisation in mouse ovarian tissue. A – Mouse 
ovary -positive control, B and C - Negative control omitting the primary and secondary antibodies, 
respectively; D- Pig wound tissue depicting localisation of TGFβRI; E and F- . Negative control omitting 
the primary and secondary antibodies, respectively; G- Pig wound tissue showing localisation of TGFβRII; 
E and F- . Negative controls omitting the primary and secondary antibodies, respectively. (x40) 
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On day 2, TGFβRI was localised in all the wound tissue examined. In the epidermis, 
there was localisation of TGFβRI in all layers except for the stratum basale and lower 
layers of the stratum spinosum.  When comparing the three ‘treatment’ groups, 
TGFβRI localisation was most intense in the untreated and the B. frutescens-treated 
wounds (Fig. 3.65 C). 
 
There was also scattered localisation of TGFβRI in the granulation tissue of the 
untreated and both the treatment groups, with no observable differences between 
the groups.   
 
Figure 3.65: Representative sections of TGFβRI localisation in day 2 wound tissue. A – Negative 
control omitting the primary antibody; B- negative control ; C- B. frutescens treated wound migrating 
keratinocytes and granulation tissue.  Note the more intense expression of TGFβRI in the more superficial 
layers of the epidermis.  (x40)  
A 
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On day 4 post-wounding, TGFβRI was again strongly localised in the epidermis of the 
wounds treated with B. frutescens and the untreated wounds (Fig. 3.66) and was 
weakest in the B. natalensis-treated wounds.  The localisation was evident in all 
layers of the epidermis except for the stratum basale.  In the granulation tissue, 
TGFβRI was localised in scattered cells and in the epithelial cells of the hair follicles.    
 
 
TGFβRII, however, was equally expressed in the epidermis of all three groups (Fig. 
3.67) on day 4 post wounding.  As for the expression of TGFβRI, the localisation of 
TGFβRII in the epidermis was evident in all layers of the epidermis except for the 
stratum basale and in the granulation tissue, in scattered cells and in the epithelial 
cells of the hair follicles.  
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Figure 3.66:  
Representative sections of 
TGFβRI localisation in day 4 
wound tissue.  
A – untreated tissue;  
B- B. natalensis- treated wound; 
C- B. frutescens- treated wound.  
Note the expression of TGFβRI is 
more intense in the more 
superior layers of the epidermis. 
(x40) WitsETD
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Figure 3.67: Representative sections of TGFβRII localisation on day 4 wound tissue. A & B– 
untreated tissue; C & D- B. natalensis-treated wound ; E & F- B. frutescens-treated wound.  Note the 
expression of TGFβRII is less intense in the stratum basale of the epidermis. (x40) 
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On day 7 post-wounding, TGFβRI was strongly expressed in the epidermis of the 
untreated tissue.  The localisation was evident in all the epidermal layers except for 
the stratum basale. The expression was weaker in both treatment groups with little 
difference between them (Fig. 3.68).  In both treatment groups, the localisation was 
limited to the upper layers of the stratum spinosum.  TGFβRI was also localised in 
cells scattered in the granulation tissue and in the hair follicles of the untreated 
wounds and both treatment groups.   This localisation appeared to be stronger in the 
untreated and the B. frutescens-treated wounds. 
 
 
 
 
 
 
  
 
 
Figure 3.68: Representative sections of 
TGFβRI localisation in day 7 wound tissue.  
A – untreated tissue; B- B. natalensis-treated 
wound ; C- B. frutescens-treated wound.  Note 
the intense expression TGFβRI in the epidermis 
of the untreated wound.  In both treatment 
groups, this localisations appears in the upper 
layers of stratum spinosum. (x40) 
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On day 7 post wounding, TGFβRII expression appeared stronger in the untreated 
tissue, being present in all the layers of the epidermis except for the stratum basale. 
The expression of TGFβRII in the epidermis of both treatment groups appeared to be 
similar to each other, but weaker than that of the untreated wound tissue (Fig. 3.69).  
In all three groups, TGFβRII was also localised in scattered cells of the granulation 
tissue and in the epithelial cells of the roots sheath of the hair follicles.  This 
localisation appeared to be stronger in the untreated wound tissue than in the 
treated groups. 
 
 
 
 
  
 
 
Figure 3.69: Representative sections of 
TGFβRII localisation in day 7 wound tissue.   
A – untreated tissue; B- B. natalensis treated 
wound ; C- B. frutescens treated wound.  Note 
the strong expression of TGFβRII in the untreated 
wound. (x40) 
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In the tissue on day 10 post-wounding, TGFβRI and TGFβRII was strongly expressed 
in the epidermis and granulation tissue of both treatment groups compared to that of 
the untreated tissue (Figs. 3.70 and 3.71).  In all three groups, the localisation was 
evident in all layers of the epidermis except for the stratum basale. TGFβRI and 
TGFβRII were also localised in cells scattered in the granulation tissue and in the hair 
follicles with the localisation of TGFβRI and TGFβRII being stronger in both treatment 
groups when compared to the untreated wound tissue. 
 
 
 
 
Figure 3.70: Representative sections of 
TGFβRI localisation in day 10 wound tissue. 
A – untreated tissue; B- B. natalensis-treated 
wound ; C- B. frutescens- treated wound.  Note 
more intense expression in both treatment 
groups than the untreated wound. (x40) 
 
 
WitsETD
The in vitro and in vivo effect of B. frutescens and B. natalensis on wound healing 
 
163 
 
 
 
 
  
 
 
Figure 3.71: Representative sections of 
TGFβRII localisation in day 10 wound tissue. 
A – Untreated tissue; B- B. natalensis- treated 
wound; C- B. frutescens- treated wound.  Note 
the expression of TGFβRII is less intense in the 
untreated wound. (x40) 
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In the tissue on day 16 post wounding, TGFβRI was equally expressed in all three 
experimental groups (Fig. 3.72).  In all of the three groups, the localisation of TGFβRI 
was evident in all the layers of the epidermis except for the stratum basale.  This 
expression appeared to be less intense than on the previous days.  TGFβRII was most 
strongly expressed in the B. natalensis- treated group and weakest in the B. 
frutescens-treated wounds (Fig. 3.73). 
 
 
 
 
 
Figure 3.72: Representative sections of 
TGFβRI localisation in day 16 wound tissue. 
A – Untreated wound; B- B. natalensis-treated 
wound; C- B. frutescens-treated wound.  Note 
the expression of TGFβRI appeared to be similar 
in the epidermis of all three groups.  (x40) 
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Figure 3.73: Representative sections of 
TGFβRII localisation on day 16 wound tissue. 
A – Untreated tissue; B- B. natalensis-treated 
wound; C- B. frutescens-treated wound.  Note 
the stronger expression TGFβRII in the B. 
natalensis-treated group than the B. frutescens-
treated group. (x40) 
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3.3. An in vivo human study of the effects of B. natalensis- and B. 
frutescens-treated wounds compared to untreated wounds in skin 
Six patients from the Dermatology Clinic at the Johannesburg General Hospital agreed 
to participate in this part of the study.  Initial digital photographs of the bilateral skin 
lesion of patients were taken (Fig. 3.74) before any treatment was administered.  The 
patients were given colour-coded bottles of the leaf gel extracts and instructions on 
how to apply the gel.  Following seven days of treatment the patients were instructed 
to return to the clinic for follow-up assessment.  None of the patients returned to the 
clinic for the follow-up assessment.  Several telephone calls to the patients remained 
unanswered.  One patient indicated that she had not used the leaf gel extract supplied 
to her.  The results of this part of the study were therefore inconclusive due to patient 
non-compliance. 
 
Figure 3.74: Representative photographs of the patient lesions before treatment. 
A –patient presented with burn wounds on both arms; B- patient presented with several 
lesions on both forearms  
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3.4. An overall summary of the results of the present study 
Table 3.10 presents a brief summary of results of each part of the present study. 
 
Table 3.10 : Summary of the results of the present study 
 Bulbine natalensis Bulbine frutescens 
Part 1: An in vitro study of the effects of B. natalensis and B. frutescens on 
human epidermal keratinocytes and dermal fibroblasts 
1. MTT ASSAY 
Keratinocyte Cell Line:  
No significant difference 
compared to untreated 
cultures at all 
concentrations  tested 
(p=0.96)  
Keratinocyte Cell Line:  
More non-viable cells than 
untreated cultures at 
concentrations greater than 
100μl/ml 
 
Fibroblast Cell Line:         
No significant difference 
between treated and  
untreated cultures 
(p=0.94) 
Fibroblast Cell Line:            
No significant difference 
between treated and  
untreated cultures (p=0.24) 
 
2. WST-1 Assay 
Keratinocyte Cell Line: 
Gradual increase in cell 
number, reaching a 
maximum at the 400μl/ml 
concentration.  
Cell number 5.1 times that 
Keratinocyte Cell Line: 
Gradual increase in cell 
number, reaching a 
maximum at the 400μl/ml 
concentration.  
Cell number 4.9 times that 
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of untreated cultures. of untreated cultures. 
Fibroblast Cell Line: 
Greatest effect on cell 
number at concentrations 
between 300-400μl/ml.  
Cell number 4.6 times that 
of untreated cultures. 
Fibroblast Cell Line: 
Greatest effect on cell 
number at a concentration 
of 50μl/ml. 
Cell number 5.2 times that 
of untreated cultures. 
3. BrdU assay 
Keratinocyte Cell Line: 
Greatest effect on cell 
proliferation at 400μl/ml. 
Keratinocyte Cell Line: 
Greatest effect on cell 
proliferation at 700μl/ml. 
Fibroblast Cell Line: 
Significantly increased cell 
proliferation at 400-700 
μl/ml. 
Fibroblast Cell Line: 
Significantly increased cell 
proliferation at 400-800 
μl/ml. 
4. Score assay 
Keratinocyte Cell Line: 
Score ‘closed’ at 32 hours. 
Keratinocyte Cell Line: 
Score ‘closed’ at 32 hours 
Fibroblast Cell Line:   
Score ‘closed’ at 36 hours. 
Fibroblast Cell Line: Score 
‘closed’ at 40 hours 
Part 2: An in vivo animal study of the effects of B. natalensis- and B. frutescens-
treated wounds compared to untreated wounds in pig skin 
5. Rate of contraction 
Significant increase in 
wound contraction when 
compared to the untreated 
wounds on days 2, 4 and 
Significant increase in 
wound contraction when 
compared to that of the 
untreated wounds evident 
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10 (p=0.004, p=0.007 and 
p=0.03, respectively). 
only on day 4 (p=0.004).  
6. Tensile Strength 
Significantly stronger than 
that of the untreated 
wounds (p=0.019). 
Significantly stronger than 
that of the untreated 
wounds (p=0.002). 
Biochemical analyses of the excisional wounds treated with B. natalensis and B. 
frutescens compared to the untreated wounds 
7. Estimation of 
Collagen 
Significant increase in 
collagen in the treated 
compared to the untreated 
wounds (p=0.014). Over the 
duration of the 16 days of 
treatment, the average 
collagen content of the 
treated wounds was 1.70 
times greater than that of the 
untreated wounds. 
Significant increase in 
collagen in the treated 
compared to the untreated 
wounds (p=0.018).  Over 
the duration of the 16 day 
treatment period, the 
collagen content of the 
treated wounds was 1.48 
times that of the untreated 
wounds. 
8. Estimation of 
Hexosamine 
Over the duration of the 16 
days of treatment, 
hexosamine content was 1.08 
times greater than that of the 
untreated group. 
Over the duration of the 16 
days of treatment, 
hexosamine content was 
1.07 times greater than that 
of the untreated group. 
9. Estimation of 
protein 
Significant increase over that 
of the untreated wounds 
Significant increase over 
that of the untreated 
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(p=0.03).  wounds (p=0.04)  
10. Estimation of 
total DNA 
Significant increase in the 
DNA content of the treated 
wounds compared to the 
untreated wound p=0.04.  
Over the 16 day treatment 
period, DNA content 1.78 
times that of the untreated 
wounds.   
Significant increase in the 
DNA content of the treated 
wounds compared to the 
untreated wound p=0.04.  
Over the 16 day treatment 
period, DNA content 1.77 
times that of the untreated 
wounds.   
11. Collagen:DNA 
ratio 
No significant difference 
between treated and 
untreated wounds (p=0.57)   
No significant difference 
between treated and 
untreated wounds (p=0.37)   
Histological analyses of the B. natalensis- and B. frutescens-treated wounds 
compared to untreated wounds in pig skin 
12. Granulation tissue 
Dense granulation tissue 
from as early as day 2 
post wounding 
continuing until day 7.  
Density of cells in wound 
space decreases at day 
10. 
Less dense granulation tissue 
at day 2 post wounding but 
equivalent to B. natalensis at 
days 4 and 7.  Density of cells 
decreased drastically at day 
10. 
13. Migrating 
keratinocytes 
The distinct migrating 
‘tongue’ at the edge of 
the wound present at day 
Some migrating 
keratinocytes visible at day 2, 
distinct migrating ‘tongue’ at 
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2 becomes more distinct 
and migrates further at 
day 7.  Distinct migrating 
tongue in untreated 
cultures only evident 
from day 7. 
the edge of the wound clearly 
visible at day 4. Distinct 
tongue in untreated cultures 
evident at day 7. 
14.  Blood Vessels 
Greater vascularity than 
untreated wounds. 
Greater vascularity than 
untreated wounds. 
15.  Wound contraction 
Wound contraction 
begins early and 
continues until wound 
closes as early as day 10. 
Wound contraction begins 
early and continues until 
wound closes as early as day 
7. 
16.  Collagen 
deposition 
Collagen deposition 
evident at day 4 
compared to at day 7 in 
the untreated wounds. 
Dense collagen fibres present  
at day 4. 
Immunohistochemical analyses of the excisional wounds 
17.  αSMA 
Expressed in the layers 
of the epidermis and in 
the myofibroblasts and 
linings of vessels in the 
dermis. 
Expressed in the layers of the 
epidermis and in the 
myofibroblasts and linings of 
vessels in the dermis. 
18.  VEGF 
Expression in the 
suprabasal layers of the 
Strongly expressed in wound 
tissue especially in 
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epidermis not as strong 
as in B. frutescens-treated 
wounds but stronger 
than in the untreated 
tissue. 
suprabasal layers of the 
epidermis. 
19. TGFβRI   
Expression weaker than 
B. frutescens-treated and 
untreated wounds. 
Strongly expressed especially 
in the suprabasal layers of 
the epidermis and in cells 
scattered in the granulation 
tissue 
20. TGFβRII 
Equally expressed: in 
early wound healing, 
weaker expression than 
in the untreated tissue 
but stronger that than 
untreated tissue in late 
wound healing 
Equally expressed: in early 
wound healing, weaker 
expression than in the 
untreated tissue but stronger 
that than untreated tissue in 
late wound healing 
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 4. DISCUSSION 
 
Wound healing commences immediately following injury and proceeds in a 
complicated but well organised sequence involving the interaction of many cell types 
and cytokines (Lin et al., 2003).  The main objective of wound management is to heal 
the injury in the shortest possible time with minimal pain and discomfort to the 
patient.  At the site of the wound, a flexible fine scar with maximal tensile strength is 
desired (MacKay and Miller, 2003).   
 
In the quest to accelerate healing, scientists have utilized medicinal plants to promote 
the various stages of wound healing (e.g. coagulation, inflammation, fibroblast 
proliferation, collagen formation and deposition, re-epithelialisation and wound 
contraction).  Some of these plants include Aloe vera (Chithra et al., 1998a; Chithra et 
al., 1998b; Choi et al., 2001; Subramanian et al., 2006), Centella asiatica (Shukla et al., 
1999) and  Calotropis procera (Rasik et al., 1999).  All three of these plants have been 
shown to promote fibroblast proliferation and collagen formation. Cudrania 
cochinchinensis, a Vietnamese folk remedy, was shown to stimulate fibroblast 
proliferation at low concentrations (Hien et al., 1997). These authors further 
suggested that the extract was able to afford fibroblast and endothelial cells some 
protection from oxidative damage by altering the cell membrane.     Rabe and van 
Staden (1997) demonstrated the antibacterial activity of a number of South African 
indigenous plants used to treat wounds including Bidens pilosa, Psidium guajava and 
Warburgia salutaris, while Thang et al. (2001) demonstrated a possible anti-oxidant 
effect of Chromolaena odorata (a plant used commonly in Vietnamese traditional 
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medicine), on wound healing.  Phan et al. (1998) further demonstrated increased 
fibroblast and endothelial cell proliferation in vitro in cultures treated with Eupolin 
(an extract of Chromolaena odorata).   
 
The present study examined the in vitro and in vivo effects of the leaf gel extracted 
from B. natalensis and B. frutescens on wound healing.  While both these leaf gels are 
used in traditional medicine for wound healing, their effects have not previously been 
scientifically validated.  In traditional medicine, the fresh leaf gel is squeezed directly 
on to the skin wound to promote healing.  In the present study, this method of 
extraction was used to mimic the use of the gel in traditional medicine.  In addition, 
the initial use of the lyophilised gel of the plant leaves in in vitro experiments, did not 
elicit results.  This may be due to some molecules being destroyed in the lyophilising 
process.  Khalil et al. (2007) also preferred to mimic the customary mode of 
administration of extracts in their experiments evaluating the wound healing effects 
of the fresh leaf extracts of Jordanian traditional medicinal plants using male albino 
Swiss mice. 
 
 
In traditional use, both the Bullbine leaf gels are used at 100% concentration.  The use 
of the crude extracts of both Bulbine leaf gels in the in vivo experiments confirmed 
their beneficial effect on wound healing when compared to untreated wounds.  It is 
possible that the effectiveness of the 100% concentrated leaf gels in vivo can be 
attributed to cell interactions between the different cell types of the dermis and 
epidermis and also between growth factors and cytokines released in the processes 
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of wound healing.  It is also possible that absorption of the active ingredient of the 
leaf gels is optimal when the leaf gels are applied in the crude form. 
 
The Bulbine leaf gel extracts tested negative for antimicrobial activity using both the 
well and disc diffusion methods of antimicrobial testing.  This confirms the negative 
antimicrobial results for both water and methanol extracts of B.  frutescens obtained 
by Rabe and van Staden (1997) who tested B. frutescens against Staphylococcus 
aureus, Staphylococcus epidemis, Escherichia coli, Bacillus subtilis and Klebsiella 
pneumoniae bacterial cultures.  B. natalensis was not previously tested for 
antimicrobial activity.  The results of the present study imply that the beneficial effect 
of both Bulbine leaf gels on wound healing is not related to a potential antimicrobial 
activity.  Interestingly, Rabe and van Staden (1997) demonstrated that of 21 South 
African indigenous plant species used for the treatment of skin lesions, only 10, 8 and 
12 of these species were active against Staphylococcus aureus, Staphylococcus 
epidemis and Bacillus subtilis, respectively.  They further concluded that as this 
activity was evident in the methanol and not the water extracts of these plants, it was 
unlikely that this antimicrobial activity was present in the traditional use of these 
plants where the plants are used as crude extracts or prepared in water.  
 
The present study is the first in vitro comparative study of the effects of B.  frutescens 
and B. natalensis on both fibroblast and the keratinocyte cell lines.  Both cell types are 
integral to the process of wound healing (Öztürk et al., 2007).  In evaluating possible 
therapeutic agents, fibroblast cell cultures have been widely accepted as an in vitro 
system for testing wound healing activity.  However, fibroblasts and keratinocytes 
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have varied responses to exogenous agents.  The inclusion of a keratinocyte cell line 
in the present study was to elucidate differences, if any, in the effects of the extracts 
on these two predominant cells present in skin.   
 
 
Medicinal plants and their extracts are often falsely perceived to be safe.  Therefore 
when assessing the therapeutic effects of medicinal plants, it is important to evaluate 
their cytotoxicity.  In the present study, the cytotoxicity of the leaf gels was evaluated 
using a MTT assay.   In the keratinocyte cultures, at low concentrations both B. 
natalensis and B. frutescens did not differ from the untreated cultures with regard to 
cytotoxicity.  However, at higher concentrations, treatment with B. frutescens 
significantly depressed keratinocyte proliferation when compared to the untreated 
cultures resulting in a dose-dependent response especially at concentrations greater 
than 100μl/ml.   This inhibition of cellular proliferation was always less than 20% 
below that of the untreated cultures.  In the fibroblast cell line, treatment with either 
of the two gels, at any of the concentration tested, did not significantly alter the 
proliferation of the cultures from that of the untreated cultures.  Generally, an 
exogenous agent is considered cytotoxic at the concentration capable of inhibiting 
cellular growth by 50% (IC50) (Mosmann, 1983). As neither of the leaf gel extracts 
achieved an IC50 in either the keratinocyte or fibroblast cell lines, it can be concluded 
that the leaf gels of both plant species were not cytotoxic to either cell lines.   
 
In interpreting the results of the MTT assay, it is important to note that the assay 
cannot be used as an accurate indicator of cell proliferation or DNA synthesis which 
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both require more sensitive assays.  Rather, Hong et al. (2001) suggests that the 
combination of a WST-1 assay and a BrdU assay is useful in evaluating the specific 
effect of a factor or drug on either DNA synthesis and metabolic activity or both.  The 
WST-1 assay indicates the number of metabolically active cells while the BrdU assay 
measures DNA synthesis and therefore indicates cell proliferation.   The WST-1 assay 
has an increased sensitivity compared to the MTT assay due to its low background 
absorbance and lower molecular mass (Tan and Berridge, 2000).  Generally during 
wound healing, cell proliferation, cell number and DNA synthesis increase.  
 
The results of this study show that the extracts of both B. frutescens and B. natalensis 
significantly increased the number of metabolically active cells (as indicated by the 
results of the WST-1 assay), cell proliferation and DNA synthesis (as indicated by the 
BrdU assay results) of both keratinocytes and dermal fibroblasts in vitro.  B. 
natalensis had the greatest effect on the number of metabolically active cells in 
keratinocyte and fibroblast cultures at a concentration of 300μl/ml and 400μl/ml, 
respectively while its effect on DNA synthesis was greatest at 400μl/ml for both cell 
cultures.  B. frutescens had its greatest effect on the metabolically active cell number 
at concentrations between 50-100μl/ml and 300μl/ml in the fibroblast cultures and 
at 300-500μl/ml in the keratinocyte cultures, while its effect on DNA synthesis and 
cell proliferation was greatest at 400μl/ml for fibroblast cultures and 700μl/ml for 
the keratinocyte cultures.  The maximal proliferative effect of B. frutescens was 
significantly greater than that of B. natalensis on the keratinocyte cultures.  The 
analysis of the cell culture experiments demonstrated that both the Bulbine  leaf gel 
extracts are able to increase fibroblast and keratinocyte cell proliferation in vitro.  
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This in vitro increase in cell proliferation was subsequently confirmed by the in vivo 
experiments that demonstrated increased granulation tissue and thus, ECM 
formation, and earlier re-epithelialisation in both treatment groups compared to that 
of the untreated wounds.   
  
In general, the maximal effect of B. natalensis on both types of cell cultures was 
achieved at the same concentration.  However, the maximal effect of B. frutescens was 
at a higher concentration in the keratinocyte cell cultures than the fibroblast cell 
cultures.  This may suggest a greater sensitivity of the keratinocyte cell cultures to B. 
frutescens.  Thang et al. (2001) also showed a varied response between fibroblasts 
and keratinocyte cell cultures treated with Chromolaena odorata (the leaves of this 
shrub are used for skin ailments in Vietnam) and suggested that human epidermal 
keratinocytes display ‘a more complicated’ response to plant extracts than do human 
fibroblast cultures.  In the Thang et al. (2001) study, fibroblasts were more 
dependent on the dose of the gel, while keratinocytes were more sensitive to 
oxidative damage. In their study, Thang et al. (2001) also demonstrated an increase 
in fibroblast and keratinocyte cell proliferation, and keratinocyte migration in 
cultures treated with Chromolaena odorata.   
 
Abdullah et al. (2003) demonstrated an increased proliferative effect on human 
diabetic fibroblasts treated with 1.25% and 2.5% of Aloe vera extract compared to no 
effect on non-diabetic fibroblasts.  The latter study did not provide a rationale for the 
concentration of the Aloe vera extract used in the experiments, which was much 
lower than the effective concentration of both B. natalensis and B. frutescens extracts 
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on fibroblast cultures (40%) and keratinocyte cultures (40% and 70% respectively).  
Due to these and other unpublished results, Abdullah et al. (2003) concluded that the 
role of Aloe vera in promoting wound healing is to decrease the glucose concentration 
at the site of the injury.   As B. natalensis and B. frutescens belong to the same family 
as Aloe vera, it is interesting to note their positive effect on non-diabetic fibroblasts.  
This suggests that the mechanism of action of B. natalensis and B. frutescens may 
differ from that Aloe vera.  As the treatment of wounds in diabetic patients is 
particularly problematic, future studies should compare the activity of B. natalensis 
and B. frutescens on diabetic fibroblasts to evaluate their potential effect, if any, on 
diabetic wounds.   
 
Treatment with B.  natalensis and B.  frutescens increased migration across a ‘score’ in 
both keratinocyte and fibroblast cultures.  In addition, the scores in B. natalensis-
treated cultures closed sooner than B. frutescens-treated cultures.   Choi et al. (2001) 
demonstrated a similar earlier closure of scores in human keratinocyte cell cultures 
treated with an Aloe vera glycoprotein fraction.  The latter study found a larger 
population of migrating cells in cultures treated with the Aloe vera fraction after 40 
hours than in the untreated cultures, which did not fully populate the scored area. 
The results of the ‘score’ assay of the present study correlates well with the results of 
the histological study which showed increased wound contraction in both treatment 
groups compared to that of the untreated wounds. This suggests increased cell 
migration leading to faster re-epithelialisation and granulation tissue formation. 
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In this study, wound contraction was measured as the percentage change in the area 
of the excisional wound. Treatment of the wounds with both leaf gels appeared to 
initiate wound contraction on days 2 and 4 which is earlier than in the untreated 
wounds.   From the histological analysis, wounds treated with either of the leaf gels 
were found to re-epithelialise significantly faster than the untreated wounds.  Once 
again, these results are comparable to the effect of Aloe vera on diabetic wounds in 
the male Wistar rat (Chithra et al., 1998a), where wounds treated with topical Aloe 
vera contracted 10% faster than the untreated wounds.   Similarly, Rasik et al. (1999) 
demonstrated increased wound contraction in guinea pig skin treated with 1% 
Calotropis procera (a well known plant of the family Asclepiadaceae, used in 
Ayurvedic medicine).   
 
Wound contraction is fibroblast-dependant and involves the deposition and 
maturation of collagen.  The role of collagen in wound healing commences 
immediately the wound is formed and continues for months after it appears to have 
healed.  Collagen is the predominant extracellular protein in the granulation tissue of 
wounds (Chithra et al., 1998b).  Immediately following injury, there is an increase in 
the synthesis of collagen in the wound area.  Collagen plays a role in haemostasis and 
in providing strength and integrity to the wound matrix.  It is also essential for re-
epithelialisation and cell-cell and cell-matrix interactions (Raghow, 1994; Chithra et 
al., 1998a).   
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Hydroxyproline is the major constituent of collagen and is also found almost 
exclusively in collagen.  The estimation of hydroxyproline is an accepted method of 
biochemically evaluating the total collagen content of a sample (Lin et al., 2003) and 
is also used as a marker of collagen synthesis (Rasik et al., 1999).  A biochemical 
analysis of the excisional wound tissue of both B. natalensis- and B. frutescens-treated 
wounds demonstrated a significant increase in the total collagen content compared to 
that of the untreated wounds.  In all three groups, the total collagen content reached a 
maximum on day 7.  The histological analysis of the untreated wound sections 
demonstrated collagen deposition on day 7 with an increase on day 10 and then to 
day 16 with some reorganisation on day 16.  In both treated groups, collagen 
deposition was evident earlier than day 7 (on day 4).  The collagen appeared more 
densely packed on day 7 in the B. frutescens-treated wounds when compared to the 
other two groups on the same day.  Re-organisation of the collagen (indicating 
collagen maturation) was evident as early as day 10 in the sections of both treatment 
groups.  Chithra et al. (1998a) reported a similar pattern in their biochemical 
estimation of collagen content (with maximal collagen content on day 8) in the 
wounds of both the diabetic rats treated with Aloe vera and their corresponding 
untreated control wounds.  An increase in the collagen content of the ECM is a 
characteristic change observed in the proliferative phase of wound healing (Lin et al., 
2003).   This suggests that in the wound tissue of the pig, the proliferative stage 
reaches a peak on day 7.   
 
According to Chithra et al. (1998a; 1998b) and Lin et al. (2003) an increase in 
collagen may be attributed to an increase in collagen synthesis or an increase in the 
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proliferation of fibroblasts which synthesise collagen, or both.   When considering the 
increase in the hydoxyproline (collagen) content of the B. natalensis- and B. 
frutescens-treated wounds, together with the increased numbers of fibroblasts seen 
in the in vitro studies, both leaf gels appear to increase collagen content by increasing 
proliferation of fibroblasts.  Chithra et al. (1998a) showed that wounds in rats given 
either topical or oral Aloe vera displayed increased collagen content with a greater 
increase present in the group receiving orally administered Aloe vera.  This increased 
collagen content was attributed to both fibroplasia and an increase in the synthesis of 
collagen per cell (indicated by the collagen/DNA ratio).  The study by Chithra et al. 
(1998a; 1998b) demonstrated that the active ingredients of Aloe vera were not 
destroyed in the stomach following oral administration.  This corroborates the earlier 
study of Davis (1987) that demonstrated a greater reduction in wound diameter in 
mice receiving 100 mg/kg/day oral Aloe vera compared to those receiving topical 
25% Aloe vera. As the present study also demonstrated a similar increase in 
fibroblast proliferation and in collagen synthesis in wounds treated topically with the 
leaf gel extracts of B.  natalensis and B.  frutescens, it would be interesting to compare 
the effect of the Bulbine leaf extracts on wound healing using different methods of 
administration.   
 
Glycoaminoglycans (GAG) and proteoglycans are synthesised by fibroblasts in the 
wound area.  These substances form a hydrated gel-like ground substance (the 
provisional matrix) on which collagen is deposited.  As the collagen content increases, 
hexosamine levels decrease (Dunphy and Udupa, 1955; Chithra et al., 1998b).  
Estimation of hexosamine therefore, estimates the amount of ground substance in a 
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wound (Chithra et al., 1998b).  From the biochemical estimation of hexosamine in the 
present study, it was found that treatment with B. natalensis and B. frutescens 
resulted in a maximal concentration of hexosamine on day 4 followed by a steady 
decrease to day 16.  This was associated with a concomitant increase in total collagen 
content  in both treated groups at day 7.  This indicates replacement of granulation 
tissue in the wound area by collagen.  This is corroborated by the increased collagen 
deposition seen in the histological sections of the treated wounds.  As collagen 
deposition increases, it begins to occupy a greater area at the wound site. 
 
In the present study, collagen deposition was evident in the granulation tissue of both 
groups of treated wounds from day 4.  The collagen deposition appeared to be 
greater in the B. frutescens-treated group than the B. natalensis-treated group only on 
day 4 (as seen with Mallory trichrome staining).  Thereafter, the amount of collagen 
in both treatment groups was similar.   In the untreated wounds, collagen deposition 
was only evident from day 7.  Reorganising of the collagen into bundles, indicating 
some maturation, was evident as early as day 10 post-wounding.  At this stage, the 
arrangement of collagen in the untreated wounds appeared to lie in parallel rows.  
The collagen in the B. frutescens-treated group appeared more dense than that of the 
B. natalensis-treated group.  In the B. natalensis-treated group however, more densely 
packed bundles of collagen was present, indicating a more advanced stage of collagen 
maturation.  In both treatment groups, the early increase in the collagen content of 
the treated groups (from the biochemical estimation of hydroxyproline) could be 
associated with an increase in the density of fibroblasts in the granulation tissue.  
Therefore, the increased collagen may be the result of fibroplasia.  
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Collagen imparts tensile strength and elasticity to healed skin.  The tensile strength of 
the incisional wounds on day 16 post wounding, was significantly greater in both 
treated groups of wounds than in the untreated wounds.  According to Singer and 
Clark (1999), wounds gain 20% of their final strength in the first three weeks post-
wounding.  Thereafter the rate at which the wounds gain tensile strength is reduced.  
Scar tissue will only ever reach 70% of the strength of normal unwounded tissue over 
a period of two years (Singer and Clark, 1999).  The tensile strength of a wound can 
be related to its collagen formation and maturation.  As the wound heals, collagen 
molecules are synthesised and laid down at the wound site.  These molecules become 
cross linked to form fibres.  The strength of the repaired wound tissue is a result of 
the remodelling of collagen and the formation of stable intra- and inter-molecular 
cross linking.  
 
The significant increase in tensile strength of the treated incisional wounds in the 
present study was corroborated by the biochemical results of the excisional wound 
tissue which confirmed the presence of a significantly greater total collagen content 
in both treated groups compared to that of the untreated wounds. This was further 
confirmed by the greater density and organisation of the collagen in the histological 
sections of the treated wounds compared to the untreated wounds.  Since the 
incisional wounds treated with B. natalensis and B. frutescens displayed greater 
tensile strength than the untreated wounds, it may imply that the leaf gel extracts are 
able to increase collagen synthesis and possibly even aid in formation of cross 
linkages as the collagen matures.  Shukla et al. (1999) demonstrated a 53% increase 
in tensile strength of wounds treated with 0.2% asiaticoside (isolated from Centella 
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asiatica, a plant widely used in eastern traditional medicine for its wound healing 
properties) compared to untreated wounds in a guinea pig wound healing 
experiment. Chithra et al. (1998b) confirmed the earlier results of Davis et al. (1987) 
who showed that treatment of wounds with Aloe vera increased collagen 
concentration and tensile strength when compared with the untreated wounds.  
Chithra et al. (1998b) attributed this to an increase in the aldehyde groups of collagen 
fibres responsible for forming cross-linkages and therefore resulting in greater 
tensile strength of the Aloe vera treated wounds.   Subramanian et al. (2006) studied 
rabbit skin excisional wounds (harvested on days 7 and 14 post-wounding) treated 
with Aloe vera and concluded that Aloe vera increased wound contraction and 
collagen synthesis and significantly increased protein and DNA synthesis.  This was 
attributed to mannose-6-phosphate known to be present in Aloe vera leaf gel 
(Subramanian et al., 2006).  Mannose containing products have been shown to 
increase macrophage activity and therefore stimulate fibrobast activity (Tizard et al., 
1989; Davis et al., 1994). 
 
Migration of keratinocytes across the wound gap is an early step in wound healing.  
Re-epithelialisation is critical to optimal wound repair because it aids in contraction 
of the wound and restores the protective barrier (Tsirogianni et al., 2006).  In the 
present study, re-epithelialisation of the wound area occurred earlier in both 
treatment groups compared to the untreated wounds.  Between the treatment 
groups, the rate of re-epithelialisation (indicated histologically by keratinocyte 
migration to form the neo-epidemis) was greater in the B. frutescens-treated wounds 
than the B. natalensis-treated wounds.  This may suggest that in addition to 
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stimulating fibroblast proliferation, both leaf gels also stimulate keratinocyte 
proliferation and migration.  This confirms the results of the in vitro part of this study 
which demonstrated increased proliferation of the keratinocyte cells in culture when 
treated with either B. natalensis or B. frutescens leaf gel extracts (as demonstrated by 
the BrdU and WST-1 assays).  This is further corroborated by the increased migration 
seen in the ‘scores’ created in the B. natalensis- and B. frutescens-treated keratinocyte 
and fibroblast cultures compared to that of the untreated cultures.  Keratinocytes are 
increasingly being accepted as the key regulators of inflammation and remodelling in 
skin wound healing (Hakvoort et al., 2000).  Keratinocyte motility is facilitated by the 
expression of surface intergrin receptors that interact with components of the ECM 
(Tsirogianni et al., 2006).   The formation of the neo-epidermis dissects the wound, 
separating the granulation tissue from the eschar.  Macrophages and keratinocytes 
produce TGF-β1 (a major modulator of wound healing) which stimulates migration, 
heparin binding epidermal growth factor and TGF-α that in turn mediates the 
migration, differentiation and proliferation of keratinocytes (Frank et al., 1996; 
Tsirogianni et al., 2006).  The intense immunolocalisation of TGFβRI and TGFβRII in 
the epidermis of the treated wounds indicates increased TGF-β receptor binding 
activity.   An increase in TGF-β corroborates the increased keratinocyte migration 
and proliferation seen in the histological sections of wounds from both treatment 
groups.   
 
According to Braiman-Wiksman et al. (2007), the histological features of wound 
healing on days 1-3 post-wounding include blood clot formation, activation of the 
epidermal edges and early inflammation.  Granulation tissue begins to fill the wound 
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space 2-3 days following injury and consists of endothelial cells, fibroblasts, 
inflammatory macrophages, lymphocytes and new ECM (Tsirogianni et al., 2006).  In 
the histological examination of the wound tissue in the present study, the granulation 
tissue in the wounds of both treatment groups was more dense than the untreated 
wounds on days 2 and 4.  The granulation tissue of the B. natalensis-treated groups 
was more dense than that of the B. frutescens-treated group on day 2.  By day 7, the 
granulation tissue of all three groups was similar.  Following day 7, the granulation 
tissue of both treatment groups became sparser, as collagen deposition increased.  
Collagen deposition of the untreated wounds remained unchanged from day 10 to 
day 16.  According to Tsirogianni et al. (2006), fibroblasts reach their peak numbers 
at 7 to 14 days following wounding when they start to produce bFGF, TGFB, PDGF, 
KGF and IGF-1.  The early density of the granulation tissue in wounds of both 
treatment groups suggests that treatment with B. frutescens and B. natalensis 
increases proliferation of fibroblasts earlier than in the untreated wounds.  This 
confirms the biochemical estimation of the total protein and DNA content of the 
excisional wound tissue which also suggested greater cell proliferation in the treated 
wounds than the untreated wounds.   The protein and DNA content of the granulation 
tissue is said to indicate the levels of protein synthesis and cell proliferation (Rasik et 
al., 1999).    Bourguinon and Bourguinon (1987) state that the increase in protein 
content is due to an increase in collagen synthesis.  In the present study, the total 
protein and DNA content of both treatment groups were similar; reaching a 
maximum on day 7 followed by a decline to day 16 and was significantly greater than 
in the untreated wounds.  There was a significant increase in both the protein and 
DNA content of both the B. natalensis- and B. frutescens-treated wounds.  In the 
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untreated wounds there was a sharp decline in protein content on day 10 – this was 
not evident in both the treatment groups.   Chithra et al. (1998a; 1998b) suggests that 
when the protein and DNA content of treated wounds are greater than in the 
untreated wounds, it implies that the treatment stimulates cell proliferation.  Thus, 
the B. natalensis and B. frutescens leaf gels appear to stimulate cell proliferation.  
Shukla et al. (1999) demonstrated a significant increase in DNA content but no 
increase in protein content in guinea pig skin wounds treated with a 0.2% 
asiaticoside isolated from Centella asiatica.  They attributed this discrepancy to the 
specificity of the assays used for the estimation of the different amino acids. 
 
Collagen: DNA ratios are said to indicate the collagen produced per cell.  In the 
present study, the collagen:DNA ratios showed no significant difference between the 
untreated wounds and the two treatment groups. There may be several reasons for 
the similarity of the collagen:DNA ratios in these three groups e.g. a rapid cell 
proliferation initiated by the inflammatory response or an initial exponential increase 
in cell numbers, followed by a stationary phase.  In vivo studies on wound healing are 
generally carried out over a period of 7 days post-wounding.  It is possible that the 
profile of the collagen:DNA ratio may change as the experimental time of the study is 
extended due to collagen deposition and maturation.  The extended experimental 
time in the present study using the pig model was essential to sample the different 
phases in wound healing.  It is possible that increasing the experimental time even 
further may demonstrate collagen remodelling more clearly.  In wound experiments 
on the red Duroc pig, Zhu et al. (2005) demonstrated that skin is restored to its 
normal structure in 6-8 weeks.  New collagen formation continues for up to 6 weeks 
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post- wounding. Thereafter the fibroblasts stop producing collagen and undergo 
apoptosis.  Remodelling of the collagen fibres by degradation and re-synthesis allows 
the wound to gain strength.  Remodelling continues for up to 2 years and the 
resulting scar is less cellular than normal skin and never achieves the same tensile 
strength as uninjured skin.  A longer experimental period would provide insight into 
the long term effects of the plant leaf gel on tensile strength and collagen maturation.   
Experimental time however inevitably needs to be guided by the aim of the study and 
the cost of the experiment. 
 
Studies have shown that, in early wounds, fibroblasts express morphological and 
functional characteristics of smooth muscle during wound healing which are 
essential to wound contraction (Desmoulière, 1995; Moulin, 1998).  It is during the 
second week of wound healing that these fibroblasts differentiate into myofibroblasts 
(Tsirogianni et al., 2006).  Myofibroblasts contain cytoplasmic inclusions which are 
microfilaments or stress fibres thought to be involved in wound contraction.  αSMA is 
the most common cell marker used to identify myofibroblasts populations based on 
their content of smooth muscle actin (Desmoulière, 1995; Moulin, 1998), which is  
located in the microfilaments.  The localisation of αSMA was thus used in the present 
study to identify myofibroblasts in the wound tissue.  Following wound contraction 
and collagen formation, both fibroblasts and myofibroblasts at the wound site 
undergo apoptosis.   
 
In the present study, in addition to the localisation of αSMA in the myofibroblasts, 
αSMA was also localised in the keratinocytes of the epidermis, root sheaths of the 
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hair follicles and the epithelium of the sebaceous glands.  The mechanism of 
keratinocyte migration is not fully understood.  Keratinocyte migration begins early 
in wound healing.  Cells at the wound edge and from the remaining skin appendages 
undergo keratinocyte activation and adapt their phenotype to facilitate migration 
across the wound (Li et al., 2007).    These adaptations include the disassembly of 
desmosomes, the development of lamellipodia, retraction of intracellular 
tonofilaments and the formation of peripheral cytoplasmic actin filaments which 
allow movement (Goliger and Paul, 1995; Kwon et al., 2007; Li et al., 2007).  When 
migration ceases due to contact inhibition, the keratinocytes reattach themselves by 
reconstituting the basement membrane and then begin the process of terminal 
differentiation to form a stratified epithelium (Li et al., 2007).  While the localisation 
of smooth muscle actin in the keratinocytes was at first surprising, Li et al. (2007) 
most recently demonstrated keratinocytes producing actin filaments at the edge of 
their cytoplasm to prepare for migration.    
 
In the underlying granulation tissue, αSMA was also localised in the walls of the blood 
vessels and in scattered myofibroblasts at the edges of the granulation area.   B. 
frutescens-treated wounds demonstrated an earlier expression of αSMA in 
myofibroblasts than the B. natalensis treated group at day 2 post-wounding.  The 
localisation of αSMA in myofibroblasts at the edge of the wound site was similar in 
both treatment groups from day 7 post-wounding, being more intense than that of 
the untreated wounds.  At day 10 post-wounding, fewer myofibroblasts appeared to 
be present in the wounds of both treated groups than on previous days and when 
compared to the untreated wounds.  This decrease in myofibroblasts was correlated 
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with wound contraction nearing completion.  Kwon et al. (2007) demonstrated a 
greater number of myofibroblasts in rat skin wounds treated with fibronectin 
compared to untreated wounds on days 5 and 7 post-wounding.  Fibronectin 
expressed primarily by fibroblasts at the wound site interacts with components of 
the ECM and is involved in fibroblast and keratinocyte migration.  From their study, 
Kwon et al. (2007) concluded that exogenous fibronectin increased macrophage, 
myofibroblasts and fibroblast migration.  The increased fibroblasts at the wound site 
increased the deposition of ECM and collagen at the wound site.  Similarly in the 
present study, the increased expression of αSMA in the granulation tissue of the 
wounds of both treatment groups at day 7 post-wounding appears to indicate 
increased myofibroblast differentiation at the wound site.  A greater number of 
myofibroblasts at the wound site would result in increased ECM and collagen 
production which correlates well with the increased hydroxyproline and total protein 
content estimated biochemically and with the histological sections of the wound site 
of both treatment groups at day 7 post-wounding compared to the untreated wounds.    
 
 
In wound healing, during granulation tissue formation, myofibroblasts develop and 
then disappear when contraction is complete (Desmoulière, 1995).  In the present 
study, the less intense expression of αSMA on days 10 and 16 post-wounding was 
concurrent with complete re-epithelialisation and wound contraction. Thus, it 
appears that the leaf gels of both plants increase wound contraction by increasing 
myofibroblast differentiation.  This supports the earlier wound contraction seen in 
both treatment groups compared with the untreated wounds. The mechanisms of 
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regulating myofibroblast formation and function are unclear.  Myofibroblasts appear 
to undergo apoptosis in the wound area (Desmoulière, 1995) after contraction.  In 
the present study, as contraction approached completion, there was a concomitant 
decrease in the presence of myofibroblasts at the wound site.   It has been shown that 
in the fetus, wound healing occurs without scar formation and that scar formation 
coincides with the development of αSMA by myofibroblasts (Desmoulière, 1995).   
Moulin (1998) demonstrated that myofibroblasts synthesize significantly higher 
amounts of collagen than fibroblasts in vitro.  In the present study, the increased 
levels of total protein and hydroxyproline content of the treated wound tissue 
compared to the untreated wound tissue coincided with the increased number of 
myofibroblasts immunolocalised in the treated wound tissue.   The increased 
collagen content of the treated wounds may thus be related to the increase in the 
myofibroblast populations of the granulation tissue.  Furthermore, TGF-β1 is the 
most recognized stimulator of myofibroblast differentiation.  The increased 
expression of αSMA in the treated wounds maybe the result of increased TGF-β 
activity (as seen in the localization of TGFβRI and TGFβRII in the present study).   
TGFβRI and TGFβRII have similar ligand binding affinities.  Both receptors have a high 
affinity for TGF-β1 and a low affinity for TGF-β2.  TGFβRIII has a high affinity for both 
TGF-β1 and TGF-β2 (Cheifetz et al., 1988).  TGF-β1 is released during the 
inflammatory stage.  In addition to embryogenesis and cell differentiation, the TGF-βs 
are also involved in apoptosis (Munir et al., 2004).  TGF-β1 promotes epithelial 
migration, fibroblast and keratinocyte proliferation and re-epithelialisation of skin 
wounds (Desmouliere, 1993; O’Kane and Ferguson, 1997; Lin et al., 2003; Kwon et al., 
2007).  One of the reasons postulated for the scarless wound healing seen in fetal skin 
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is the low levels of TGF-β1, which is considered to be a scar promoting cytokine 
(Singer and Clark, 1999).  Scarring is reduced in adults who are given antibodies to 
neutralise TGF-β1 and TGF-β2, or TGF-β3 which down regulate TGF-β1 and TGF-β2 
(Sullivan et al., 1995).  
 
 
In the present study, TGFβRI and TGFβRII were localised in the wound tissue of all 
three groups from day 2 to day 16.  This localisation was in all the layers of the 
epidermis except the stratum basale.  This expression was initially (on days 2-4) 
stronger in the B. frutescens-treated and in the untreated wounds than in the B. 
natalensis-treated wounds.  On day 16, the expression was stronger in the B. 
natalensis-treated wounds than in the B. frutescens-treated and the untreated 
wounds.  According to Lin et al. (2003), a decrease in TGF- β1 is responsible for 
reduced collagen accumulation.  TGF- β is thought to exercise an inhibitory effect on 
keratinocyte proliferation (Yang et al., 1996; Werner and Smola, 2001).  When found 
in high concentrations at the wound site, TGF-β, especially TGF-β1, stimulates 
fibroblast proliferation and plays a role in hypertrophic scarring.  Several researchers 
suggest that TGF-β has a paradoxical effect on re-epithelialisation and granulation 
tissue formation.  It is said to be a negative regulator of re-epithelialisation but also 
induces the expression of integrins needed for keratinocyte migration (Gailet et al., 
1994; Zambruno et al., 1994; Werner and Grose, 2002).  Werner and Grose (2002) 
showed that exogenous TGF-β increases both the rate of wound healing and the 
strength of the healed wound. Broadley et al. (1990) demonstrated that elevated 
levels of TGF-β1 lead to the stimulation of monocytes and further increases in cellular 
proliferation.  Kwon et al. (2007) stated that the increased cellular proliferation at the 
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wound site would lead to a further increase of TGF-β1.  In the present study, the 
localization of TGFβRI and TGFβRII was stongest in early wound healing and was 
progressively weaker after day 7.  This could be related to the initial increase in cell 
proliferation followed by collagen production at the wound site which was confirmed 
from the histological analysis of the wound sections. 
 
VEGF is critical for angiogenesis during the formation of granulation tissue from day 
4 to day 7 post-wounding (Nissen et al., 1998).  In addition, VEGF mediates vascular 
hyper-permeability and promotes the secretion of active growth factors and 
cytokines necessary for wound repair (Corral et al., 1999).  VEGF is expressed in 
macrophages and in keratinocytes migrating to cover a wound defect (Brown et al., 
1992), with the keratinocytes in the basal and suprabasal layers expressing VEGF 
equally (Brown et al., 1992) even when wound re-epithelialisation is complete.  
Senger and Van de Water (2000) stated that epidermal keratinocytes are the 
principal source of VEGF during wound healing.  They further commented that during 
wound healing, the ‘avascular epidermis regulates plasma protein extravasation and 
angiogenesis in the underlying dermis through a paracrine mechanism involving 
keratinocyte expression of VEGF’.  The present study also confirms previous reports 
that VEGF expression in wound healing is greater in the epidermis than in the 
underlying dermis (Brown et al., 1992; Kishimoto et al., 2000;  Senger and Van de 
Water, 2000).  In the present study, VEGF expression was evident in the epidermis 
and scattered in the granulation tissue of the wound tissue of all three groups from 
day 2 to day 16.  This expression, however, was stronger in the B. frutescens-treated 
wounds than in the B. natalensis-treated group.  This is in keeping with the results of 
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the histological study which showed greater vascularity of the B. frutescens-treated 
wounds than the untreated wounds, and to a lesser extent, the B. natalensis-treated 
wounds.  In general, the expression of VEGF was stronger in the more superficial 
layers of the epidermis than in the stratum basale.   A similar non-staining stratum 
basale in normal human skin was previously reported by several researchers (Viac et 
al., 1997; Harada et al., 2001).  Viac et al. (1997) investigated the relationship 
between VEGF expression and keratinocyte proliferation and differentiation.  They 
suggested that the expression of VEGF by suprabasal keratinocytes correlates VEGF 
production with keratinocyte differentiation.  Their explanation for this was that the 
extracellular calcium concentration increases with keratinocyte differentiation and 
calcium modulates VEGF production and secretion by keratinocytes.    
 
An increase in vascularity of the granulation tissue was noted in the histological 
analysis of the present study, in both groups of treated wounds compared to the 
untreated wounds.  Although not quantified, more vessels were noted in the B. 
frutescens-treated wounds than in the B. natalensis-treated wounds on day 4.  On day 
10 post-wounding, the vascularity of all three groups appeared to be similar, while on 
day 16 both treatment groups displayed a more dense collagen network with 
interspersed capillaries in the wound area.  Localisation with αSMA confirmed larger 
vessel formation in the wound area of both treated groups.  The formation of new 
blood capillaries is essential to provide nutrients and oxygen to the granulation tissue 
(Tsirogianni et al., 2006).  During this process, endothelial cells proliferate and 
migrate through the ECM to form capillary buds.  The main stimuli for endothelial 
proliferation are the increase in aFGF (now known as FGF-1) by macrophages and 
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damaged endothelial cells and the production of VEGF by keratinocytes and 
macrophages.   
 
Humans have always been faced with the dilemma of how to treat wounds (MacKay 
and Miller, 2003).  Many diverse and interesting approaches have been applied 
throughout medical history.  Although scientific proof was lacking, some wound care 
therapies applied by ‘adventurous’ physicians are still considered valuable today e.g. 
honey and sugar paste were used for scarless healing and Symphytum officinalis 
(comfrey) was initially applied externally to the skin to heal fractures (MacKay and 
Miller, 2003).  As recent as 2000, Aljady et al. (2000) demonstrated a significant 
increase in DNA and collagen content in male rats treated with honey.  They also 
showed an increase in wound contraction on days 4, 8 and 12 post-wounding and 
concluded that treatment with honey increased cell proliferation in early granulation 
tissues. 
 
Similarly, Centella asiatica and Aloe vera have been used for decades as folk remedies 
for burns, wounds and scars (Subramanian et al., 2006).  Centella asiatica has been 
documented to aid wound healing primarily by stimulating collagen type 1, 
production thus significantly increasing the breaking strength of treated wounds 
(MacKay and Miller, 2003).  Topical administration of Aloe vera to wounds of both 
diabetic and non-diabetic rats has demonstrated improved healing (Davis et al., 
1988).  It is postulated that the benefit in wound healing is due to an increased 
collagen content of the granulation tissue as well as the degree of cross linkage of the 
collagen fibres.  This increase in collagen content may be due to an increase in 
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collagen synthesis or in fibroblast proliferation or both (MacKay and Miller, 2003).  In 
spite of their wide use, the biochemical basis for action or influence in wound healing 
of Centella asiatica and Aloe vera is just beginning to be understood (MacKay and 
Miller, 2003).  The mechanism by which B. natalensis and B. frutescens promote 
wound healing appears to be similar to that of Aloe vera and Centella asiatica in that 
they increases fibroblast and keratinocyte proliferation and collagen deposition.  It 
would be interesting to investigate if this effect differs with variable modes of 
administration (eg. topical vs oral administration).  Moreover, as with Aloe vera and 
Centella asiatica, extensive well-defined, blinded clinical trials to assess the safety, 
efficacy and potential active ingredients of these two plants in wound healing needs 
to be carried out before these can be administered in mainstream medicine.  It is, 
however, difficult to assess the administration of these indigenous plants clinically, as 
it is difficult to get patients to comply in a study of this kind.  The human study which 
was initially planned as part of the present study had to be discontinued due to 
difficulties in obtaining suitable patients and also due to poor patient compliance.  It 
was surprising that many of the people of African descent (the population group that 
uses these plants as a traditional medicine) refused to participate in the present 
study and preferred to use established ‘western’ medication.   Six patients consented 
to participate in the present study but none of them returned to the clinics for 
evaluation after using the leaf extracts. 
 
The present study demonstrated that the fresh leaf gels of B. frutescens and B. 
natalensis have a beneficial effect on several phases of wound healing such as 
keratinocyte and fibroblast proliferation, collagen synthesis, angiogenesis and wound 
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contraction resulting in faster healing than in the untreated wounds.   The 
mechanism by which these leaf gels bring about these effects is however unclear.  
Future studies screening the water soluble fractions of the leaf gels using 
chromatography, ultraviolet and infrared spectrophotometery may elucidate the 
chemical components of the leaf gels active in wound healing.  Aloe vera has also been 
shown to heal wounds faster when used as a crude gel.  Chithra et al. (1998a; 1998b) 
claims that this is due to the polysaccharides found in the gel.  It may be important to 
evaluate the component of the leaf gel that is effective in wound healing so that 
treatment and therapeutic agents are developed more effectively.  Van Wyk et al. 
(2000) speculate that since Bulbine  belongs to the same family as Aloe vera, that its  
healing effect is more likely to be due to glycoproteins (such as  Aloctin A and Aloctin 
B) which have been found in the leaf gel of Aloe vera, a plant internationally 
recognised for its healing properties. These glycoproteins have not yet been 
identified in Bulbine.  Additionally, since the first reported treated data on Aloe vera 
in the 1930s, there is still much doubt as to its active ingredient(s) and their 
biological effects (Reynolds and Dweck, 1999). This is further complicated by the 
contradictory results reported from research on Aloe vera (Reynolds and Dweck, 
1999).  Davis et al. (1987) demonstrated anti-inflammatory properties following 
topical application of the Aloe gel on skin punch biopsies. Later, in 1989, the same 
researchers demonstrated improved healing following systemic administration of the 
Aloe vera.  In contrast, Schmidt and Greenspoon (1991) reported delayed healing in 
dermal wounds treated with Aloe vera gel. Reynolds and Dweck (1999) in a review of 
research on Aloe vera indicated that amidst all this controversy, a clearer picture of 
its biological activity is slowly beginning to emerge.  They ascribe the delay in 
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isolating the active ingredients and the conflicting published results to the 
conundrum of wound healing in that it involves a number of interacting factors.   
 
Although the stem and root of Bulbine are known to contain anthraquinones such as 
chrysophanol (which has anti-bacterial properties) and knipholone (Dagne and 
Yenesew, 1994), these are thought to be of minor importance in wound healing.    
Widgerow and Chait (2000) describe the use of a microporous tape treated with both 
B.  frutescens and Centella asiatica.  They claim that the B.  frutescens increases 
hydration by ‘leaving a layer of fatty vesicles of glycoprotein on the skin surface 
which also has anti-bacterial properties’.  This claim was previously purported by 
Briggs (1995). While this may be so in vivo, it does not account for the significant 
increase in cell numbers seen in vitro in the present study.  Both the in vitro and in 
vivo results of this study indicate that both leaf gels stimulate fibroblast and 
keratinocyte proliferation and collagen deposition.  Widgerow and Chait (2000) 
reported improved wound healing in 90% of patients using the microporous tape 
containing the combination of B.  frutescens and Centella asiatica.  They claim that the 
major component responsible for healing is the Centella asiatica and that B. frutescens 
is responsible for the hydration of the wound.  A similar reason for the efficacy of Aloe 
vera in wound healing is proposed by Meadows (1980), Fox (1990), Marshall (1990) 
and Briggs (1995).  Sudworth (1997) however showed that Aloe vera was as effective 
in treating oral wounds that were always moist.  This study proposes that the leaf gel 
of both B. natalensis and B. frutescens plants contain active ingredients (yet to be 
isolated) that impacts keratinocyte and fibroblast proliferation and collagen 
deposition which could be the major contributor to increased ECM deposition and 
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wound healing.  In addition, both leaf gels increase wound contraction by increasing 
the differentiation of myofibroblasts. 
 
Ethnopharmacology investigates the ‘pharmacological basis of culturally important 
plants’ (Gertsch, 2009).  Reports of plants that are beneficial to wound healing 
abound in the literature.  These reports however are inconsistent and often draw 
conclusions from in vitro studies alone that use inconsistent bioassays.   In evaluating 
wound healing using exogenous agents (such as plant extracts) in both in vitro and in 
vivo models, there is a need to standardise the experiments in order to make 
comparisons between the different therapeutic agents more meaningful.  
Maenthaisong et al. (2007) in a systematic review of 1069 scientific articles of the 
efficacy of Aloe vera for the healing of burns found  a lack of consistency in the 
amount of the active ingredient used, the age of the plants, the harvesting times and 
the extraction methods.  They also concluded that the outcome of interest (complete 
epithelialisation) was very subjective and suggested that studies evaluating 
histological changes in wound healing needed multiple assessors and standard 
controls to be accepted.  The need to standardise the protocol used to evaluate the 
potential pharmacological application of natural products has previously been 
acknowledged by the Editorial Board of the Journal of Ethnopharmacology 
(Verpoorte, 2006) and has most recently been highlighted by Gertsch (2009) who 
also stated that ‘few claims from in vitro observations stand the test in vivo’.  In the 
present study, the in vitro ‘wound healing’ effect of the Bulbine leaf gels were  
subjected to in vivo confirmation using the pig animal model as porcine skin has the 
closest histological structure to human skin.   
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Naturally derived compounds are purported to be the most relevant compounds for 
future drug discovery, yet the biological activity of much of the world’s biodiversity 
remains scientifically untested (Harvey, 2000; Harvey, 2008).  This is particularly 
true for much of the flora of South Africa.  Despite the anecdotal evidence of the use of 
B. frutescens as a traditional wound healing agent and more recently its appearance in 
a variety of ‘healing’ lotions and creams, the previous literature does not present 
scientific data supporting the wound healing capabilities of either B. frutescens or B. 
natalensis.    In rural communities in South Africa, skin lesions arising from bruises, 
cuts and scratches amongst others are sometimes untreated at the initial stages 
especially in children (Grierson and Afolayan, 1999).  In most cases such wounds 
become infected and septic.  Primary health care in these situations is often sought 
from traditional healers and herbalists.  The validation of herbal remedies is 
therefore essential and in addition to preserving the indigenous heritage, has an 
enormous beneficial value to these communities.  This study is the first to 
scientifically evaluate the effects of B. frutescens and B. natalensis in wound healing 
using both in vitro and in vivo experiments.   
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5. CONCLUSION 
Wound healing is a complex process involving the interaction of many cytokines and 
growth factors.  The present study has demonstrated the ability of B. natalensis and B. 
frutescens to facilitate the process of wound healing.  This is achieved by decreasing 
the time taken for complete re-epithelialisation and wound contraction.  The present 
study further demonstrated, by histological analysis of the Bulbine- treated and the 
untreated wound sections, to increase fibroblast and keratinocyte proliferation and 
migration, increase ECM and collagen deposition and to promote collagen 
remodelling.   Biochemical analysis of the wound tissue confirmed increased total 
collagen, protein and DNA in the treated wound tissue when compared to the 
corresponding untreated wound tissue.  The increase of these biochemical molecules 
have resulted in increased tensile strength of the treated wounds when compared to 
the untreated wounds.  Both B. natalensis and B. frutescens appear to act in a similar 
manner.  The active ingredients of these plants that effect wound healing are not 
known as yet.  This present study further highlighted the need for a ‘gold’ standard to 
assess wound healing activity of endogenous agents. 
 
The present study is the first comprehensive study of the in vitro and in vivo effects of 
B. natalensis and B. frutescens on wound healing.  The results of this study validate the 
traditional use of these plants to treat skin ailments and may have an impact primary 
on health care especially in rural communities. 
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APPENDICES 
REAGENTS AND BUFFERS FOR TISSUE CULTURE (2.2) 
A1. Phosphate buffered saline (PBS)                                                 pH 7.6  
Na2HPO4.2H2O     3.5 g 
NaCl   
KCl 
KH2PO4 
16 g 
0.4g 
0.4g 
 
Make up in 2L distilled water and pH to 7.6 
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2. REAGENTS AND BUFFERS FOR COLLAGEN ESTIMATION (2.3.2.3 a) 
 
B1.  Saline 0.9% solution  
1. Sodium chloride 0.9g 
2. dH20 100ml 
 
Dissolve in dH20 
B2.  Chloramine – T reagent – 0.056M  
1. Chloramine-T 0.32g 
2. dH20 5.2ml 
3. n-propanol 6.5ml 
4. Stock buffer (Appendix B2.1 above) 13.3ml 
Solution is unstable 
Make fresh each time it is needed 
B 2.1.  Acetate – citrate buffer pH 6.5 (stock buffer)  
1. Citric acid monohydrate 50g 
2. Glacial acetic acid 12ml 
3. Sodium acetate truhydrate 120g 
4. Sodium hydroxide 34g 
 
Dissolve in 1L dH2O 
pH solution to 6.5 and store at 4⁰C in a dark bottle  
Solution is stable for 2 months 
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B3.  p-dimethylamino-benzaldehyde (Ehrlich's reagent) – 1M  
1. Dimethylaminobenzaldehyde 3.73g 
2. n-propanol 15ml 
3. Perchloric acid 6.5ml 
Bring to a volume of 25ml with dH2O 
Make fresh each time it is needed 
Collagen assay buffer  
1 part stock buffer to 10 parts dH2O 
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REAGENTS AND BUFFERS FOR HEXOSAMINE ESTIMATION (2.3.2.3 b) 
 
C1.  Potassium tetraborate   0.8M                  pH 9.1  
1. Borate (Boric Acid H3BO3) 61.1g 
2. dH2O 250ml 
C2.  Chloramine – T reagent – 0.056M  
1. Chloramine-T 0.32g 
2. dH20 5.2ml 
3. n-propanol 6.5ml 
4. Stock buffer (Appendix B2.1 above) 13.3ml 
Solution is unstable 
Make fresh each time it is needed 
C2.  p-dimethylamino-benzaldehyde (Ehrlich's reagent) – 1M  
1. Dimethylaminobenzaldehyde 3.73g 
2. n-propanol 15ml 
3. Perchloric acid 6.5ml 
Bring to a volume of 25ml with dH2O 
Make fresh each time it is needed 
C3.  0.1% N-acetylglucosamine  
1. N-acetylglucosamine 0.1g 
2. dH20 100ml 
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REAGENTS AND BUFFERS FOR PROTEIN ESTIMATION (2.3.2.3c) 
D1.  Homogenising buffer 
 50mM Tris HCl (pH 7.5) 
5mM acetate   
0.2mM EDTA 
10% glycerol 
1% Triton X-100 
 
Add 500μl of 0.5M DTT and 50μl of protease inhibitor to 10ml homogenizing buffer just before protein 
extraction. 
D2.  Lowry protein assay  
1. Reagent A 2% sodium carbonate (Na2CO3) made up in 0.1M 
NaOH 
20ml 
    1% copper sulphate (CuSO4.5H2O) 200μl 
    2% sodium potassium tartrate (NaKC4H4O6.4H2O)  200μl 
2. Folin 
Reagent 
Folin reagent (diluted 1:4 in distilled H2O  
    
Add 50μl of sample  to an ELISA plate 
Add 200μl of reagent A – incubate at room temperature on a shaker for 10 minutes 
Then add 50μl of Reagent B – incubate at room temperature on a shaker for 30 
minutes. 
Read Absorbance at 690nm 
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REAGENTS AND BUFFERS FOR DNA ESTIMATION (2.3.2.3d) 
 
 E1.  Lysis buffer –  pH 8  
1. 50mM TRIS 0.606g  
2. 5mM EDTA 0.186g 
3. 0.5% Tween 20 (Merck)  
   
Autoclave before use 
E2.  Proteinase K                                                                                       pH 8 
1. Proteinase K (Roche Boehringer Mannheim) 100mg  
 Dissolve in 2ml MilliQ H20, aliquot into 50μl aliquots and store 
in the freezer. 
 
To use: 
Add 200μl MilliQ H20. 
 
 Sodium acetate           pH 5.2 
1. 3M sodium acetate (BD) 100mg  
E3.  Phenol chloroform  
 1 part Tris buffer saturated phenol (Sigma-Aldrich) to 1 part chloroform (Merck).  
Invert gently to mix and leave undisturbed to allow the phases to separate (± 2 
days) 
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REAGENTS AND BUFFERS FOR HISTOLOGY (2.3.2.4) 
 
F1.  Silane coated slides (Mutter, 1988)  
1. Soak slides in 10% Contrad or Super 10 overnight 
2. Rinse in hot running water – minimum – 2 hours 
3. Dry in oven at 60°C 
4. Dip in Acetone (optional) 
5. Dip in 2% Silane in Acetone for 30 minutes (6ml Silane + 294ml Acetone) 
6. Wash in two changes of acetone 1-2 dips 
7. Wash briefly in distilled water 
8. Dry in 42°C incubator overnight 
 
 
10% Neutral buffered formalin  
1. Formalin 100ml 
2. Sodium dihydrogen phosphate 3.4g 
3. di-sodium hydrogen phosphate 6.5g 
4. Distilled water 900ml 
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F2.  Haematoxylin and Eosin stain 
1. Haematoxylin Haematoxylin  4g 
  Distilled H2O 1000ml 
  Potassium alum  50g 
  Citric acid 1.5g 
  Chloral hydrate 75g 
2. Eosin 1% Eosin  500ml 
  1% phloxine 250ml 
  Distilled H2O 750ml 
   
 Dewax in two changes of Xylene 
 Pass through graded alcohols 
 Rinse in running water 
 Stain in haematoxylin for 5 minutes 
 Wash in tap water to ‘blue’ – check staining under a microscope 
 If necessary, differentiate by dipping slides for 2-3 minutes in 1% acid alcohol 
 Wash in running water for 5 minutes until nuclei are bright blue 
 Counter stain in eosin for 30 seconds to 1 minute 
 Wash briefly in running water 
 Slides are passed through alcohol series and then into Xylene 
 Mount with Entellan and coverslip 
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REAGENTS AND BUFFERS FOR IMMUNOHISTOCHEMISTRY (2.3.2.5) 
 
G1.  Silane coated slides (Mutter, 1988)  
1. Soak slides in 10% Contrad or Super 10 overnight 
2. Rinse in hot running water – minimum – 2 hours 
3. Dry in oven at 60°C 
4. Dip in Acetone (optional) 
5. Dip in 2% Silane in Acetone for 30 minutes (6ml Silane + 294ml Acetone) 
6. Wash in two changes of acetone 1-2 dips 
7. Wash briefly in distilled water 
8. Dry in 42°C incubator overnight 
 
G2. Phosphate buffered saline (PBS) 7.6 pH 
Na2HPO4.2H2O     3.5 g 
NaCl   
KCl 
KH2PO4 
16 g 
0.4g 
0.4g 
Distilled water 2l 
 
pH to 7.6 
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G3. BSA – PBS    7.6 Ph 
BSA     0.3 g 
PBS 10 ml 
 
 
G4. D.A.B. 
Weight 1mg (0.001g) D.A.B. into new Bijou bottle 
At start of second day of run put measuring cylinder containing 29ml distilled water 
into fridge at 4C 
Just before use add 2ml Tris HCl pH 7.6 to D.A.B. in bijou bottle 
Then add 1ml 30% Perhydrol to the now cold distilled water to make a 1% solution 
and mix well. 
Add 20ul of the 1% perhydrol to the D.A.B. solution, mix on whirlimix 
Filter before use 
Pipette onto section timing each individually for 5 minutes 
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G5. Citrate Buffer pH 6 
Solution A 
 
0.1 M Citric acid 
10.5 g Citric acid in 500ml distilled water 
 
Solution B 
 
 
 
0.1 M Sodium Citrate 
29.4g Sodium Citrate in 1000ml distilled 
water 
 
Mix 9ml of solution A and 41 ml of solution B  
Make  up to 500 ml at distilled water 
 
Microwave slides in this solution for 2 x 5 minutes at high power 
Allow slides to cool for 20 minutes at room temperature 
 
G6. Tris buffered saline 7.6 pH 
Tris base                                                    12.12 g 
NaCl   17.54 g 
 
Distilled water                                                 2L 
pH to 7.6 
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G7. Tris HCl (PBS) pH7.6 
Tris HCl     7.88 g 
Tris base  
Tween 20 
NaCl    
6.06 g 
0.5ml 
8.77g 
Distilled water 1L 
 
pH to 7.6 
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H1: HUMAN STUDY - SUBJECT INFORMATION SHEET 
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H2: HUMAN STUDY – CONSENT FORM 
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RESULTS APPENDICES 
COLLAGEN ESTIMATION 
 
COLLAGEN CONCENTRATION (mg/100ml) 
AVERAGE PER DAY 
B. natalensis Animal Group 
DAY Treated wounds Untreated wounds 
Treated wounds 
S.D. 
Untreated 
wounds S.D. 
2 20.3096 13.3390 2.07 2.56 
4 16.2664 15.5782 0.97 5.75 
7 21.3198 16.1520 4.86 0.65 
10 26.5396 8.4738 5.44 1.41 
16 16.8911 10.9096 2.32 2.04 
 
        
B. frutescens Animal Group 
DAY Treated wounds Untreated wounds 
Treated wounds 
S.D. 
Untreated 
wounds S.D. 
2 15.9727 12.9099 3.91 1.40 
4 15.2926 12.3013 0.96 2.01 
7 19.8647 13.9170 6.63 3.12 
10 16.3311 7.6565 0.49 3.82 
16 12.8121 9.0961 1.75 5.31 
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COLLAGEN RATIO : 
 TREATED/CONTROL WOUNDS  
Average per day 
DAY B. natalensis B. frutescens 
2 1.52 1.24 
4 1.04 1.24 
7 1.32 1.43 
10 3.13 2.13 
16 1.54 1.41 
MEAN 1.71 1.49 
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